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1. INTRODUCTION 
 
Bovine tuberculosis (bTB) is a chronic bacterial disease of cattle. Tuberculosis causes death 
in humans and animals world-wide. This disease still remains a major global health problem 
despite the control and prevention strategies and can cause severe economic losses. The 
etiologic causes of the disease are Mycobacterium (M.) bovis (KARLSON & LESSEL, 1970) 
and M. caprae (ARANAZ et al., 2003), which are members of Mycobacterium tuberculosis 
complex (MBTC). 
 
An increasing number of bTB in cattle herds has been detected in some countries in Europe. 
Germany also plays a role by showing interval outbreaks in the recent years. Alpine 
countryside, especially the grazing pastures located at the border of Bavaria and western 
Austria have been reported to have bTB outbreaks caused by M. caprae among wild animals 
and domestic cattle herds in these regions (PRODINGER et al., 2002; KUBICA et al., 2003). 
However, through the eradication programs, the infection could be kept under control. 
Regular intra-dermal testing and removal of the infected and reactor animals by culling are 
the standard control programs of bTB in Bavaria (LGL, 2014).  
 
In this study, some cattle flocks in Bavaria were screened through intra-dermal testing 
between 2009 and 2014. Subsequently, the positive reactors were culled in the regional 
rendering plant regarding the governmental regulations in Germany. Throughout the gross 
examination, tissue samples from 84 animals with macroscopic lesions of tuberculosis were 
collected for pathological and bacteriological investigations. The microbiological examination 
was performed by the ‘Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit’, 
Oberschleißheim and the results were positive for M. caprae.  
 
Pathological investigations were performed at the Institute of Veterinary Pathology at the 
Center of Veterinary Medicine of the Ludwig-Maximilians-University, Munich. Histological 
investigations were performed using paraffin, plastic and epoxy resin tissue embedded 
materials. In addition to the routine staining methods (H&E, Giemsa), the tissue samples were 
also examined using special stainings and immune-labelling methods. Acid-fast staining 
according to modified Fite-Faraco (FF staining), immunohistochemistry (IHC) and in situ 
hybridization (ISH) were used to demonstrate the mycobacteria, mycobacterial antigen and 
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mycobacterial DNA, respectively. Transmission electron microscopy (TEM) was performed 
to detect intra- or extracellular mycobacteria within the ultra-thin sections.  
 
It has been known for a long time that mycobacterium fights against the immune defence of 
the host. This bacillus can enable itself to evade from this immune response and pursue its 
own life in the host for a long time. However, little is known about the mechanism of 
tuberculosis. During the course of this work, it was aimed to determine the possible routes of 
infection; the pathomorphological alterations on the basis of both macroscopical and 
histological point of view; the developmental stages of the tuberculous inflammation and to 
demonstrate the mycobacteria within the affected organs.  
 
With this purpose, this doctoral thesis was supported by the Bavarian State Ministry of Food, 
Agriculture and Forestry, research project "Bovine Tuberculosis im Allgäu" under the 
research number (A / 13/37). The processing of the acid-fast staining and the distribution of 
the acid-fast bacilli within the affected organs were performed in collaboration with Ms. 
Rieseberg (RIESEBERG, 2016).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LITERATURE OVERVIEW 3 
2. LITERATURE OVERVIEW 
 
2.1. Scientific Classification of Mycobacteria 
 
Tubercle bacillus was first described by Robert Koch in 1882 as a causative agent of 
tuberculosis (KOCH, 1882). It was renamed as Mycobacterium tuberculosis and had its place 
under the new genus Mycobacterium, and was placed in the Mycobacteriaceae family 
(LEHMANN & NEUMANN, 1896). 
 
The classification method is formed according to the features which all members of a group 
have. The genus of Mycobacterium is separated into two groups as “rapidly growing” and 
“slowly growing”, depending on the time required of the visible colonies to appear on a solid 
medium. The appearance of colonies needs more than 7 days for slowly growing species and 
less than 7 days for rapidly growing species (WAYNE & KUBICA, 1986). Three minimal 
standards are defined for the genus of Mycobacterium. These are acid-alcohol fastness, having 
long-chain mycolic acids (containing between 60 and 90 atomic carbons), which are cleaved 
to C22 to C26 fatty acid methyl esters by pyrolysis, and the presence of a DNA guanine-plus 
cytosine (G+C) content (LEVY-FREBAULT & PORTAELS, 1992).  
 
The Mycobacterium genus is further separated into 4 groups based on their pigmentation, 
growth rate, drug resistance, type of colonies and catalase activity properties (RUNYON, 
1959); 
• Photochromogens (Runyon group I) 
• Scotochromogens (Runyon group II) 
• Nonphotochromogens (Runyon group III) 
• Rapid growers 
 
2.1.1. Mycobacterium tuberculosis Complex  
 
Mycobacterium tuberculosis complex (MBTC) is composed of slowly growing, 
nonphotochromogenic (Runyon group III) species (SHINNICK & GOOD, 1994). These 
members have close genetic relationship which has been demonstrated by several methods 
such as DNA-DNA hybridization, multilocus enzyme electrophoresis, sequencing of 16S 
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ribosomal rRNA gene and 16S-to-23S rDNA internal transcript spacer (KIRSCHNER et al., 
1993; FROTHINGHAM et al., 1994; FEIZABADI et al., 1996). The polymerase chain 
reaction (PCR) has also been used as a diagnostic tool for mycobacteria detection through 
determining the 16S rRNA gene or a number of repetitive sequence elements. For instance, 
the insertion sequence IS6110 is present only in species belonging to MBTC 
(BODDINGHAUS et al., 1990; THIERRY et al., 1990). The other specific genetic markers 
for the members of MBTC are determined as insertion sequences IS1081 and the MPB70 
genes (RADFORD et al., 1990; COLLINS & STEPHENS, 1991; COUSINS et al., 1991; 
LIEBANA et al., 1996). In spite of these common properties as mentioned above, they are 
separated from one another by having gene variations as follows; M. tuberculosis, M. 
africanum, M. bovis, M. bovis BCG, M. canetti, M. microti, M. caprae (BROSCH et al., 2002; 
MOSTOWY et al., 2002) and M. pinniedii (COUSINS et al., 2003). 
 
2.1.2. The Taxonomy and Nomenclature of M. caprae 
 
M. caprae was first isolated from goats and described as subspecies of M. tuberculosis. This 
new species has negative reaction for niacin accumulation and nitrate reduction and this 
differentiates it from M. tuberculosis. It shows no growth in the presence of thiophene-2-
carboxylic acid hydrazide and this differentiates it from M. africanum. Having pyrazinamide 
susceptibility differentiates M. caprae from M. bovis. Showing negative reaction for niacin 
accumulation differentiates M. caprae from M. microti. In addition, this new species has its 
own genetic properties such as pncA, katG and gyrA gene polymorphism, which do not exist 
in any member of MBTC (ARANAZ et al., 1999). Restriction fragment length polymorphism 
(RFLP) with IS6110, polymorphic GC-rich repeat sequences (PGRS) (ROSS et al., 1992) and 
direct repeats (DR) (HERMANS et al., 1991) are shown to distinguish the caprine isolates 
from M. bovis (LIEBANA et al., 1997; ARANAZ et al., 1998). Spacer-oligotyping 
(spoligotyping) and DRs have been developed as a target for in-vitro DNA amplification to 
detect the presence or absence of spacer in the DR locus (KAMERBEEK et al., 1997). 
Spoligotyping is evaluated as a promising tool for typing M. bovis isolates from various 
animal sources isolates (ARANAZ et al., 1996). There is another technique which is based on 
gyr-B sequence. It works by using both PCR and PCR-RFLP methods. According to this, M. 
caprae can be distinguished from other MTBC strains by gyr-B sequence (KASAI et al., 
2000; NIEMANN et al., 2000a).  
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M. caprae was first presented as Mycobacterium tuberculosis subsp. caprae (ARANAZ et al., 
1999). Then it was considered as a subspecies of M. bovis and the name was changed to 
Mycobacterium bovis subsp. caprae (NIEMANN et al., 2002). But thereafter, in accordance 
with these various genetic and biochemical properties, this bacillus has been represented as M. 
caprae (ARANAZ et al., 2003).   
 
Despite all of these differences between the two M. caprae and M. bovis, it is assumed that 
they cause tuberculosis in humans with no significant difference in age, gender or localisation 
among the patients (KUBICA et al., 2003). It is also concluded that M. caprae causes 
tuberculosis among the same animal species as M. bovis does (PRODINGER et al., 2005). 
 
2.2. Morphology of Mycobacterium 
 
The genus of mycobacterium is determined as lightly curved or as straight rods, 0.2 – 0.6 x 
0.1 - 10 µm in length and width, less commonly branching; filamentous or mycelium-like 
growth may appear, but always become fragmented into rods or coccoid elements. Despite not 
being appropriate to staining with Gram’s method, they are still named as Gram positive. 
They have no endospores, no capsules, no visible aerial hyphae (WAYNE & KUBICA, 
1986).  
 
Morphologically, M. caprae is described as an acid-alcohol-fast, non-spore forming, non-
motile rod that grows slowly (dysgonic) at 36˚C and forms smooth and non-chromogenic 
colonies. In the case of the presence of pyruvate, visible growth can be recognized after 4-6 
weeks of incubation at 36˚C (ARANAZ et al., 1999). 
 
2.2.1. The Envelope of Mycobacterium 
 
The envelope of mycobacteria consists of a plasma membrane and a cell wall (BRENNAN & 
NIKAIDO, 1995). The plasma membrane consists of phospholipids, which are derivatives of 
phosphatidic acid. The most common are phosphatidylglycerol, diphosphatidylglycerol, 
phosphatidylethanolamine, and phosphatidylinositol and its mannosides (PIMs). The PIMs 
are the major plasma membrane components and also participate in the formation of 
lipoarabinomannan and lipomannan, as described below (BRENNAN & NIKAIDO, 1995).   
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Peptidoglycan (murein) constitutes the basal unit of the mycobacterial cell wall structure. This 
unit covalently links to the mycolylarabinogalactan (mAG) via phosphodiester bonds and 
mAG layer is composed of α-branched, β-hydroxylated long chain fatty acids. Peptidoglycan-
mAG structure also contains carbon atoms, which are covalently linked to arabinogalactan 
(AG). Mycolic acids are linked to this peptidoglycan-mAG structure at the carboxyl ends to 
D-arabinofuranose, and they are also linked to the AG polymer by the peptidoglycan-mAG 
(KANETSUNA, 1968; BARKSDALE & KIM, 1977; NIKAIDO et al., 1993; CHATTERJEE, 
1997).  
 
Peptidoglycan (mucopeptid or murein) is formed by a glycan and a peptide moiety. The 
peptide moiety has four aminoacids (GHUYSEN, 1968). The glycan substance consists of a 
repeating disaccharide unit linked to the peptide moiety. This disaccharide unit consists of N-
glycolyl group, which is found in all mycobacteria species (AZUMA et al., 1970; LEDERER 
et al., 1975). Mycobacteria, nocardia and corynebacteria have the same deamidated 
tetrapeptide. The important adjuvant activity of the peptidogylcan is indicated as N-acyl 
muramyl L-Ala-D-isoglutamine (LEDERER et al., 1975).  
 
Arabinogalactan (AG), glucan, mannan, and arabinomannan are determined as common 
constituents of mycobacterial polysaccharides and it is concluded that arabinomannan and AG 
are common immunologically active polysaccharide antigens in the mycobacteria (AZUMA 
et al., 1968). AG is composed of distinctive arabinan and galactan segments (DAFFE et al., 
1990; BESRA et al., 1995).  
 
The lipopolysaccharides of mycobacteria are lipoarabinomannan (LAM) and lipomannan 
(LM), within the bonds of AG, are anchored via phosphatidylinositol (HUNTER & 
BRENNAN, 1990). LAM and LM are based on the phosphatidylinositol mannosides (PIM) 
(CHATTERJEE et al., 1992a). ManLAM, which is also a derivative of LAM, is characterised 
by extensive mannose capping arabinan termini, which may affect the interaction of the 
mycobacteria with the host cell (CHATTERJEE et al., 1992b).  
 
Mycolic acids are defined as high-molecular weight β-hydroxyl fatty acids with a long α-side 
chain (ASSELINEAU & LEDERER, 1950). These fatty acids are described as bound esters of 
AG and there they appear as tetramycolylpentaarabinosyl clusters and also extractable lipids, 
especially as α,α’-treholase dimycolate (Cord factor) (BRENNAN & NIKAIDO, 1995). The 
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other extractable glycolipids of the cell wall surface are lipooligosaccharides (LOSs), 
phenolic glycolipids (PGLs) and glycopeptidolipids (GPLs) (BRENNAN & NIKAIDO, 
1995). M. bovis has ‘Mycoside B’ (MACLENNAN et al., 1961), which is a type of phenolic 
glycolipids characterised by a very large hydrophobic part (BRENNAN & NIKAIDO, 1995). 
 
Waxes are another important antigenic cell wall component (AZUMA et al., 1968) and have 
the phenolic glycolipids in their core (BRENNAN & NIKAIDO, 1995).  
 
2.3. Virulence Effect of Cell Wall Components 
 
The cell wall components of the tubercle bacillus have crucial roles in the interaction of 
pathogenic species with their host (BRENNAN & NIKAIDO, 1995). 
 
LAM suppresses immune responses and thereby contributes to the pathogenesis of 
mycobacterial infection (BRENNAN & NIKAIDO, 1995). This molecule inhibits the function 
of macrophages by scavenging toxic oxygen free radicals, inhibiting protein kinase C activity, 
and restricting transcriptional activation of the interferon-gamma (IFN-γ)-inducible genes 
(CHAN et al., 1991). 
 
LM is responsible for apoptosis of macrophages via interaction with toll-like receptor (TLR) 2 
on the surface of macrophages and also has an effect on interleukin (IL)-12 (DAO et al., 
2004). However, ManLAM possesses an inhibitor effect on apoptosis mechanism of 
macrophages and on the IL-12 response (KEANE et al., 2000; ROJAS et al., 2000; 
HICKMAN et al., 2002). ManLAM also prevents the phagosome-lysosome fusion. The arrest 
of phagosome-lysosome maturation results and this could be defined as the most important 
factor in the pathogenesis of M. tuberculosis (FRATTI et al., 2001; FRATTI et al., 2003). 
PIMs, which are precursor molecules of LAM and LM, have an important role of maintaining 
granuloma formation by recruiting the natural killer (NK) cells (GILLERON et al., 2001). 
 
Cord factor is another virulence factor for inducing immune response in the host. It has both 
leukotactic and leukotoxic properties. This effect inhibits leukocytic migration (BLOCH, 
1950). 
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2.4. Transmission Pathways  
 
The most important transmission route of bovine tuberculosis occurs by inhaled organisms via 
the respiratory route. The bacilli can spread via droplets, contact, dust or within droplet nuclei 
and is emanated from infected animals into the environment when they cough or sneeze. 
Aerosol droplet nuclei can exist in the air for a long time (LANGMUIR, 1961). Ambient air 
contains viable tubercle bacilli as a result of the exhalation by infected animal, so this 
condition can facilitate the transportation of organisms among indoor housing cattle 
(BURRELL, 1991). Other projects point out the transmission of mycobacterial infection from 
deer to cattle or from deer to deer by studying experimentally inoculated deer. It has been 
shown that these animals transmit the infection by shedding the bacilli through their saliva, 
nasal secretion, urine and faeces. In addition, the lesions have been found most commonly in 
respiratory tract instead of alimentary tract. It is supposed to be a result of inhalation of 
droplet nuclei on small fed particles during feeding (PALMER et al., 1999; PALMER et al., 
2001; PALMER et al., 2004). On the other hand, it has been shown in cattle that the oral route 
plays an important role when the lesions are in the lymphoid organs of the head and the 
gastrointestinal tract (LIEBANA et al., 2008). In young calves, the consumption of infected 
raw milk from tuberculous udders may cause bovine tuberculosis via alimentary tract (NEILL 
et al., 1994). Animals also can be infected from contaminated pastures when they graze 
(MORRIS et al., 1994). Congenital transmission can rarely occur via umbilical vessels from 
infected cow (NEILL et al., 1994). 
 
2.5. Source of Infection 
 
Bovine tuberculosis has a wide range of sources that causes the infection among domestic and 
wildlife animals as well as humans. Both M. bovis and M. caprae can cause bovine 
tuberculosis and share the same resources and target populations (PRODINGER et al., 2005; 
PAVLIK, 2006). It is also indicated that infected purchased animals can be an important 
threat from an epizootiological aspect (PAVLIK, 2006). 
 
Wild animal resources may also cause a disease threat and according to the report from 
United Kingdom (UK), moles (Talpa europaea), foxes (Vulpes vulpes), rats (Rattus 
norvegicus), wild deer (various species) and badgers play an important role in transmission of 
the disease to cattle (KREBS, 1997). It has been indicated that natural habitat of badgers is 
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placed just near the grazing land (TUYTTENS et al., 2000). Infected badgers can shed the 
acid-fast bacilli via their excretions of respiratory, urinary, digestive tract and also skin 
(GAVIER-WIDEN et al., 2001) and then, cattle may inhale the bacilli from contaminated 
pastures (HUTCHINGS & HARRIS, 1997). In a free-ranging area in Michigan, the white 
tailed deer has also been shown as a reservoir of mycobacterium (SCHMITT et al., 1997). 
Wild boar and red deer play an important role for the spread of bTB to the domestic livestock 
(GORTAZAR et al., 2005). It should not be forgotten that humans also constitute another 
source of bTB (GRANGE & YATES, 1994).  
 
2.6. Survival of the Organism in the Environment  
 
M. bovis is an facultative intracellular organism that survives for substantial periods in the 
environment under favourable conditions (MORRIS et al., 1994). In south of England, 
experimental studies with artificially infected faeces show that the tubercle bacilli can survive 
and remain virulent after exposure to pasture land for at least 5 months during winter, for 2 
months during spring and for 4 months during autumn. There are no signs of live bacilli after 
2 months of exposure in summer. The survival period of bacilli has been assumed to be 
approximately 4 months during summer when protected from sunlight. If the bacilli are 
protected from direct insolation, earthworms and insects, the survival period takes longer, 
about 6 months in autumn (WILLIAMS & HOY, 1930). Maddock recovered tubercle bacilli 
from the soil and dung after insolation of 178 days. Furthermore, in another study of 
MADDOCK (1933, 1934), the tubercle bacilli could be recovered under inappropriate 
drought and warm weather conditions after 152 days. 
 
2.7. Epidemiology of Bovine Tuberculosis in European Countries 
 
In 2012, Austria, Belgium, the Czech Republic, Denmark, Estonia, Finland, France, Germany, 
Latvia, Luxembourg, the Netherlands, Poland, Slovakia, Slovenia, Sweden, Norway and 
Switzerland have Officially Tuberculosis Free (OTF) status in accordance with European 
Union (EU) legislation (Decision 2012/204/EU29). Liechtenstein and Switzerland have the 
same status. The last epidemic of bovine tuberculosis occurred in 1959, in Iceland. But a 
special agreement concerning animal health status between this country and the EU does not 
exist. Furthermore, 5 Italian regions and 17 Italian provinces, Algarve in Portugal, Scotland in 
UK have obtained OTF status (EFSA, 2015). 
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Member states Bulgaria, Croatia, Cyprus, Greece, Hungary, Ireland, Italy, Lithuania, Malta, 
Portugal, Romania, Spain and the UK did not obtain country-level OTF status in 2013. 
Croatia, as a new member state, reported information for the first time in 2013 (EFSA, 2015). 
 
In the EU OTF regions, out of the 1.384.692 existing cattle herds, 207 were positive for M. 
bovis. The ratio of herds with M. bovis was reported to be 0.015% in 2013, whereas out of the 
1.362.234 existing cattle herds in the EU non-OTF regions, 18.256 herds were found to be 
infected with or positive for M. bovis in 2013. This group of infected/positive herds indicated 
1.33% of the total number of herds in the EU non-OTF regions. Overall, in the EU OTF and 
non-OTF regions, the ratio of herds infected with M. bovis was 0.68% in 2013. The 
prevalence can range from nonexistence of positive animals in many OTF regions to a 
prevalence of 12.1% in the non-OTF regions of the United Kingdom (England, Northern-
Ireland and Wales). Although there is a slight increase of positive herds between 2009 and 
2012 (from 0.45% up to 0.68%), the ratio remains almost the same between 2012 and 2013 
(0.67% - 0.68%). The number of herds infected with M. bovis decreased in France and 
increased in Belgium, Germany, Italy, and Poland in 2013 (EFSA, 2015). 
 
Most of epidemiological studies of bTB are principally performed by spoligotyping and 
IS6110 RFLP analyses (VANEMBDEN et al., 1993; KAMERBEEK et al., 1997). M. caprae 
has been shown to be widely distributed in Europe among humans and animals. Particularly, 
Austria, Italy, Spain, and Germany are the main countries (PRODINGER et al., 2005). 
Furthermore, the detection of M. caprae has also been presented, as following: 
 
• Spain (GUTIERREZ et al., 1995; PRODINGER et al., 2005) 
• France (HADDAD et al., 2001; PRODINGER et al., 2005) 
• Czech Republic (PAVLIK et al., 2002b) 
• Slovakia (PAVLIK et al., 2002a) 
• Slovenia (ERLER et al., 2004) 
• Croatia (CVETNIC et al., 2006) 
• Austria (PRODINGER et al., 2002; PRODINGER et al., 2005) 
• Italy (PRODINGER et al., 2005) 
• Germany (KUBICA et al., 2003) 
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2.8. Bovine Tuberculosis in Germany 
 
Germany obtained the status of "officially free of tuberculosis" on 1st July, 1996 (it was first 
declared according to EU Decision 97/76 / EC, then replaced by EU Decision 99/467/EC and 
then by EU Decision 2003/467/EC). EU definition is given as “the percentage of infected 
bovine herds has not been more than 0,01 % for six consecutive years and at least 99,9% of 
the herds have been declared officially tuberculosis free for 10 years” (Council Directive 
97/12 / EC). 
 
A systematic analyses of human patients was done between 1999 and 2001 by using 
spoligotyping and PCR-RFLP analysis. The regional propotion of M. caprae infections 
indicates that southern Germany has a large proportion (more than 80%) as compared with the 
northern parts of the country (less than 10%) (KUBICA et al., 2003). Between 2008/2009 and 
2012/2013 bTB increased, especially in Bavaria, Allgäu (LGL, 2014). In Bavaria, in 2009 M. 
caprae was detected in cattle (LEIPIG et al., 2009) and in 2011, it was detected among red 
deer (GERSTMAIER, 2011). In 2012, 24 outbreaks of bTB were reported compared to 2011 
with 5 outbreaks (FLI, 2012).  
 
2.9. Tuberculosis Infection in Humans 
 
TB still causes death in humans. The last report from the World Health Organization (WHO) 
indicates that in 2014, estimated 9.6 million developed TB and 1.5 million died from it 
(WHO, 2015). 
 
Bovine tuberculosis (bTB) possesses a zoonotic risk to the public; especially to people who 
have close contact with infected animals (PATE et al., 2006). The isolation of M. bovis strains 
in humans shows that infected cattle constitute an important threat factor for the transmission 
of the disease from livestock to humans (GUTIERREZ et al., 1997). In the UK, agricultural 
workers have been detected to develop tuberculosis as a consequence of close contact with 
infected cattle (SMITH et al., 2004). In Spain, M. caprae has been isolated from hunters and 
wildlife managers (GORTAZAR et al., 2005).  
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The other important potential of transmission of bovine tuberculosis from animals to human 
occurs when consuming raw milk or non-pasteurized milk and milk products (CVETNIC et 
al., 2007). 
 
Systematic analyses show the population structure of mostly human-origin M. bovis in 
Germany and indicate a high ratio of human tuberculosis (KUBICA et al., 2003). Moreover, 
another research in Germany verifies that M. caprae affects humans (NIEMANN et al., 
2000b). 
 
2.10. Control of Bovine Tuberculosis 
 
In the European Community, member states regulated legislation to trade cattle, beef and 
products without risk of spreading the disease. Regulations in Council Directive 97/12 / EC 
states that no bovine animal over six weeks old can be introduced into a herd unless it has 
reacted negatively to an intradermal tuberculin test performed and assessed according to 
Annex B and carried out either in the 30 days prior to, or the 30 days after the date of its 
introduction into the herd. In Germany, the control of bTB is managed by “Regulations for 
Protection from Bovine Tuberculosis”. According to these regulations, control is depended on 
the diagnosis of clinical symptoms, official meat inspection and post mortem examination by 
veterinary service laboratories and tuberculin testing in certain cases. In case of clinical 
suspicion or pathological tissue lesions, further diagnostic investigations including 
bacteriology, molecular biology, epidemiology, tuberculin testing of contact animals, gamma 
interferon test are initiated for clarification (TUBERKULOSE-VERORDNUNG, 2014). 
In case of existence of the wild-life TB sources, the countries must develop their own 
strategies for prevention. Besides culling, applying the treatment regime and vaccination 
programs have been suggested to handle tuberculosis in wild-life animals (ARTOIS et al., 
2011). It is emphasized that the vaccination strategies are applicable in the wild-life reservoir 
hosts (e.g. eurasian badgers in England, white-tail deer in the United States, wild boar and red 
deer in Spain) to limit the transmission of tuberculosis to cattle and also among wild-life 
populations (BUDDLE et al., 2011).  
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2.11. Vaccination 
 
Bacillus Calmette Guérin (BCG) is an attenuated strain of M. bovis, which was developed by 
Calmette and Guérin. After a large scale of animal experiments, it was used in children to 
protect them from tuberculosis (CALMETTE, 1931). The efficacy of this vaccine has been 
seen in cattle and human. Low doses of BCG induce protection against tuberculosis (FINE, 
1995; BUDDLE et al., 2002). This vaccine works via stimulation of the cellular immune 
response against the bacteria, which can replicate in the host macrophages. IFN-γ produced by 
T-cells helps to control the intracellular growth of mycobacteria in macrophages by activating 
these cells. T-cell immune responses occur in a higher amount in vaccinated cattle compared 
to non-vaccinated cattle (LIEBANA et al., 2000; VORDERMEIER et al., 2002). Besides this, 
some other vaccination methods have also been developed such as adjuvant subunits, virus-
vectored or DNA vaccines, which are combined with BCG (BUDDLE et al., 2011). The 
combination of the adjuvant subunit vaccine with BCG maintains more effective protection 
than BCG used alone (WEDLOCK et al., 2005). The low doses of BCG have also been 
confirmed to be adequate in calves to initiate an immune response (BUDDLE et al., 1995).  
 
According to the legistation in Germany vaccinations against tuberculosis in cattle and 
therapeutic trials are prohibited. The competent authority may permit exceptions to conduct 
scientific experiments, when issues of disease control do not preclude (TUBERKULOSE-
VERORDNUNG, 2014). 
 
2.12. Host Susceptibility 
 
It is assumed that genetic predisposition plays an important role in the susceptibility of the 
bTB. In a study, the prevalence and the pathology of bTB among Holstein, Zebu and Zebu x 
Holstein cross bred cattle have been compared. High differences in prevalence and severity of 
the pathology among these breeds have been demonstrated. Holstein (Bos taurus) cattle have 
been found to be more susceptible than crosses or Zebu (Bos incidus) cattle (AMENI et al., 
2007). 
 
It is suggested that susceptibility to tuberculosis infection may increase as a consequence of 
being persistently infected with immunosuppressive viruses such as bovine viral diarrhoea 
virus or bovine immunodeficiency virus (MENZIES & NEILL, 2000). Besides this, poor 
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nutrition can be demonstrated as a predisposing factor for tuberculosis (DOHERTY et al., 
1996). Furthermore, grazing in an area of poor quality soil with deficient mineral content can 
cause an increased risk of having severe course of tuberculosis, if the animals are not 
supported with mineral supplements (GRIFFIN et al., 1993). In winter time, cattle are housed 
in most countries, which is thought to be a reason for an increased incidence of bTB, so-called 
seasonal effect (MENZIES & NEILL, 2000). Moreover, it is emphasized that housed cattle, 
even if better fed, show a higher incidence of tuberculosis than cattle which are exposed to the 
rigors of life in the open (FRANCIS, 1971). 
 
2.13. Immune Response 
 
The immune reaction is considered to be an interplay between the cell mediated immunity and 
delayed type hypersensitivity (DTH) throughout the course of the infection (DANNENBERG, 
1993). It can be concluded from the previous studies that bovine tuberculosis shows a 
spectrum of immune responses, in which cell mediated immune response dominates the 
infection (RITACCO et al., 1991; NEILL et al., 2001).  
 
2.13.1. Initiate and Cellular Immune Response 
 
Initiate immunity is developed by non-specific mechanisms, in which neutrophils and 
macrophages manage the rate of the inflammation (SILVA et al., 1989; TURNER et al., 
2003). It is mainly characterised by imigration of monocytes and occasional immature 
macrophages. In seven days, these monocytes evolve into mature macrophages and then into 
much larger epithelioid cells (ADAM, 1975). On the other hand, M. bovis has regulatory 
effects on neutrophils, which accumulate rapidly to the sites of infection to eliminate the 
bacilli (WANG et al., 2013). IL-17 induces this recruitment and the T-helper (Th) 1 type 
acquired immunity. This cytokine is produced mainly by TCR γδ T cells and is stimulated 
mainly by IL-23 (UMEMURA et al., 2007). Stimulated neutrophils can generate a respiratory 
burst and up-regulate the microbicidal activity and the expression of some cell surface 
receptors. The infection of neutrophils with M. bovis results in the increase of tumour necrosis 
factor alpha (TNF-α) and IL-10 secretion and an up-regulation of early apoptosis rate, late 
necrosis, and autophagy (WANG et al., 2013). In addition, neutrophils also have an effect on 
the development of CD4+ T cells, which facilitates dendritic cell (DC) migration and antigen 
presentation (BLOMGRAN & ERNST, 2011).  
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Toll-like receptors (TLRs) recognize the mycobacterium as a pathogen (KOPP & 
MEDZHITOV, 2003). Macrophages recognize the mycobacterial cell wall component via 
TLR2 and become stimulated to produce TNF-α (UNDERHILL et al., 1999). It was 
confirmed that TLR2 possesses an important function on the progression of the inflammation. 
After the recognition of microbial lipoproteins, monocyte-derived DCs become activate and 
express TLR2. Monocytes and DCs participate in the production of IL-12 and IL-10, but DCs 
have little effect on the IL-10 production (THOMA-USZYNSKI et al., 2000).  
 
Interleukin (IL)-12 triggers NK and Th1 cells to release IFN-γ (TRINCHIERI, 1993), while 
IL-10 has an antagonistic effect by inhibiting both the release and the function of IL-12 
(BUELENS et al., 1997; DESMEDT et al., 1997). IFN-γ activates macrophages via the nitric 
oxide synthase (NOS)-dependent way and allows the production of reactive nitrogen 
intermediates (RNI). IFN-γ also has an effect on macrophages to express more major 
histocompatibility complex (MHC) class II molecules (DALTON et al., 1993; FLYNN et al., 
1993).  
 
Dendritic cells (DCs) are induced to become antigen presenting cells (APCs) (DEMANGEL 
et al., 1999), which have MHC class II molecules on their surface (BANCHEREAU & 
STEINMAN, 1998). Lipopolysaccharides induce nuclear translocation of nuclear factor (NF)-
κB, which stimulates the maturation of DCs to up-regulate MHC and co-stimulatory 
molecules (RESCIGNO et al., 1998). They also up-regulate some important cytokines: IL-1, 
IL-6, IL-12, IL-10 and TNF-α (HENDERSON et al., 1997; THOMA-USZYNSKI et al., 2000; 
DEMANGEL et al., 2002). Mycobacteria-infected DCs migrate to the draining lymph nodes, 
where they initiate the development of native T cells into the Th1-polarized CD+4 T cells 
(HICKMAN et al., 2002) and CD8+ cells (PETERS & ERNST, 2003). This process starts 
after the interaction between T lymphocytes and MHC molecules of APCs via their T cell 
antigen receptors (TCRs). MHC Class I and MHC Class II stimulate cytotoxic CD8+ T cells 
and CD4 helper T cells, respectively (BANCHEREAU & STEINMAN, 1998). After the 
activation of naïve T cells, they migrate via the bloodstream to the site of inflammation 
(PETERS & ERNST, 2003).  
 
T cell subpopulations have a role in response to mycobacterial infection in the host. At the 
initial phase of infection, WCI γδ T cells become predominant (POLLOCK et al., 1996; 
CASSIDY et al., 2001). CD8+ T lymphocytes mediate the lysis of host cells infected with 
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mycobacteria (KAUFMANN, 1988). An experimental study indicates that the major role of 
CD4+ T lymphocytes is to participate in early immune response against mycobacteria, to 
establish the granuloma formation by producing IFN-γ and also to stimulate NOS expression. 
In addition, this study also shows the occurrence of IFN-γ response from CD8+ T 
lymphocytes after two weeks of infection (CARUSO et al., 1999). 
 
2.13.2. Delayed Type Hypersensitivity  
 
The delayed type hypersensitivity is principally mediated by the T cell response and 
corresponding sets of cytokines. In an experimental study with M. bovis purified protein 
derivative (PPDb) injected cattle, these animals show an accumulation of T cells, especially 
γδ T cells and a CD4+ T cell proliferation, and an increased IFN-γ production (WATERS et 
al., 2000). This cytokine amplifies the release of TNF-a from macrophages. Moreover, local 
tissue cells and leukocytes also participate in this reaction by producing chemokines to recruit 
monocytes and macrophages from the blood into the infected area. Subsequently, TNF-a up-
regulates the release of chemokines to recruit blood-borne monocytes to the infected area. 
Thus, the believed theory of ‘walling off’ is developed to prevent the dissemination of 
bacteria (ORME & COOPER, 1999). 
 
2.13.3. Humoral Immune Response 
 
Experimental studies conducted with M. bovis infected cattle have determined varying 
amounts of antigen recognition (FIFIS et al., 1994; LYASHCHENKO et al., 1998). The 
antibody levels increase in the late stages of the infection (HARBOE et al., 1990; FIFIS et al., 
1994). The relationship between cell mediated immune response and humoral immune 
response has been investigated. The observation of the late stage of infection shows a high 
amount of IL-10, a decreased amount of cellular response and IFN-γ. Moreover, a positive 
correlation has been seen between the severity of infection and the amount of 
immunoglobulin G (IgG) (WELSH et al., 2005). The role of B cells has been studied in mice 
and it has been seen that these lymphocytes have striking role in managing the granuloma 
development by producing chemokines and cytokines. They also participate in the protective 
immunity by producing IgG and IgM (MAGLIONE et al., 2007). 
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2.14. Pathogenesis 
 
In animals and humans, tuberculosis infection can be divided into two different periods. These 
are the primary infection period and the super infection or re-infection period. Principally, the 
exudative or the productive type of granulomatous inflammation can be predominant during 
the infection (NIEBERLE, 1938; PALLASKE, 1961).  
 
The productive type starts with an accumulation of macrophages, which phagocytise the 
bacilli. The bacilli are killed within the macrophages, if the immune response of the host is 
adequate. Otherwise, the balance turns the other way and ingested bacilli in the macrophages 
proliferate and are released from the killed macrophages. In the meantime, cellular and 
hypersensitivity immune responses develop against the mycobacteria (JUBB & KENNEDY, 
1963). Inflammatory cell infiltration mainly consists of mononuclear cells and their 
derivatives, epithelioid and Langhans-type multinucleated giant cells. The admixture of 
epithelioid and multinucleated giant cells forms the centre of the young granulomas. The 
periphery is surrounded by a narrow zone of lymphocytes. Subsequently, fibrous 
encapsulation develops in the periphery and caseous necrosis in the centre, if the lesion 
progresses. Caseous necrosis is assumed to be a result of hypersensitivity reaction and may 
liquefy or calcify in time (JUBB & KENNEDY, 1963). 
 
Exudative granuloma formation occurs acutely and results in caseation necrosis, too. The 
exudative form consists of an accumulation of fibrin and neutrophils as well as monocytes. 
There are many factors that cause exudative tuberculosis. The main factor is stated to be a 
high degree of altered reactivity. A high burden of bacteria, bacilli of high virulence, and a 
susceptible host are other factors for the development of the exudative granuloma type (JUBB 
& KENNEDY, 1963). 
 
2.14.1. Primary Infection and Early Generalisation 
 
The beginning of the tuberculosis is characterised by a development of a primary focus. This 
primary focus can develop in any organ depending on the transmission pathways. The 
tubercle bacilli can enter the host via alimentary, respiratory or congenitally ways and create 
the primary focus at the portal of entry. Subsequently, the bacteria reach the regional lymph 
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nodes via lymphatic vessels (NIEBERLE, 1938). Both affected organ and associated lymph 
nodes together form a primary complex (JUBB & KENNEDY, 1963). 
  
The characteristic feature of the primary infection and early generalisation are concurrent 
lesions in an organ and in the regional lymph nodes with a tendency to calcification 
(NIEBERLE, 1938). In cattle, depending on the transmission pathway, primary foci are 
observed mostly (90%) in the lungs. They occur in the best ventilated portion of the lung, just 
beneath the pleura, in the main lobe or in the lower parts of the lung. Extensive alterations are 
also seen in the regional lymph nodes (NIEBERLE, 1938; PALLASKE, 1961). The primary 
foci in alimentary tract can initially occur in the tonsils, and also in retropharyngeal lymph 
nodes (NIEBERLE, 1938). But if the primary focus is seen only in retropharyngeal lymph 
nodes, this can be associated with both the respiratory and alimentary ways (STAMP, 1944). 
Primary focus in the alimentary tract is found in the posterior part of the intestine and 
especially associated with individual or multiple lymph nodes alterations. However, it is 
indicated for both alimentary and respiratory infection that bacteria can only affect the 
regional lymph nodes without alterations in the organ. This situation is named as incomplete 
primary complex (NIEBERLE, 1938).  
 
Primary infections can also develop by congenital pathway. The congenital tuberculosis is 
pointed out as the most common (39%) transmission pathway in calves (NIEBERLE, 1938). 
The infection spreads via umbilical cord to the fetus, thus the lesions arise in the liver and 
portal lymph nodes. Congenital tuberculosis in calves progresses rapidly and causes death in a 
few weeks or months, usually due to a generalisation with lesions in spleen, lung, and 
occasionally in heart muscle (STAMP, 1944).  
 
The inflammatory process of the primary complex might stop and heal, or might progress to 
an early generalisation. In the healing process, the primary focus calcifies progressively and is 
surrounded by fibrous tissue. This encapsulated focus can remain stable lifelong in this form 
(NIEBERLE, 1938; PALLASKE, 1961). The early generalisation occurs when the bacteria 
are released into the blood stream, and spread out to the different organs. Other forms of 
spreading besides haematogenous occur via contact growth, lymphogenous, or 
intracanalicular ways (NIEBERLE, 1938). In the initial phase, the occurrence of small 
cavities allows a local dissemination of the bacteria via intracanalicular ways (JUBB & 
KENNEDY, 1963). The course of the disease depends on the burden of bacilli in the blood 
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and the defence mechanisms of the host. Multiple metastatic foci can arise in different organs 
such as lung, liver, kidney, spleen and also bone marrow through the haematogenous or 
lymphogenous spread. Lesions occur in different forms; a) acute miliary tuberculosis, b) 
protracted generalisation (NIEBERLE, 1938). 
 
2.14.2. Re-infection 
 
Observations of pulmonary tuberculosis in men reveal that primary infection and early 
generalisation commonly occur in children. However, the chronic tuberculosis occurs in 
adults. Primary infection may persist for a long time without any clinical signs and it can arise 
again following puberty. In this case, clinical signs become indicative and re-infection period 
starts (NIEBERLE, 1938). The outcome of re-infection may develop by either endogenous 
way, as a result of reactivation of an old primary focus, or exogenous way (NIEBERLE, 
1938; AUERBACH, 1959). In animals, this form is generally seen in cattle (NIEBERLE, 
1938). 
 
2.14.2.1. Chronic tuberculosis (Organ Tuberculosis) 
 
Chronic organ tuberculosis in cattle progresses slowly in time and causes distinctive 
emaciation. The pathological alterations in chronic organ tuberculosis are especially seen in a 
particular organ, which is generally the lung with acinar tuberculosis (NIEBERLE, 1938). The 
progression may result in either fibrous encapsulation and eventually heals or progresses 
through large confluent acinar nodular foci. These foci can dissolve and cause cavities as a 
result of liquefaction necrosis (NIEBERLE, 1938; PALLASKE, 1961).  
 
The distinctive feature of the chronic organ tuberculosis is a lack of alterations in lymph 
nodes and lack of haematogenous spreading. Only canalicular spread can occur within the 
affected organ (NIEBERLE, 1938). This canalicular spread causes bronchiolitis, caseation 
and ulcers in bronchia, trachea and larynx. Caseating bronchiolitis causes destruction on the 
bronchial muscles and elastic walls, thus bronchioectatic tuberculous cavities develop after 
destruction of the bronchial walls (PALLASKE, 1961). Besides the lung, the organ 
tuberculosis can also be seen in the udder. Three different forms of mammary tuberculosis are 
described by Nieberle. These are the miliary tuberculosis, the lobular infiltrative or chronic 
mammary tuberculosis and the mastitis caseosa. The most common form is the chronic 
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infiltrative lobular tuberculosis, which is seen approximately in 80-90% of mammary 
tuberculosis cases (NIEBERLE, 1938). 
 
2.14.2.2. Late Generalisation  
 
In the late generalisation, it is assumed that the immune response of the host has been broken 
down, which permits the bacteria to spread via haematogenous or lymphogenous ways. 
Haematogenous metastases can arise in most of the major organs, and also in the regional 
lymph nodes, serous membranes, including the peritoneum, pericardium, and menings and 
skeleton (JUBB & KENNEDY, 1963). This phase of disease is dominated by an acute 
exudative and caseating process. Regional lymph node alterations are common, as described 
in the primary infection (PALLASKE, 1961). Late generalisation can occur in different types, 
which are miliary tuberculosis, multiple lobular caseating pneumonia and galloping acinar 
pneumonia (NIEBERLE, 1938). 
 
2.14.2.2.1. Acute Miliary Tuberculosis 
 
Miliary tuberculosis in cattle can be lethal or lesions can be found during the slaughter as an 
incidental finding. In case of the weakening of the immune response, the bacteria can largely 
increase and spread out to the other organs (generalisation). The distinctive alterations seen in 
lung consist of miliary foci and there are not any alterations in the regional lymph nodes 
(NIEBERLE, 1938).  
 
2.14.2.2.2. Lobular Caseating Pneumonia 
 
Mostly, the massive destruction of tissue is a finding of lobular caseating pneumonia. It 
spreads over the entire cross section of the lung lobes. In addition to that, miliary foci can also 
be observed in the lung following lympho-haematogenous spread (PALLASKE, 1961). 
 
2.14.2.2.3. Galloping Acinar Pulmonary Tuberculosis 
 
The galloping acinar pulmonary tuberculosis is restricted in the bronchial tree branches in the 
form of a caseating bronchitis. Acinar pulmonary tuberculosis develops in large part of the 
lung, and the regional lymph nodes are affected, too (NIEBERLE, 1938). 
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2.15. Pathology  
 
2.15.1. Macroscopic Findings 
 
2.15.1.1. Lung and Regional Lymph Nodes 
 
2.15.1.1.1. Initial Phase and Early Generalisation 
 
In lung and mediastinal lymph nodes, the tuberculous lesions are found in the initial phase of 
the infection as complete primary complexes (STAMP, 1944). Tubercles can be found sub-
pleurally in any lobe of the lung. They are caseated and calcified approximately from hazelnut 
size to fist size and are encapsulated by granulation tissue (NIEBERLE, 1938; PALLASKE, 
1961). Lesions in regional lymph nodes have the same appearances as seen in the lung 
(PALLASKE, 1961). 
 
Lesions in cases of early generalisation are divided into different groups, as mentioned above 
(see in chapter 2.14.1. primary infection and early generalisation) (NIEBERLE, 1938). 
Lesions in the acute miliary tuberculosis appear as glassy and translucent fine submiliar foci 
at first. Later, they are greyer and yellowish. The regional lymph nodes are also affected and 
appear swollen, necrotic and calcified. In calves, this process is associated with translucent 
tubercles in the lung (NIEBERLE, 1938). The protracted generalisation is characterised by 
presence of caseated and calcified tubercles, which are in different sizes (NIEBERLE, 1938). 
Another form is the lobular infiltrative tuberculosis, which shows whitish, rough and greasy 
foci in the emphysematous lung lobes. The lymph nodes are severely enlarged and calcified 
(NIEBERLE, 1938). The galloping acinar and lobular caseating pneumonia is another lesion 
pattern in calves and young cattle. This form is characterised by multiple, greasy, partly 
calcified foci of variable size in the lung lobes. Mediastinal lymph nodes are found enlarged 
and in association with the alterations in the lung (NIEBERLE, 1938). 
 
2.15.1.1.2. Chronic Tuberculosis (Organ Tuberculosis) 
 
The pathological alterations in chronic organ tuberculosis of lung are described as acinar and 
acinar-nodular foci, cavities, and ulcerations in bronchia and trachea. The acinar foci are 
generally found in the main lobes, but can also be seen in cranial lobes. The affected lobe or 
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lobes are found in purple-red colour with compact, smooth and moist cut surface. These lobes 
consist of millet seed to lentil-sized foci, which form small groups and appear as a shamrock. 
Intra- and inter-lobular bronchia are characterised by a thickened bronchial wall. As a result 
of a liquefaction of acinar-nodular foci they have purulent cheesy masses in their lumens. The 
cavities in the organ tuberculosis appear either as melting cavities or bronchioectatic 
tuberculous cavities. But bronchioectatic cavities are pathognomonic for bovine chronic lung 
tuberculosis (NIEBERLE, 1938).  
 
2.15.1.1.3. Late Generalisation  
 
Three different pathological reaction patterns can be found in the case of the late 
generalisation (NIEBERLE, 1938; PALLASKE, 1961). The first one is the miliary 
tuberculosis and is characterised by a voluminous lung, which shows partly emphysematous, 
partly oedematous alterations and also small, irregularly scattered foci (miliary pneumonia). 
The regional lymph nodes are mildly enlarged (NIEBERLE, 1938). The second one is the 
acute multiple, lobular caseating pneumonia. It is mainly characterised by an exudative 
process. The main macroscopic picture is a composition of caseous foci, which are irregular 
in size and shape within the lobules, either only in some parts of a lobule or the entire lobule. 
The cut surface is moist, cheesy and yellow, commonly accompanied by fine blood spots and 
disintegration, possibly with cavity formation. The lymph nodes appear oedematous and 
enlarged (NIEBERLE, 1938). The third reaction pattern is the galloping acinar pulmonary 
tuberculosis. It is characterised by acinar tubercles scattered throughout the emphysematous 
lung. The regional lymph nodes are enlarged, oedematous and caseated (NIEBERLE, 1938; 
PALLASKE, 1961).  
 
2.15.1.2. Intestine and Regional Lymph Nodes 
 
Intestinal alterations are generally seen in the posterior part of the intestinal tract. Frequently, 
they are only found in mesenterial lymph nodes without alterations in intestine, as incomplete 
primary complex form. Affected mesenterial lymph nodes are either mildly or severely 
swollen. The cut surface shows tubercles with caseation and/or calcification, and fibrous 
demarcation. On the other hand, lesions in intestine are occasionally seen in calves and young 
cattle, as complete primary complex form. In calves, they also show lentil-sized ulcerations 
(PALLASKE, 1961).  
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2.15.1.3. Liver and Regional Lymph Node 
 
In the liver, the lesions appear as nodular, capsulated, centrally caseous, calcified foci in pea-
size (NIEBERLE, 1938). The portal lymph nodes are also affected and generally swollen, 
caseated and calcified (PALLASKE, 1961). The nodules tend to be rounded and often appear 
hemispherically above the surface. A thick capsule and the pale, yellow and caseous content 
can be seen on the cut surface. The caseous exudate may be dense and calcified, but 
occasionally it is liquefied like pus (JUBB & KENNEDY, 1963). 
 
2.15.1.4. Kidney 
 
In the kidneys, tuberculous lesions can be found in form of few encapsulated nodules or as 
large destructive caseous lesions (STAMP, 1944). Most kidney lesions are seen in the renal 
cortex at the phase of acute miliary tuberculosis (NIEBERLE, 1938).  
 
2.15.1.5. Pearl Disease  
 
An involvement of the serosal surfaces can also be seen, especially the pericardium, pleura or 
peritoneum, during generalisation (DOMINGO et al., 2014). Pleural tuberculosis is 
characterised by nodular lesions, which have a tendency to calcify and to occur in clusters. 
These lesions can also appear pedunculated, and can coalesce to form cauliflower-like 
masses. The severe calcification gives the name of the term as ‘pearl disease’. Caseous 
tuberculous pleuritis is characterised by large plaques of caseous exudates and a thickened 
pleura. The peritoneal lesions are softer, more diffuse and have tubercles embedded in 
extensive granulation tissue. Although these lesions are found similar as those of the pleura, 
they are not exactly nodular or ‘pearly’ (JUBB & KENNEDY, 1963). 
 
2.15.1.6. Skeleton, Brain and Meninges 
 
Tuberculous lesions in the skeleton occur due to haematogenous dissemination during early 
generalisation and result in osteomyelitis characterised by large granulomas with extensive 
caseation (JUBB & KENNEDY, 1963).  
 
LITERATURE OVERVIEW 24 
The lesions in the brain are found after the primary infection and/or during the early 
generalisation phase of the mycobacterial infection and are characterised by the presence of 
focal, caseated, calcified tubercles with fibrous encapsulation in walnut size. The meningeal 
lesions are seen in the acute miliary tuberculosis, most frequently affecting the leptomeninges 
(PALLASKE, 1961). 
 
2.15.1.7. Spleen, Muscles, Pancreas and Salivary Glands  
 
Tuberculous lesions occur rarely in salivary glands and muscles, including myocardium, and 
spleen following haematogenous dissemination in postnatal infection (JUBB & KENNEDY, 
1963). 
 
2.15.1.8. Genital Organs 
 
Genital tuberculosis can be seen both in male and female sexual organs. In females, uterus is 
the most encountered organ. In males, caseated, calcified tubercles occur at the penis and the 
prepuce as primary infection or more frequently in testicles and the epididymis following 
haematogenous dissemination (PALLASKE, 1961).  
 
2.15.1.9. Mammary and Supramammary Lymph Nodes 
 
Mammary lesions can be divided into three groups by Nieberle; the first form is the miliary 
tuberculosis, which occurs in context of an early generalisation in form of miliar or large foci 
with central caseation and calcification. The mammary lymph nodes are also affected. The 
second form is a chronic infiltrative lobular tuberculosis form with the usually caseified 
tubercles. They are enlarged, dry, compact and grey-reddish with a greasy transparent 
appearance on the cut surface. Mammary lymph nodes are generally not affected. The last 
form is described as mastitis caseosa, which display an exudative inflammatory process 
(NIEBERLE, 1938). Supramammary lymph nodes are barely found swollen and are mostly 
without any tubercle (PALLASKE, 1961).  
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2.15.2. Histological Findings 
 
Histologically, tuberculous inflammation can be divided into a productive type and an 
exudative type, as mentioned above (see in 2.14. Pathogenesis). Classical productive 
granuloma formation is predominantly characterised by a proliferation of epithelioid and 
Langhans-type multinucleated giant cells (NIEBERLE, 1938; PALLASKE, 1961). The 
epithelioid cells stain palely and have large vesicular nuclei, and broad, pale cytoplasma with 
uncertain cell borders. Langhans-type multinucleated giant cells have extensive cytoplasma 
and several nuclei. Intracytoplasmic ingested bacilli can be seen in these cells (JUBB & 
KENNEDY, 1963). A narrow zone of lymphocytes, plasma cells and macrophages surrounds 
this epithelioid cell proliferation. The central necrosis has caseous character and appears as 
amorphous eosinophilic material with necrotic debris and central calcification. Small numbers 
of bacilli are present within the necrotic mass. The granuloma is encapsulated by an outer 
layer of fibrous connective tissue (NEILL et al., 2001). However, the fibroplasia and the 
central necrosis are related to the progressive proliferative granulomas. They are not seen in 
all granulomas (JUBB & KENNEDY, 1963). 
 
Exudative inflammation is predominantly composed of plasma cells, lymphocytes and 
neutrophil granulocytes; unlike an accumulation of the “specific” cells (epithelioid and 
Langhans-type giant cells). In pulmonary tuberculosis, a caseation necrosis is often 
surrounded by a perifocal zone of inflammation consisting of alveolar and bronchiolar 
inflammation with capillary hyperaemia, exudation of fibrin, and desquamation of alveolar 
epithelium, and neutrophil infiltration. In addition there are no specific cells and no bacteria 
can be found in this inflammation zone (PALLASKE, 1961). 
 
2.16. Differential diagnosis  
 
2.16.1. Paratuberculosis  
 
In cattle, paratuberculosis is clinically presented with watery diarrhoea, chronic weight loss 
despite normal appetite, and decreased milk production (WHITLOCK & BUERGELT, 1996). 
Macroscopically, lesions can be found segmental or diffuse throughout the intestine and the 
mesenterial lymph nodes. The lesions can be found from duodenum to rectum throughout the 
intestine. The ileocecal valve is affected most commonly (BUERGELT, 1978). The intestinal 
LITERATURE OVERVIEW 26 
wall is mostly thickened, oedematous and has transversal folds of the mucosa. Lymphatic 
vessels are dilated and prominent. Mesenterial lymph node enlargement is also seen 
predominantly. Histologically, there is a multifocal to diffuse granulomatous inflammation in 
the intestine, the mesenterial lymph nodes and the liver without necrosis or calcification 
(BUERGELT, 1978).  
 
2.16.2. Parasitic Granulomas 
 
Parasite larvae (trematodes) in cattle form nodules within the mesenterial lymph nodes, where 
they die. First, the nodules have pus-like consistence, then they dry and calcify. Histological 
examination serves for the differentiation from tuberculosis through the detection of remnants 
of the trematodes and infiltration with eosinophils (PALLASKE, 1961).  
 
2.16.3. Rhodococcosis 
 
Rhodococcus (R.) equi causes bacterial disease in foals, which is characterised by a 
pyogranulomatous pneumonia, granulomatous lymphadenitis and enteritis (PRESCOTT, 
1991). In a study, the bacteria are also found in the lymph nodes with similar macroscopic 
alterations as seen in tuberculosis. In the histology, infected cattle show severe accumulation 
of neutrophil granulocytes nearby the caseous necrosis. But the definitive diagnosis should be 
done by Gram staining or culture media (MCKENZIE & DONALD, 1979).  
 
2.16.4. Actinomycosis 
 
Actinomycosis affects submaxillar, submandibular, and retropharyngeal lymph nodes in cattle 
and causes gray-yellowish granulation tissue, which is associated with purulente clot material, 
but without calcification. The differentiation is possible by histological examination. 
Typically single or multiple inflammatory foci are found in the tongue with a plate-like 
expansions originating from the superficial mucosa without calcification. This finding helps 
to macroscopically differentiate actinomycosis from tuberculosis. Lip lesions are 
characterised by the presence of nodules, ulcers or a diffuse thickening. In the nasal cavity, 
nodules, ulcers or flat growths of granulation tissue can be observed. Scattered metastatic 
focal lung lesions consist of grey-yellowish soft granulation tissue with purulen clot material. 
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Liver lesions consist of either isolated or metastatic foci in connection with actinomycosis of 
the maxilla (PALLASKE, 1961). 
 
2.17. Diagnosis of Tuberculosis 
 
2.17.1. Intra-dermal Testing 
 
The tuberculin test has been developed for the detection of tuberculosis and has been used 
over years based on the immune response against the intra-dermal injection of tuberculin. 
This test technique has facilitated the eradication of the disease in cattle. The basic principle is 
a delayed-type hypersensitivity response. There are two types of tuberculin tests currently in 
use; single intra-dermal test (SIT), consisting of bovine tuberculin, and the single intra-dermal 
comparative tuberculin test, including both bovine and avian tuberculin (SICTT) 
(MONAGHAN et al., 1994). In Germany tuberculin testing is regulated as indicated in 
Commission Regulation (EC) No 1226/2002 of 8 July 2002 amending Annex B to Council 
Directive 64/432/EEC. On the other hand, a recent survey study shows that many practitioners 
do not follow the requirements of the Council Directive 64/432/EEC when evaluating the 
results of intradermal test. The same study also guides the farm animal practitioners to 
improve the performance of the intradermal test (PUCKEN et al., 2015). According to 
Council Directive 64/432/EEC, the injection site for tuberculin should be in the transition 
region between the first and middle thirds of the neck (in cranio-caudal direction). The 
injection side of avian tuberculin shall be about 10 cm from the crest of the neck and the site 
of injection of bovine tuberculin about 12,5 cm lower on a line roughly parallel with the line 
of the shoulder or on different sides of the neck. The interpretation can be done 72 hours after 
the injection based on the clinical findings at the site of injection as following; 
 
1. Negative reaction: if there is only limited swelling lesser than 2 mm in the thickness 
and no clinical signs such as diffuse or extensive oedema, exudation, necrosis, pain or 
inflammation of the lymphatic ducts in that region or of the lymph nodes.  
2. Inconclusive reaction: if no clinical signs are observed (as mentioned 1.) and if the 
increase of the skin-fold thickness is found more than 2 mm and less than 4 mm.  
3. Positive reaction: if clinical signs (as mentioned 1.) are found or there is an increase of 
4 mm or more in the thickness of the fold of skin at the injection site. 
 
LITERATURE OVERVIEW 28 
2.17.2. In vitro Immunodiagnostic Assays 
 
Interferon gamma (IFN-γ) is a cytokine released by T lymphocytes after the infection of 
tuberculosis and plays an improtant role in the immune response process. IFN-γ test is used to 
detect cellular immune response of the host against bTB (WOOD et al., 1991, POLLOCK et 
al., 2005). Regulations in Germany indicate that IFN-γ test (for example; Bovigam®) can be 
used as an altenative diagnostic tool to intra-dermal skin test (TUBERKULOSE-
VERORDNUNG, 2014). The estimated sensitivitiy of IFN-γ test in international studies 
ranges between 73.0 and 100%, with a median value 87.6%. Its median specificity is 96.6%, 
with a range of 85.0 to 99.6% (DE LA RUA-DOMENECH et al., 2006). 
 
2.17.3. Serological Diagnosis 
 
Enzyme-linked immunosorbent assay (ELISA) has been used as a diagnostic tool for the 
diseases with the high rate of sensitivity and specificity (RITACCO et al., 1987), but also with 
a low sensitivity (RITACCO et al., 1990). Extensive antigenic cross-reactivity between the 
strains of mycobacterium occurs as a problem for the sensitivity of this method (WOOD & 
ROTHEL, 1994). In another study, M. bovis-specific protein (MPB70), a purified component 
of main antigen of M. bovis, has been shown to improve the specificity of an ELISA (FIFIS et 
al., 1991). 
 
2.17.4. Necropsy 
 
Necropsy is a procedure to examine the suspected cattle after a positive tuberculin test. The 
first step is the macroscopical examination of the organs, followed by the collection of the 
tissue specimens for bacteriological and histological examinations. The gross examination 
must be done thoroughly. All organs should be examined, because sometimes lesions cannot 
be visible, but can be detected by bacteriological examinations (CORNER, 1994; WHIPPLE 
et al., 1996).   
 
The sensitivity of gross necropsy as a diagnostic tool has been investigated and the proportion 
has been assessed as high as caudal fold or cervical intradermal skin tests (NORBY et al., 
2004). 
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2.17.5. Microbiological Examination  
 
Microbiological cultivation is an effective traditional diagnostic tool for the identification of 
mycobacterium. Two basic media are used for the cultivation of M. bovis. They are agar and 
egg based. B-83 Agar (COUSINS et al., 1989) and Middlebrook 7H11 (GALLAGHER & 
HORWILL, 1977) are used as an agar medium. Stonebrink (LESSLIE, 1959) and 
Lowenstein-Jensen mediums are used as an egg medium. The growth and appearance of 
bacteria on these media take several weeks. For instance, the first appearance occurs after 3 
weeks of incubation in use of B-83 blood agar medium. However the incubation period 
should be at least 8 weeks in order to obtain high number of bacilli (COUSINS et al., 1989). 
The first appearance is obtained in 28 days of incubation with Middlebrook 7H11 
(GALLAGHER & HORWILL, 1977). 
 
Lowenstein-Jensen medium is utilised to cultivate M. caprae and the first appearance of the 
colonies occurs after 4-6 weeks of incubation (as indicated in 2.2 Morphology of 
Mycobacterium) (ARANAZ et al., 1999). 
 
2.17.6. PCR Analysis 
 
Polymerase Chain Reaction (PCR) is described as a practical technique and can be used in 
most fields of science for biological investigations that require the demonstration of DNA 
(EISENSTEIN, 1990). This method permits detecting and identifying the mycobacteria in 
animals and humans as an alternative choice, besides other traditional diagnostic tests. PCR 
analyses can be performed on biological samples, such as milk, nasal swab, lymph node 
aspirates, which are taken from the suspected animals. The detection of tuberculosis depends 
on their remarkable nucleotide sequences. It is considered that PCR method enables a rapid 
and accurate differentiation of members of MTBC by amplifying different specific DNA 
regions (VITALE et al., 1998; HUARD et al., 2003; WARREN et al., 2006). The sensitivity 
of the sequence-capture PCR technique is confirmed by detecting the mycobacterial DNA in 
the culture-negative pleural fluid samples from patients with tuberculosis (MANGIAPAN et 
al., 1996). 
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2.17.7. Histopathological Diagnostic Methods 
 
Histopathological techniques are utilised to detect tuberculosis in cattle by their classical 
histomorphologic appearance. These techniques serve as rapid diagnostic tools after post-
mortem examination (VARELLO et al., 2008). In the light microscope, the basic architecture 
of tubercles can be examined by H&E staining (PALMER et al., 2007; LIEBANA et al., 
2008) as also described above (see pathology 2.15.2.).  
 
Giemsa staining is used to demonstrate estimated amount of neutrophils, which migrated to 
the granulomatous inflammation site (ERUSLANOV et al., 2005). 
Masson’s trichrome staining is applied on the tissue sections for the demonstration of fibrous 
connective tissue in the granulomatous inflammation. The collagen appears blue following the 
staining. The aim is to classify the granuloma formation into the developmental stages by 
evaluating of the thickness of the surrounding fibrous tissue. Von Kossa staining is also used 
concurrently for the detection of mineralization (RHOADES et al., 1997; PALMER et al., 
2007). The stages of granuloma development can also be demonstrated by using 
immunohistochemical staining methods against T and B cell lymphocytes and also pro-
collagen I, which is a precursor of new collagen synthesis (WANGOO et al., 2005).  
 
2.17.7.1. Auramine O/rhodamine B Staining 
 
By using auramine O/rhodamine B staining and fluorescence microscopy, bacilli are 
recognized as yellow against the dark background staining at higher magnification. The 
sensibility is considered to be between immunohistochemistry and Ziehl-Neelsen staining 
(WATRELOT-VIRIEUX et al., 2006). Prior to that, auramine O and acridine orange staining 
has been used to identify Runyon Group III mycobacterium species (MOTE et al., 1975).  
 
2.17.7.2. Ziehl-Neelsen (ZN) Staining 
 
The first attempt to demonstrate the mycobacterium by light microscopy was achieved by 
Robert Koch, and so the first rod-like structure became visible after 24 h of incubation with a 
solution consisted of distilled water, methylene-blue and potassium hydroxide, (KOCH, 
1882). Subsequently, the staining method was developed by using aniline oil and fuchsine that 
helped to reduce the time from 24 h to 1 h (EHRLICH, 1882). In Ziehl`s studies, aniline oil 
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solution was used in combination with carbolic acid (ZIEHL, 1882). Thereafter, Neelsen 
combined Ziehl`s carbolic acid with Ehrlich`s red stain fuchsin. In this way, the “Ziehl- 
Neelsen Staining” was born (MADKOUR, et al. 2004).   
 
Studies show that the acid-fast bacilli can be recognized in the cytoplasm of epithelioid cells, 
macrophages, multinucleated giant cells and also free in the caseous debris. According to 
comparative studies between ZN and immunohistochemistry, ZN staining method is 
confirmed to have high specificity but lack sensibility (CANCELA & MARIN, 1993; 
WATRELOT-VIRIEUX et al., 2006; VARELLO et al., 2008), thus it is deemed that this 
technique can detect only perfect (complete) organisms (CANCELA & MARIN, 1993).  
 
2.17.7.3. Immunohistochemistry (IHC) 
 
IHC has been used for the detection of mycobacterial antigen. Whole organisms or fragments 
of those can be determined both in the intracellular and extracellular localisations (ULRICHS 
et al., 2005; WATRELOT-VIRIEUX et al., 2006). Moreover, it allows us to investigate the 
development of granulomatous lesion in tissue samples with tuberculosis by simultaneously 
immunolabelling of the cell subsets and nitrite oxide synthase at the side of inflammation 
(PALMER et al., 2007). 
 
Monoclonal and polyclonal antibodies have been developed against the antigens of 
mycobacterium (CORNER et al., 1988; BARBOLINI et al., 1989; BONENBERGER et al., 
2001; MUSTAFA et al., 2006).  
 
Although the sensitivity is found high, the specificity of IHC interpreted different. While 
some authors see this method with a good specificity (HUMPHREY & WEINER, 1987; 
CORNER et al., 1988; PUROHIT et al., 2007), some authors think the opposite (CASSIDY et 
al., 1999; WATRELOT-VIRIEUX et al., 2006). 
 
2.17.7.4. In Situ Hybridization  
 
In situ hybridization is considered to be a diagnostic tool with high specificity and sensitivity. 
This method detects the distribution of the tuberculous bacilli in the granulomatous lesion 
(STENDER et al., 1999b; FENHALLS et al., 2002a and b). Mycobacterial DNA probes allow 
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the observation of the spatial arrangement between the host cells and the bacilli, while mRNA 
probes provide us to see whether the bacilli are alive or not (FENHALLS et al., 2002b). 
Peptide nucleic acid (PNA) probes distinguish the bacilli, which belong to MTBC, from non-
tuberculosis mycobacterium species by using fluorescence in situ hybridization (FISH) 
method (STENDER et al., 1999a). 
 
This method has also been used to simultaneously detect type I pro-collagen, and so to 
evaluate the thickness of the fibrous capsule around the granulomas and thereby makes it 
possible to divide the granulomatous inflammation into the developmental stages (WANGOO 
et al., 2005). 
 
2.17.8. Electron Microscopy  
 
Electron microscopy methods demonstrate the ultra-structure of the mycobacterial cell wall 
components, and their roles in mycobacterial biogenesis (BARKSDALE & KIM, 1977).  
 
In addition, the progression of epithelioid granulomatous inflammation is demonstrated with 
the ultra-structural differentiation of monocytes into macrophages, and then into well-
developed epithelioid cells by electron microscopy (ADAM, 1974, 1975). 
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3. MATERIALS AND METHODS 
 
3.1. Materials and Sampling Period 
 
The examined cattle in this study derived from different herds located in Allgäu, Germany, 
suffering from bovine tuberculosis (bTB) outbreaks from 2009 to 2014. The herds included 
tuberculin positive reactor animals. The animals were submitted to the flaying house. During 
necropsy, tissue samples were collected for histopathological and bacteriological 
investigations. Further processes for histopathological investigations were carried out at the 
Institute of Veterinary Pathology at the Center of Veterinary Medicine of the Ludwig-
Maximilians-University in Munich.  
 
3.1.1. Preparation of Tissue Samples  
 
The collected tissue samples included retropharyngeal lymph node, lung, mediastinal lymph 
node, liver, portal lymph node, small intestine and mesenterial lymph node. The tissue 
samples were fixed in 4% buffered formaldehyde (Appendix 9.2.1.) for 24 to 48 h. 
Subsequently, tissue pieces of approximately 3 mm thickness were cut from the tissue 
samples, placed in the tissue-embedding capsules and then embedded in the paraffin, glycol-
methacrylate (GMA) resin or epoxy resin. Blocks were cut using different types of 
microtomes. Sections were stained with H&E and the Giemsa stain for light microscopy. For 
further analyses special stainings including a modified acid-fast staining according to Fite-
Faraco (FF), immunohistochemistry, in situ hybridization as well as electron microscopy were 
performed.  
 
3.1.2. Preparation of Positive Control Materials 
 
Positive control specimens were prepared in collaboration with the Institute for Infectious 
Diseases and Zoonoses (Head Prof. Dr. R. Straubinger) of the Veterinary Faculty, Ludwig-
Maximilians University in Munich. M. kansasii and M. bovis BCG subtype were cultured in 
Loewenstein-Jensen medium and embedded as mentioned above. In the course of this study, 
sections from these specimens served as positive controls for immunohistochemistry and in 
situ hydridization.  
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3.2. Methods 
 
3.2.1. Methods for Tissue Samples 
 
3.2.1.1. Embedding, Sectioning, and Staining Procedures for Paraffin Wax Technique 
 
Dehydration of the tissue samples was done in a tissue processor (Gewebeeinbettungsautomat 
Histomaster Modell 2050/DI, Bavimed, Birkenau): 
 
• 30 min washing with aqua dest.  
• 2 x 1.5 h 70% ethanol 
• 2 x 1.5 h 96% ethanol 
• 2 x 1.5 h 100% ethanol 
• 2 x 30 min xylene (SAV Liquid Production, Flintsbach, No. XTR-5000-97-1) 
• 1.5 h xylene  
• 2 h paraffin 60˚C (SAV Liquid Production, Flintsbach, No. PFNP-5-5658-1) 
• 3 h paraffin 60˚C  
 
After this process, tissue samples were embedded in paraffin (Unilink-embedding cassette, 
No. 17985k, light blue and No. 17980, green, Langenbrinck, Emmendingen) using an 
embedding device (TBS 88 Paraffin Embedding System, Medite Medizintechnik, Burgdorf). 
Sections of 4 µm thickness were cut from each tissue block with a rotary microtome (HM 
315, Microm, Walldorf) and were mounted on object slides (Engelbrecht, Edermünde, No. 
1110022 or No. 11250 Star Frost). A decalcification process was applied for severely 
calcified tissues before the cutting process using a decalcification solution (VWR, 
International GmbH, Darmstadt, No. 11028304.P). The cut sections were stored at 40˚C for 
24 h before further use.  
 
Each sample was stained using H&E, according to Giemsa, and the modified acid-fast 
staining according to Fite-Faraco (FF). In some cases, Masson´s trichrome (MT) staining for 
connective tissues was applied.  
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Except for FF staining, the tissue slides were deparaffinised by a 10 min incubation in xylene. 
The rehydration was done using a descending ethanol-series and finally distilled water. 
Paraffin oil was used for the deparaffinisation for the FF staining method.  
 
3.2.1.1.1. Haematoxylin Eosin (H&E) Staining 
  
• 5 min Mayer`s haemalaun (Appendix 9.3.1.1.)  
• 4 min rinsing in running warm tap-water  
• 5x immersion in 0.5% HCl acid alcohol (Appendix 9.3.1.3.)  
• 4 min rinsing in running warm tap-water 
• 2 min eosin (Appendix 9.3.1.4.) 
• Rinsing in aqua dest. 
• Dehydration with an ascending ethanol-series (70%, 96%, 100% ethanol) 
• Clearing in xylene  
• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500)  
 
3.2.1.1.2. Giemsa Staining 
 
• 1 h in Giemsa solution (Appendix 9.3.2.2.) at 65˚C  
• Rinsing in aqua dest. 
• 1 sec differentiation using 0.5% acetic acid (until the colour changes from blue to red!) 
(Appendix 9.3.2.3.) 
• 5x immersion in 96% ethanol 
• 5x immersion in 100% ethanol 
• Clearing in xylene 
Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500) 
 
3.2.1.1.3. Masson´s Trichrome (MT) Staining 
 
• 5 min Weigert’s iron-haematoxylin (Appendix 9.3.3.1.) 
• 5 min rinsing running warm tap-water 
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• Differentiation with 0.5% HCl acid alcohol (Appendix 9.3.1.3.) 
• 5 min rinsing in running warm tap-water 
• 5 min red-colour solution (Appendix 9.3.3.4.) 
• Rinsing in 0.5% acetic acid (Appendix 9.3.2.3.) 
• 3 min phosphotungstic acid-orange G (connective tissue must be decolorized!) 
(Appendix 9.3.3.5.) 
• Rinsing in 0.5% acetic acid (Appendix 9.3.2.3.) 
• 5 min aniline blue (Appendix 9.3.3.6.) 
• Short rinsing in 0.5% acetic acid (Appendix 9.3.2.3.) 
• Dehydration in an ascending ethanol-series (96%, 100% ethanol) 
• Clearing in xylene 
• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500) 
 
3.2.1.1.4. Acid-Fast Staining Modified According to Fite-Faraco  
 
• 2x 10 min deparaffinisation in paraffin oil (Appendix 9.3.4.1.) 
• 30 min Ziehl-Neelsen carbolfuchsin (VWR, International GmbH, Darmstadt, No. 
1.092152500)  
• 10 min rinsing in running cold tap-water 
• Decolorisation with 1% HCl acid alcohol (until light pink and colour stops running 
out) (Appendix 9.3.4.2.) 
• 5 min rinsing in cold tap-water 
• 3x immersion in methylene blue 
• 5 min rinsing in running cold tap-water 
• Dehydration in 100% ethanol 
• Clearing in xylene 
• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500) 
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3.2.1.1.5. Immunohistochemistry on Paraffin Sections  
 
Immunohistochemistry was performed for all tissue samples against mycobacterial antigens 
using the polyclonal primary antibodies rabbit anti-M. tuberculosis complex (Rb x tbc) and 
rabbit anti-M. bovis, to determine the localisation of mycobacterial antigens within the 
granulomatous inflammation. Furthermore, antibodies against CD3, CD20, CD79a, 
calprotectin (MAC387), and lysozyme were used to specify inflammatory cells in selected 
cases.  
 
The standard protocol for the avidin-biotin complex (ABC) method was used for the 
antibodies against CD3, CD20, CD79a, and M. bovis. The standard protocol for the indirect 
immunoperoxidase method was used for antibodies against calprotectin (MAC387), 
lysozyme, and M. tuberculosis complex. The used antigen retrieval methods including used 
buffer solutions, the normal serums and the antibodies for each procedure are outlined in 
Table 1.  
 
Antigen retrieval procedures were performed following deparaffinisation. For the heat 
induced antigen retrieval method, two different buffer solutions were used: citrate buffer 
(Appendix 9.7.5.) and tris/EDTA buffer (Appendix 9.7.2.). Sections were incubated in these 
solutions in the microwave oven at 800 W for 2x 10 minutes followed by a cool down period 
of approximately 20 minutes. Enzymatic antigen retrieval process was performed using 
proteinase K (Dako, Hamburg, No. S3020) at room temperature (RT).  
  
3.2.1.1.5.1. Standard Protocol for ABC-Method  
 
• Deparaffinisation for 20 min in xylene (SAV Liquid Production, Flintsbach No. XTR-
5000-97-1) 
• Rehydration in a descending ethanol-series (2x 100%, 2x 96%, 1x 70% ethanol) and 
aqua dest. 
• Antigen retrieval procedure (Table 1) 
• Blocking the endogenous peroxidase activity by incubation in 1% hydrogen peroxide 
(Appendix 9.7.6.) for 15 min at RT 
• 5 min washing in TBS (Appendix 9.7.1.)  
MATERIALS AND METHODS 38 
• Reduction of non-specific binding sites by incubation with normal serum for 30 min 
(diluted in TBS, Table 1) 
• Incubation for 1 h with the primary antibody (diluted in TBS, Table 1) at RT  
• 5 min washing in TBS 
• Incubation for 1 h with the secondary antibody (diluted in TBS, Table 1) at RT  
• 5 min rinsing in TBS 
• 30 min incubation with ABC (diluted 1:100 in TBS) (Appendix 9.7.8.) at RT  
• 5 min rinsing in TBS  
• 3 min incubation with substrate and chromogen (Appendix 9.7.7.) at RT  
• 5 min rinsing in running cold tap-water 
• 20 sec counterstaining with 10% haemalaun (Appendix 9.3.1.1.)  
• 5 min rinsing in running cold tap-water  
• Dehydration in an ascending ethanol-series (70 %, 96 %, 100 % ethanol) 
• Clearing in xylene  
• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500) 
 
Table 1. IHC using the ABC-method.  
 
                     Dilution 
 
CD3        
Antigen retrieval: tris/EDTA buffer (Appendix 9.7.2.) 
Normal serum: goat (MP Biomedicals, Eschwege, No. 092939149)     1:10 
Primary antibody: polyclonal rabbit anti-CD3 (Dako, Hamburg, No. 0452)    1:100 
Secondary antibody: monoclonal biotinylated goat anti-rabbit IgG     1:200 
(Vector Laboratories, Burlingame, No. 41228)       
      
CD20 
Antigen retrieval: - 
Normal serum: goat (MP Biomedicals, Eschwege, No. 092939149)    1:10 
Primary antibody: polyclonal rabbit anti-CD20       1:400 
(Thermo Scientific, Waltham, No. RB-9013R7) 
Secondary antibody: polyclonal biotinylated goat anti-rabbit IgG1     1:200 
(Vector Laboratories, Burlingame, No. BA-1000) 
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CD79a 
Antigen retrieval: tris/EDTA buffer (Appendix 9.7.2.) 
Normal serum: goat (MP Biomedicals, Eschwege, No. 092939149)     1:10 
Primary antibody: monoclonal mouse anti-CD79a (Linaris, Dossenheim, No. MAK 2538) 1:100 
Secondary antibody: polyclonal biotinylated goat anti-mouse     1:200  
(Dako, Hamburg, No. E0433)  
 
M. bovis 
Antigen retrieval: citrate buffer (Appendix 9.7.5.) 
Normal serum: goat (MP Biomedicals, Eschwege, No. 092939149)    1:10 
Primary antibody: polyclonal rabbit anti-M. bovis (Biorbyt, California, No. orb100411)   1:50 
Secondary antibody: goat anti-rabbit IgPO (Dako, Hamburg, No. 20003813)     1:100
  
3.2.1.1.5.2. Standard Protocol for the Indirect Immunoperoxidase Method 
 
• Deparaffinisation for 20 min in xylene (SAV Liquid Production, Flintsbach, No. XTR-
5000-97-1) 
• Rehydration in a descending ethanol-series (2x 100%, 2x 96%, 1x 70% ethanol) and 
aqua dest. 
• Antigen retrieval procedure (Table 2) 
• Blocking the endogenous peroxidase by incubation in 1% hydrogen peroxide 
(Appendix 9.7.6.) for 15 min at RT 
• 5 min washing in TBS (Appendix 9.7.1.)  
• Reduction of non-specific binding sites by incubation with normal serum for 30 min 
(diluted in TBS, Table 2) 
• Incubation for 1 h with the primary antibody (diluted in TBS, Table 2) at RT  
• 5 min washing in TBS  
•  Incubation for 1 h with the secondary antibody (diluted in TBS, Table 2) at RT  
• 5 min rinsing in TBS  
• 3 min incubation with substrate and chromogen (Appendix 9.7.7.) at RT  
• 5 min rinsing in running cold tap-water  
• 20 sec counterstaining with 10% haemalaun (Appendix 9.3.1.1.)  
• 5 min rinsing in running cold tap-water  
• Dehydration in an ascending ethanol-series (70%, 96%, 100% ethanol) 
MATERIALS AND METHODS 40 
• Clearing in xylene (SAV Liquid Production, Flintsbach No. XTR-5000-97-1) 
• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500) 
 
Table 2. IHC using the indirect IPO-method.  
 
                     Dilution 
 
MAC387 
Antigen retrieval: proteinase K (Dako, Hamburg, No. S3020)  
Normal serum: rabbit (MP, Biomedicals, Eschwege, No. 092941149)    1:10 
Primary antibody: monoclonal mouse anti-MAC387 (Dako, Hamburg, No. M0747)  1:300 
Secondary antibody: polyclonal rabbit anti-mouse IgPO (Dako, Hamburg, No. P0161)  1:100 
 
Lysozyme 
Antigen retrieval: proteinase K (Dako, Hamburg, No. S3020)  
Normal serum: porcine  (MP, Biomedicals, Eschwege, No. 092924149)    1:10 
Primary antibody: polyclonal rabbit anti-lysozyme (Dako, Hamburg, No. A 0099)  1:50 
Secondary antibody: polyclonal swine anti-rabbit IgPO (Dako, Hamburg, No. P0217)  1:100 
 
M. tuberculosis complex 
Antigen retrieval: citrate buffer (Appendix 9.7.5.)        
Normal serum: goat (MP Biomedicals, Eschwege, No. 092939149)    1:10 
Primary antibody: polyclonal rabbit anti-M. tuberculosis complex     1:100 
(Bio-Rad, Munich, No. 220713)   
Secondary antibody: polyclonal goat anti-rabbit IgPO (Dako, Hamburg, No. 20003813)   1:10 
 
3.2.1.1.6. In situ Hybridization    
 
Non-radioactive hybridization method was performed to determine the localisation of 
mycobacteria. Previously described M. tuberculosis-oligonucteotide DNA probes were used 
as a cocktail for hybridization (AMAND et al., 2005). EU bacteria DNA probe (AMAND et 
al., 2005) was separately performed on some positive slides as control. The used probes and 
their sequences are given in Table 3.  
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Table 3. The sequences of ISH probes against mycobacterial genes.  
 
Probe Sequence 
MTB770 (5- CACTATTCACACGCGCGT-3) 
MTB226 (5- CCACACCGCTAAAG-3) 
MTB187 (5- TGCATCCCGTGGTCCTATCC-3) 
EUB338 (5- GCT GCC TCC CGT AGG AGT -3) 
 
Besides the standard protocol (see 3.2.1.1.6.1.), numerous variations of the protocol were 
performed to obtain a positive reaction. Citrate buffer, different enzyme types and their 
combinations were used for the pre-treatment step. Instead of proteinase K, achromopeptidase 
and lysozyme were used as alternative enzyme types. Red substrate kit (Vector Laboratories, 
Burlingame, No. SK-5100), in the colour reaction step, and levamisole (Applichem, 
Darmstadt, No. A4341) pre-treatment against endogenous alkaline phosphatase activity were 
tested. Furthermore, different incubation times and temperatures were applied. Alternative 
applications in some steps of the standard protocol are listed (in Chapter 3.2.1.1.6.2.). 
 
3.2.1.1.6.1. Standard Protocol of ISH  
  
• Deparaffinisation of paraffin slides for 5 min in xylene 
• Rehydration in a descending ethanol-series (100%, 96%, 70% ethanol, and aqua dest.) 
5 min each  
• 15 min incubation in proteinase K buffer (Appendix 9.8.9.) at 37˚C in the water bath 
• Deactivation of proteinase K: 2x aqua dest., 1x 96% ethanol, 5 min 100% absolute 
ethanol 
• Air-drying of the Slides 
• Hybridization: 
o Mix of solution I (Appendix 9.8.10.) and solution II (Appendix 9.8.11.), 
applying the mixed solutions on the slides and heating at 95˚C for 6 min. 
o Incubation overnight at 40˚C  
• Post-hybridization Washes: 
o 10 min immersion in SSC (2x) (Appendix 9.8.3.) 
o 10 min immersion in SSC (1x) (Appendix 9.8.4.) 
o 10 min immersion in SSC (0.1x) (Appendix 9.8.5.) 
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• Immunochemical Detection: 
o 30 min equilibration buffer (Appendix 9.8.14.) 
o 60 min anti-digoxigenin antibody solution (Appendix 9.8.15.) 
• Rinsing with 
o 15min buffer I (1x) (Appendix 9.8.12.2.) 
o 15 min buffer I (1x) (Appendix 9.8.12.2.) 
o Immersion in buffer III (Appendix 9.8.13.) 
• Colour Reaction: 
o 1 h incubation with NTB-BCIP solution (Appendix 9.8.16.), in a dark place  
• Stopping the Colour Reaction: 
o TE-buffer (1x) (Appendix 9.8.17.1.) pH 8.0 10 min 
o Aqua dest. 
• Counterstaining: 
o Immersion once in haemalaun solution (VWR, International GmbH, 
Darmstadt, No. 1.092492500) 
o Rinsing in aqua dest. 
• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440), using aqua dest. 
 
3.2.1.1.6.2. Alternative Applications for ISH 
 
ISH-M. tuberculosis complex-oligonucleotide DNA probes 
 
• Pre-treatment with proteinase K for 1 hour 
  
• Pre-treatment with higher concentration of proteinase K (Appendix 9.8.26.) 
 
• Decreased hybridization temperature: 37˚C 
 
• Pre-treatment with 1 and 10 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W  
 
•  
o Incubation of proteinase K for 30 min, 
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o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W 
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W  
o Hybridization of tissue sections at 37˚C 
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W  
o Overnight incubation with the anti-digoxigenin antibody 
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W  
o Using red substrate kit for the colour reaction 
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W 
o Incubation of tissue sections in saline sodium citrate (SSC) (2x/1x/0.1x) 
(Appendix 9.8.3.4.5.) rinse solutions, 20 min each 
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W  
o Pre-treatment with levamisole before the colour reaction  
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W 
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o Incubation of tissue sections in SSC (2x/1x/0.1x) rinse solutions at 40˚C, 20 
min each 
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W 
o Incubation of tissue sections in SSC (2x/1x/0.1x) rinse solutions at 40˚C, 20 
min each 
o Pre-treatment with levamisole (Appendix 9.8.27.) at 40˚C before the colour 
reaction  
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W 
o Incubation of tissue sections in SSC (2x/1x/0.1x) rinse solutions at 37˚C, 20 
min each, 
o Pre-treatment with levamisole at 37˚C before the colour reaction 
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W 
o Hybridization at 37˚C and incubation in SSC (2x/1x/0.1x) rinse solutions at 
37˚C, 20 min each 
 
•  
o Pre-treatment with achromopeptidase (60 U/ml) solution (Appendix 9.8.22.) 
for 30 min at 37˚C 
o Incubation in lysozyme (10 mg/ml) solution (Appendix 9.8.23.) for 1 h  
o Stopping of the enzyme treatment by incubation in 0.01 M HCl solution 
(Appendix 9.8.25.) for 5 min  
o Incubation of tissue sections in SSC (2x/1x/0.1x) rinse solutions at 40˚C, 20 
min each 
•  
MATERIALS AND METHODS 45 
o Pre-treatment with achromopeptidase (30 U/ml) and lysozyme (10 mg/ml) 
solution (Appendix 9.8.24.) for 25 min at 37˚C 
o Stopping of the enzyme treatment by incubation in 10 M tris solution 
(Appendix 9.8.20.3.) for 5 min 
o Incubation of tissue sections in SSC (2x/1x/0.1x) rinse solutions at 40˚C, 20 
min each 
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at       
800 W  
o Incubation with achromopeptidase (30 U/ml) and lysozyme (10 mg/ml) 
solution (Appendix 9.8.24.) for 25 min at 37˚C   
o Stopping of the enzyme treatment by incubation in 10 M tris solution 
(Appendix 9.8.20.3.) for 5 min  
o Incubation of tissue sections in SSC (2x/1x/0.1x) rinse solutions at 40˚C, 20 
min each 
 
•  
o Pre-treatment with 1 mM citrate buffer for 2x 5 min in the microwave oven at      
800 W, then proteinase K at 37˚C 
o Incubation with achromopeptidase (30 U/ml) and lysozyme (10 mg/ml) 
solution (Appendix 9.8.24.) for 25 min 
o Stopping of the enzyme treatment by incubation in 10 M tris solution 
(Appendix 9.8.20.3.) for 5 min 
o Incubation of tissue sections in SSC (2x/1x/0.1x) rinse solutions at 40˚C, 20 
min each 
 
•  
o Incubation with proteinase K at 37˚C, and then microwaving in 1 mM citrate 
buffer 2x 5 min at 800 W  
o Pre-treatment of tissue sections with achromopeptidase (30 U/ml) and 
lysozyme (10 mg/ml) solution (Appendix 9.8.24.) for 25 min 
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o Stopping of the enzyme treatment by incubation in 10 M tris solution 
(Appendix 9.8.20.3.) for 5 min 
o Incubation of tissue sections in SSC (2x/1x/0.1x) rinse solutions at 40˚C, 20 
min each 
 
3.2.1.2. Embedding, Sectioning and Staining Procedure for GMA Embedded Tissues 
  
The tissue samples were incubated in a rinsing solution (Appendix 9.4.1.) in a tissue processor 
(Citadel 1000, Shandon GmbH, Schwerte) for 3 h followed by an ascending ethanol-series (2x 
1 h 30%, 2x 1 h 50%, 2x 2 h 70%, 2x 2 h 96 %, 2 x 3 h 96% ethanol). 
 
The tissue samples were put into the 1:1 plastic monomer mixture of glycol methacrylate 
(GMA, Merck, Darmstadt, No. 8.00588.0250) and methyl methacrylate (MMA, Merck, 
Darmstadt, No. 8.00590.1000) for 24 h at 4˚C on a shaking device. 
 
Afterwards tissue samples were incubated in solution A of the embedding medium (Appendix 
9.4.2.) for at least 2 hours at 4˚C on a shaking device. Thereafter samples were placed in air-
tight plastic tubes containing solution B of the embedding medium (Appendix 9.4.3.) with 
benzoyl peroxide as starter of the polymerization process and N,N-dimethylaniline (Merck, 
Darmstadt, No. 803060) as accelerator. Polymerisation took place in a water bathtub in the 
fridge at 4˚C, to reduce polymerisation heat, for 24 h. After removing the polymerised plastic 
blocks from the plastic tubes, 0.5 µm sections were cut using a heavy duty rotary microtome 
(HM 360, Microm, Walldorf) with special tungsten carbide knifes with profile d. After 
mounting on object slides, sections were stained with haematoxylin eosin-phloxine or Giemsa 
staining. In addition, a silver staining was performed on selected tissue samples.  
 
3.2.1.2.1 Haematoxylin Eosin-Phloxine Staining 
 
• 5 min acidic haemalaun, after Mayer (Appendix 9.3.1.1.) 
• 10 min rinsing in running tap-water 
• 2 sec differentiation in 1% HCl alcohol (Appendix 9.5.1.1.) 
• 10 min rinsing in running tap-water 
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• 2 min air dry, first between two blotting papers, then on a heating plate (OTS 40, 
Medite Medizintechnik, Burgdorf) at 60˚C 
• 20 min eosin-phloxine ready to use solution (Appendix 9.5.1.3.) 
• 2 x 2 min rinsing in aqua dest. 
• 2 min air dry, first between two blotting papers, then on a heating plate at 60˚C 
• 2 sec xylene 
• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500) 
 
3.2.1.2.2 Giemsa Staining 
 
• 1.5 h incubation in the Giemsa ready to use solution (Appendix 9.5.2.2.) in a water 
bathtub at 65˚C 
• 2 sec phosphate-buffer (Appendix 9.5.2.1.) 
• 2 x 2 sec differentiation in 0.5% acetic-acid (Appendix 9.5.2.3.) 
• 2 sec rinsing in aqua dest. 
• 2 min air dry, first between two blotting papers, then on a heating plate at 60˚C 
• 2 sec xylene 
• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500) 
 
3.2.1.2.3. Silver Staining 
 
• 15 min incubation in 1% periodic acid (Appendix 9.5.3.5.) 
• Rinsing in aqua dest. 
• 25 min incubation in the silver nitrate solution at 65˚C (Appendix 9.5.3.3.) 
• Rinsing in aqua dest. 
• 10-20 sec toning in 0.1% gold chloride (Appendix 9.5.3.4.2.) 
• Rinsing in aqua dest. 
• 1 min incubation in 2% sodium thiosulphate (Appendix 9.5.3.6.) 
• Rinsing in aqua dest. 
• Air-drying 
• 2 sec xylene 
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• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500) 
 
3.2.1.3. Tissue Preparations for Transmission Electron Microscopy (TEM) 
 
The tissue samples were cut into small pieces approximately 1 mm³, fixed in 6.25% buffered 
glutardialdehyde (Appendix 9.6.1.2.) and then embedded in epoxy resin. The epoxy resin 
blocks were cut in semi-thin sections of approximately 0.5 µm thickness using an 
ultramicrotome (Ultracut E, Reichert und Jung, Vienna, Austria) with a histo-diamond knife 
(Diatome, Bienne, Switzerland). Staining with toluidine blue-safranin and postembedding 
immunohistochemistry with the antibody against Mycobacterium tuberculosis (Rb x tbc) were 
performed on selected cases. 
 
Similarly, ultra-thin section examination on the transmission electron microscope was carried 
out on selected cases, cases which showed a good positive reaction in IHC against 
mycobacterial antigen on semi-thin sections (especially intracellular positivity was taken into 
account). The ultra-thin sections were examined at an electron microscope (EM 10, Zeiss, 
Oberkochen) and were photographed on flat films (ES206, Maco Photo Products, Stapelfeld).  
 
3.2.1.3.1. Embedding Procedure 
 
• Washing with rinse solution (Appendix 9.6.1.3.) 
• Incubation in 1% osmium(VIII)oxide solution (Appendix 9.6.1.5.) 2 h in the fridge, 
part of the tissue blocks was not postfixed with osmium to avoid cross reactions 
between osmium and the IHC 
• Washing 3x in washing buffer, then storage in the fridge for 24 h 
• Rinsing 3x in 50% acetone (Roth, Karlsruhe, No. CP40.4) 
• 2x 10 min immersion in 70% acetone in the fridge 
• 2x 10 min immersion in 90% acetone in the fridge 
• 2x 20 min immersion in 100% acetone in the fridge 
• 1x 20 min immersion in 100% acetone (RT) 
• 1 h immersion in 100% acetone/epon  
• 2x 30 min immersion in epon (Appendix 9.6.1.6.) 
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• Embedding the tissue samples in fresh epon and storage at 60˚C for 48 h 
• Cutting process of the resin blocks 
• Drying of sections at 60˚C before the next staining procedures 
 
3.2.1.3.2. Toluidine Blue-Safranin Staining of Semi-thin Sections 
  
• Short fixation of the air-dried tissue sections over a flame  
• Staining with toluidine blue for 45 sec (Appendix 9.6.2.1.) 
• Rinsing with aqua dest. 
• Counterstaining with safranin (Appendix 9.6.2.2.) 
• Air-drying 
 
3.2.1.3.3. Postembedding Immunohistochemistry on Semi-thin Sections  
 
• 2-3 min keep of sections at 80˚C, then storage overnight at 60˚C  
• 1 h incubation in sodium ethylate solution to remove the epon (Appendix 9.7.9.) 
• Immersion 3x in 100% ethanol 
• Rehydration in a descending ethanol-series (2x 2 min in 100% l, 2x 2 min in 96%, 1x 
2 min 70% ethanol) 
• Immersion in aqua dest. 
• 10 min incubation in 1% H2O2 (only used for samples treated with osmium to remove 
the osmium) (Appendix 9.7.6.) 
• 5 min rinsing in TBS (Appendix 9.7.1.) 
• 30 min incubation with normal goat serum, diluted 1:10  
• 1 h incubation with the primary antibody (polyclonal rabbit anti-Mycobacterium 
tuberculosis complex antibody, Bio-Rad, Munich, 220713), dilution 1:100 
• 5 min rinsing in TBS (Appendix 9.7.1.) 
• 1 h incubation with secondary antibody (polyclonal goat anti-rabbit IgPO, Dako, 
Hamburg, No. 20003813) dilution 1:100 
• 5 min rinsing in TBS (Appendix 9.7.1.) 
• 30 min incubation with avidin-biotin complex 1:100 (ABC) (Appendix 9.7.8.) 
• 5 min rinsing in TBS (Appendix 9.7.1.) 
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• 3 min incubation with H2O2 and 3,3`-diaminobenzidine tetrahydrochloride (Appendix 
9.7.7.) 
• 5 min rinsing in running tap-water 
• 30 sec immersion in 10% haemalaun (Appendix 9.3.1.1.) 
• 5 min rinsing in running tap-water 
• Dehydration with ascending ethanol-series (70%, 96%, 100% ethanol) 
• Clearing in xylene 
• Mounting with cover slips (Engelbrecht, Edermünde, No. k 12440) and a mounting 
medium (K. Hecht, Sondheim, Histokitt, No. 1025/500) 
 
3.2.1.3.4. Preparation and Contrasting of Ultra-thin Sections 
 
• The ultra-sections of approximately 70 nm thickness were cut from the resin blocks of 
preselected tissue samples  
• Mounting the ultra-sections on formvar film-coated cooper grids 
• 30 min contrasting with uranyl acetate (Appendix 9.6.3.1.) 
• Rinsing in aqua dest. 
• Air-drying the sections  
• Contrasting with lead citrate (Appendix 9.6.3.2.) 
• Rinsing in aqua dest. 
• Air-drying  
 
3.2.2. Methods for Positive Control Materials 
 
To prepare positive control blocks, the bacteria M. kansasii and M. bovis BCG subtype were 
cultured in Loewenstein-Jensen medium in glass tubes at the Institute of Microbiology. After 
the colonies were recognizable, 4% buffered formalin (Appendix 9.2.1.) was added in the 
tubes and fixed for 2 days. After the fixation process, the bacteria were placed in the tissue 
embedding capsules. Two different embedding methods were used to embed the 
mycobacteria: first method was done using agar (see 3.2.2.1.) and the second method was 
done without agar (see 3.2.2.2.). 
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3.2.2.1. Method with Agar 
 
• Mix aqua dest. and agar powder (Agar-Agar, Kobe I, Roth, Karlsruhe, No. 5210.3) 
• Heat the agar-aqua dest.-mix in the microwave oven at 800 W  
• Draining formalin from the tube 
• Filling up the metal embedding tubes with the agar 
• Taking little pieces from culture consisting of bacteria, using a spatula  
• Embedding bacteria into the agar  
• Embedding in paraffin, GMA or epoxy 
• Further staining procedures (including H&E, Giemsa and FF staining), 
immunohistochemical investigations and examination using the TEM were performed 
as described above for the tissue sections.  
 
3.2.2.2. Method without Agar 
 
• Take out the bacteria from the culture by a spatula 
• Put into a piece of blotting paper to prevent slipping of the material 
• Embedding in paraffin, GMA or epoxy 
• Further staining procedures (including H&E, Giemsa and FF staining), 
immunohistochemical investigations and examination using the transmission electron 
microscope were performed as described above for the tissue sections.  
 
The same procedures as applied to materials from the diseased cattle were performed on the 
positive control material. 
 
3.2.5. Measuring of the Mean Diameter of the Granulomas and Statistical T-Test  
 
A total of 668 granulomas were measured, 251 and 417 granulomas presented pattern I and 
pattern II, respectively. The mean diameters of the granulomas were analysed using Ferret’s 
diameter methods (Videoplan® image analysis system, Zeiss-Kontron, Erding) using colour 
prints of macroscopic pictures of affected organs. The mean diameter values were compared 
using T-test program of the Microsoft Office Excel 2007 program.  
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4. RESULTS 
 
4.1. Materials 
 
4.1.1. Numbers of Investigated Animals 
 
Post-mortem investigations were performed on 241 cattle with suspected bovine tuberculosis 
(bTB), on the basis of a positive dermal tuberculin test. They were examined for the presence 
of macroscopic lesions compatible with bTB. Tissue samples were collected from the cattle 
with tuberculous lesions for detailed histological and bacteriological investigations. 
 
4.1.2. Cattle Diagnosed with Bovine Tuberculosis 
 
Eighty-four out of 241 necropsied animals showed macroscopic lesions, which were 
compatible with tuberculosis. The collected tissue samples for bacteriological investigation 
were submitted to the ‘Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit’ in 
Oberschleissheim. Bovine tuberculosis was confirmed by the bacteriological detection of M. 
caprae in the investigated herds.  
 
4.1.3. Distribution and Quantification of Macroscopic Lesions in the Examined Organs  
 
Collected tissue samples consisted of lung, liver, small intestine, their regional lymph nodes 
and the retropharyngeal lymph nodes. The quantity of the affected organs is demonstrated in 
Table 4.  
 
In lungs, the lesions occurred in different lobes. There was only one lobe in which the pleura 
was also affected.  
 
Similarly affected livers showed lesions in their different lobes and in one case the 
peritoneum was affected, too. The small intestine showed a focal lesion in the ileum on the 
edge of a Peyer’s patch. In lymph nodes, lesions were observed both in the cortical and 
medullary zones.  
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Table 4. Number of affected organs in 84 animals. 
 
Lung 11 
Mediastinal lymph node 20 
Small intestine 1 
Mesenterial lymph node 63 
Liver 5 
Portal lymph node 11 
Retropharyngeal lymph node 6 
 
4.2. Investigations on Positive Control Material 
 
The positive control slides were prepared using cultivated M. bovis BCG and M. kansasii 
provided by the Institute for Infectious Diseases and Zoonoses. The main purpose for the 
positive control material was to demonstrate that the immunohistochemistry against 
mycobacterial antigen works reliably.  
 
4.2.1. Paraffin Sections 
 
All paraffin sections of the positive control material were stained with H&E, Giemsa, and the 
acid-fast staining according to Fite-Faraco (FF staining). Mycobacteria were detected on the 
top surface and slightly in the inner side of the agar medium. Acid-fast rods appeared as pink-
reddish, purple and red in H&E, Giemsa and FF staining, respectively. The positive 
immunohistochemical reaction presented as dense brown spots in the same localisation as 
seen in other staining methods (Fig. 1). The bacteria were displayed light purple by ISH, but 
the reaction was only weakly positive. 
 
RESULTS 55 
 
Figure 1. M. bovis positive control. Paraffin section:  
A: Overview of H&E staining. Right: Higher magnification of the square, bacilli can be recognized 
(B) in Giemsa staining (purple), (C) in FF staining (red), (D) in immunohistochemistry for 
mycobacterial antigen (dark brown reaction); E 2245/14; bars in A = 1 mm, B, C and D = 50 µm. 
 
4.2.2. Plastic (GMA) Sections 
 
H&E and Giemsa staining were performed for plastic (GMA) sections and the bacilli were 
detected in red and purple colours on the top surface and slightly on the inner side of the agar 
medium (Fig. 2). 
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Figure 2. M. bovis positive control. GMA section:  
A: H&E staining, bacilli can be seen. B: Giemsa staining, bacilli can be seen purple in the same area; 
E 2245/14; bars in A and B = 25 µm. 
 
4.2.3. Semi-thin Sections 
 
On the semi-thin sections, toluidine blue-safranin staining and IHC against mycobacterial 
antigen were performed. The rod-shaped bacteria appeared in red colour. They were found 
scattered within the agar medium. The mycobacterial antigen was demonstrated as compact, 
dark brown spots at the same localisation as in the toluidine blue-safranin staining (Fig. 3). 
   
4.2.4. Transmission Electron Microscopy (TEM) 
 
The ultra-sections of the acid-fast bacilli were investigated using TEM. Longitudinal and 
cross sections of bacteria are demonstrated in the Figure 4.  
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Figure 3. M. bovis positive control. Semi-thin section: 
A and B: Toluidine blue-safranin staining. C: Bacilli can be recognized in anti-mycobacterium 
immunohistochemistry (dark-brown positive reaction); E 1588/14; bars in A = 200 µm, B and C = 25 
µm. 
 
 
Figure 4. Longitudinal and cross sections of M. bovis BCG in TEM. 
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4.3. Investigations on Material of Cattle with Bovine Tuberculosis 
 
4.3.1. Macroscopic Findings of Bovine Tuberculosis  
 
The macroscopic appearance of the tuberculous lesions could be classified into five patterns 
according to three measurements, i. the macroscopically visible components of the 
inflammation (yellowish caseous necrosis with or without calcification, light brown areas of 
inflammation, greyish fibrous tissue), ii. the arrangement of these components (concentric 
layering of the three components or an unordered arrangement within the affected organ), and 
iii. the number and size of the tuberculous foci. The lungs showed additional macroscopic 
features (liquefying necrosis and cavitating tuberculosis), which were described separately. 
The study of RIESEBERG (2016) has also described macroscopic patterns; these patterns 
were revised and additionally compared with the histologic alterations in this study. 
 
4.3.1.1. Patterns of Macroscopic Alterations  
 
4.3.1.1.1. Pattern I 
 
This pattern occurred as solitary or rarely multiple roundish foci measuring between 0.5 and 
2.4 cm in diameter (Fig. 5 and 6). These foci were characterised by the presence of three 
concentric layers on the cut section. The two outer layers were the most prominent in large 
lesions. The centre was yellowish, dry, eventually greasy and showed white-yellowish 
irregular foci, which crepitated during cutting. Adjacent, there was a narrow light brown zone 
with scattered small pale foci, surrounded by the outer large whitish-grey zone. 
 
In addition to the macroscopic view the histological overview showed that the centre 
consisted of caseous necrosis with irregular calcified foci; followed by a middle layer of 
inflammatory cell infiltration, and an outer fibrous capsule. 
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Figure 5. Macroscopic pattern I of bovine tuberculosis: 
A: Macroscopy; focal, roundish, tuberculous granuloma (tubercle) with a yellow, dry centre with 
yellowish to white irregular foci, surrounded by a narrow light brown zone, and an outer large, 
whitish-grey zone (the organ was fixed in Klotz´s solution). B: Histology; central necrosis with 
calcification, surrounded by inflammatory cells and a capsule of fibrous connective tissue; liver,         
E 110/09, H&E (GMA); bars in A = 1cm, B = 1 mm. 
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Figure 6. Macroscopic pattern I of bovine tuberculosis: 
A: Macroscopy; multifocal, roundish tuberculous granulomas (tubercles) with a yellow, dry centre 
with yellowish to white irregular foci, surrounded by a narrow light brown zone and an outer whitish-
grey zone (the organ was fixed in Klotz´s solution). B: Histology; central necrosis with calcification, 
surrounded by inflammatory cells and a capsule of fibrous connective tissue; mediastinal lymph node, 
E 110/09, H&E (Paraffin); bars in A = 1 cm, B = 2 mm. 
 
4.3.1.1.2. Pattern II 
 
The form and organisation of the foci in pattern II was similar to the foci in Pattern I. In 
contrary to pattern I, they occurred generally multifocal (on the sectional surface up to 124 
foci) and the foci were smaller than the foci of pattern I with up to 0.5 cm in diameter (Fig. 7). 
Histologically, the same layering was visible as seen in pattern I. Pattern I and II could be 
distinguished only by the size and number of foci. This was confirmed by measuring large 
number of foci in cases from both patterns (see 4.3.4).  
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Figure 7. Macroscopic pattern II of bovine tuberculosis: 
A: Macroscopy; small, multifocal yellowish circumscribed granulomas (tubercles) (the organ was 
fixed in Klotz´s solution). B: Histology; regular layers of multiple typical tubercles; lung, S 605/13, 
H&E (Paraffin); bars in A = 1 cm, B = 2 mm.  
 
4.3.1.1.3. Pattern III 
 
Macroscopic lesions classified under this pattern had not a clearly layering structure in 
comparison with patterns I and II. Frequently, large areas of the organ (lung) or the complete 
cut surface (lymph nodes) were altered. The lesions consisted of irregularly formed pale foci 
(Fig. 8) or the cut surface was completely greasy-yellow with intercalated pale, not well 
distinguishable foci (Fig. 9). Histologically, there was a disorderly coexistence of caseous 
necrosis, lymphocyte aggregates, and an irregularly formed fibrosis.  
RESULTS 62 
 
Figure 8. Macroscopic pattern III of bovine tuberculosis: 
A: Macroscopy; greasy-yellowish cut surface with multiple irregularly formed, yellow foci (the organ 
was fixed in Klotz´s solution). B: Histology; necrosis, inflammatory infiltrates and fibrous tissue 
irregularly intermingled without a regular layering; mediastinal lymph node, E 108/09, H&E 
(Paraffin); bars in A = 1 cm, B = 2 mm. 
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Figure 9. Macroscopic pattern III of bovine tuberculosis: 
A: Macroscopy; the whole cut surface consisted of irregular yellow and light-grey foci (the organ was 
fixed in Klotz´s solution). B: Histology; unregular accumulations of necrosis, inflammatory cells and 
fibrous tissue; mediastinal lymph node, E 322/09, H&E (Paraffin); bars in A = 1 cm, B = 2 mm. 
 
4.3.1.1.4. Pattern IV 
 
Pattern IV was characterised by the extent of the lesion. Frequently, the entire cut surface of 
the lymph node was altered (Fig. 10). The lesion consisted predominantly of the caseation. 
The middle and the outer layers of the typical tubercles were clearly smaller than in pattern I 
or not discernible. 
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Figure 10. Macroscopic pattern IV of bovine tuberculosis: 
A: Macroscopy; yellow, well-circumscribed foci of caseating necrosis with a thin capsule of light 
brown tissue. B: Histology; predominant necrosis, surrounded by a small layer of inflammatory cells 
and fibrous tissue; mesenterial lymph node, E 110/09, H&E (Paraffin); bars in A= 1 cm, B = 2 mm. 
 
4.3.1.1.5. Pattern V 
 
This pattern occurred generally in combination with pattern I. Main feature of this pattern was 
the formation of cavities caused by liquefaction of the caseated tissue (cavitating tuberculosis) 
(Fig. 11). The histological overview showed remnants of caseous necrosis adjacent to a 
central cavity surrounded by an extensive accumulation of inflammatory cells consisting 
predominantly of neutrophilic granulocytes. Discrete infiltrates of other inflammatory cells 
were visible in the lesion periphery (Fig. 11). 
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Figure 11. Macroscopic pattern V of bovine tuberculosis: 
A: Macroscopy; multiple, roundish, yellowish tubercles, some of them with cavities. B: Histology; a 
central cavity surrounded by caseous necrosis, inflammatory cell infiltrations and fibrous tissue with 
layer formation; lung, S 770/13, H&E (GMA); bars in A = 1 cm, B = 1 mm.  
 
4.3.1.1.6. Lung – Additional Macroscopic Alterations (Macroscopic pattern VI) 
 
In the lung, a further pattern of alterations could be found in addition to the five macroscopic 
patterns described above (Fig. 12). Individual lung lobules or parts of lung lobules were 
showing a brown discoloration with irregular yellowish foci. The surface was moister than the 
surrounding lung area. Severe alveolar oedema with focal acute degeneration of lung 
parenchyma was obvious in the histological overview.  
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Figure 12. Macroscopic pattern VI of bovine tuberculosis: 
A: Macroscopy; individual lobule with brownish discoloration and small yellow, irregular formed foci 
(the organ was fixed in Klotz´s solution); E323/09. B: Histology; severe alveolar oedema, oligofocal 
inflammatory cell infiltrates and necrotic areas; lung, E 322/09, H&E (GMA); bars in A = 1 cm,         
B = 1 mm. 
 
4.3.1.2. The Differentiation of Macroscopic Pattern I and II   
 
Although there was a striking difference in the size of the foci between macro-patterns I and 
II at the macroscopic point of view, this distinction could not be well determined in the 
histological investigations. For that reason, this question was analysed using t-test method in 
Excel-07. The null hypothesis was ‘pattern I is equal in diameter to pattern II’. The mean 
diameter values of each tuberculous granuloma of both patterns were measured. These mean 
diameter values were listed under pattern I and II in Excel-07. The calculated t-value showed 
that the probability of the null hypothesis was extremely low. Thus, it could be proved that 
there was a significant difference in diameter between patterns I and II. 
 
4.3.1.3. Quantification of the Macroscopic Patterns 
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The macroscopic lesions from 76/84 animals were evaluated previously, as seen in the study 
of Rieseberg (RIESEBERG, 2016).  
 
In the present study, the macroscopic lesions were revaluated and two of them were re-
classified. The total numbers of macroscopic patterns are demonstrated in Table 5. 
 
Table 5. The total numbers of macroscopic patterns seen in the organs affected by tuberculosis. 
 
Pattern I 23 
Pattern II 14 
Pattern III 42 
Pattern IV 4 
Pattern V 7 
 
4.3.1.4. Organ Distribution of the Macroscopic Patterns 
 
The numbers of patterns detected in each organ are summarized in Table 6. The macroscopic 
lesions of the lungs and the lymph nodes showed different patterns. All liver samples and the 
intestinal sample were compatible with pattern I.  
 
Table 6. The distribution of the five macroscopic patterns in the individual organs. 
 
Organ Pattern I Pattern II Pattern III 
Pattern 
IV Pattern V 
Lung 4 2 1 - 3 
Mediastinal lymph node 3 4 7 - 1 
Small intestine 1 - - - - 
Mesenterial lymph node 9 5 33 4 2 
Liver 2 - - - - 
Portal lymph node 2 - 2 - - 
Retropharyngeal lymph node 2 2 - - 1 
 
4.3.1.5. Possible Routes of Infection 
 
On the basis of the distribution of the lesions in the different organ systems, possible routes of 
transmission (portal of entrance) were determined. Lesions restricted to the gastrointestinal 
tract including intestine, mesenterial lymph nodes, liver and portal lymph nodes were defined 
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to the originate from the alimentary infection route. Lesions restricted to the respiratory tract 
including lung and mediastinal lymph nodes were defined to reflect an aerogen transmission 
type. All combinations of lesions in the gastrointestinal tract, the respiratory tract and other 
organs were defined to display combination of the aerogen and alimentary transmission route. 
 
A total of 68%, 19% and 13% of animals acquired tuberculosis via alimentary, aerogen, and 
via both transmission ways, respectively. 
 
4.3.2. Histological Findings of Bovine Tuberculosis 
 
4.3.2.1. Components of Tuberculous Granulomatous Inflammation   
 
All tissue samples showing macroscopic lesions were examined for histopathological 
diagnosis (in a pre-study tissue samples from macroscopically unaltered organs were 
examined histologically, no lesions pointing to an infection could be found). The diagnostic 
inclusion criterion was the presence of a granulomatous inflammation, as a possible sign for 
bovine tuberculosis. Histological diagnoses were evaluated through H&E, Giemsa, Masson´s 
trichrome, and Silver staining methods. In addition, immunohistochemical methods were 
utilized to determine the type of cells and their localisation within the lesions.  
 
The granulomatous inflammation seen in the tissue sections was principally composed of 
macrophages (epithelioid cells), commonly accompanied by multinucleated giant cells 
(MNGC) of the so-called Langhans-type. The other components of a tuberculous 
inflammation consisted of a caseous necrosis with or without amorphous multiple calcified 
foci, infiltration of neutrophilic polymorphonuclear granulocytes, lymphocytes, plasma cells, 
and fibrous tissue proliferation. These components were found mostly together within a 
granuloma, but sometimes epithelioid cells and/or MNGCs were the only participants.  
 
Tuberculous granulomatous inflammation showed distinct histological appearances, similarly 
as seen macroscopically (see 4.3.1.1.). Histological lesions were characterised by two main 
types epithelioid cell granulomatous inflammation and tubercles containing the cytological 
components described above. Granulomas (tubercles) occurred as solitary, multiple or 
coalescent foci.  
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Epithelioid cell granulomatous inflammations were seen as small or large clusters of 
epithelioid cells and commonly MNGCs. Epithelioid cell granulomatous inflammations could 
also be associated with an encapsulation by thin fibrous connective tissue or a small central 
necrotic area often associated with a small number of neutrophils.  
 
The components of the tuberculous inflammation appeared mainly either in a concentric 
layering or in an irregular arrangement. In the first type central caseous necrosis with 
calcification was surrounded by neutrophils, epithelioid cells, and MNGCs as the first zone of 
the inflammatory reaction, which was then followed by lymphocytes and smaller numbers of 
plasma cells. The outer layer was characterised by an encapsulation with fibrous connective 
tissue. In the second histological type, the components are arranged in a totally unordered 
manner. 
 
The characteristic features and localisations of the components within a tubercle structure 
were described in the following: 
 
4.3.2.1.1. Caseous Necrosis and Calcification 
 
Caseation was a special form of coagulation necrosis typical for tuberculosis. The 
characteristic feature for caseation should be its relatively high lipid content. Macroscopically, 
the caseation was a pale, yellowish, solid elastic, dry material with fatty gloss. Histologically, 
the caseation represented as almost amorphous, distinct eosinophilic mass. A caseation could 
occur in various types of the tuberculous inflammation: in the epithelioid cell granulomatous 
inflammation, in the classical tubercle, with in fibrous foci, and in the acute tuberculous 
inflammation of the lung. 
 
In the epithelioid cell granulomatous inflammation, caseation could occur in the centre of the 
foci (Fig. 13). It could not be determined, whether the occurrence of the caseation depended 
on a particular size of the foci, because no serial sections were prepared. Thus, in areas with 
numerous foci caseation could be found in individual tubercles only (Fig. 13 A), while others 
were found as solid cell accumulations. The size of the caseation could only be estimated in 
relation to the size of the entire focus (Fig. 13 B and C). A pale border around a caseation in 
H&E stainings pointed commonly to a fatty degeneration of the epithelioid cells (Fig. 13 B 
and C). But a sudden change of intact cells to caseation occurred, too (Fig. 13 D). 
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Figure 13. Caseation and calcification in bovine tuberculosis: 
A: Numerous foci with epithelioid cell granulomatous inflammation; central caseation is found in 
several foci, the other foci consist only of intact cells; mesenterial lymph node, S 413/14, H&E 
(GMA). B: Focal epithelioid cell granulomatous inflammation with central caseation; a pale rim of 
fatty degenerated epithelioid cells surround immediately the caseation; mesenterial lymph node,          
S 413/14, H&E (GMA). C: Focal epithelioid cell granulomatous inflammation with extensive central 
caseation and a beginning calcification; again with a pale rim of fatty degenerated epithelioid cells; 
mesenterial lymph node, S 413/14, H&E (GMA). D: Focal epithelioid cell granulomatous 
inflammation, the border between the caseation and the intact epithelioid cells is clearly demarcated, 
there is no indication of fatty degeneration; mesenterial lymph node, E 97/09, H&E (GMA); bars in   
A = 1 mm, B and C = 200 µm, D = 100 µm. 
 
The central caseation was the main component in large classic tubercles (Fig. 14 A). Mostly, 
the outer line of the caseation was not completely round; the cause is explained below (see 
4.3.2.2.). Foci of calcification could occur in the caseation (see below and Fig. 14 A). 
Commonly, fatty degenerated epithelioid cells were found adjacent to the caseation (Fig. 14 B 
and C). Despite the apparent amorphousness of the caseation in the H&E section, different 
amounts of fiber remnants could often be detected in the Silver staining (Fig. 14 D), which 
could point to a previously existing fibrous capsule. 
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Figure 14. Caseation and calcification in bovine tuberculosis: 
A: Typical tubercle with extensive central caseation and multiple foci of calcification; the outer line of 
the caseation is irregularly formed; a pale rim of fatty degenerated epithelioid cells immediately 
around the caseation; liver, E 110/09, H&E (GMA). B: Band of fatty degenerated epithelioid cells 
between the central caseation (above) and intact epithelioid cells and lymphocytes (below); 
mesenterial lymph node, S 413/14, H&E (GMA). C: Ultrastructure of epithelioid cells with marked 
accumulation of lipid droplets in the cytoplasm; the cells show numerous finger-like projections of the 
cell membrane, typical for epithelioid cells; mesenterial lymph node, E 325/09, TEM. D: Remnants of 
collagen fibres in the centre of an extensive caseation focus; liver, E 110/09, Silver staining (GMA); 
bars in A = 1 mm, B and D = 100 µm. 
 
The occurrence of caseation in fibrous foci (Fig. 15) was related to an infiltration with 
inflammatory cells, especially with epithelioid cells (Fig. 15 A). These cells could then 
undergo caseation (Fig. 15 B) with simultaneous lysis of collagen fibres (see 4.3.2.1.3.). 
 
 
 
Figure 15. Caseation and calcification in bovine tuberculosis: 
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A: Infiltration of epithelioid cells and lymphocytes in an extensive fibrosis near a large tubercle (top 
right calcification); mesenterial lymph node, E 97/09, H&E (GMA). B: Caseation necrosis of the 
epithelioid cells in fibrous connective tissue; mesenterial lymph node, E 108/09, H&E (GMA); bars in  
A = 100 µm, B = 50 µm. 
 
The acute inflammation of the lung (Fig. 16) was accompanied by a severe alveolar 
pulmonary oedema. Foci developed in this oedema that striked by their strong eosinophilia 
(Fig. 16 A and B). There were only a few inflammatory cells at the beginning; later the 
infiltration with neutrophils and epithelioid cells appeared, followed by an encapsulation by 
fibrous connective tissue. In addition to the oedema, fibrin is presumably also involved (Fig. 
16 B) in the development of this caseation form. The degree of lung parenchyma destruction 
was more obvious in Silver staining (Fig. 16 C and D).  
 
 
Figure 16. Caseation and calcification in bovine tuberculosis: 
A: Acute tuberculous inflammation of the lung, there is a focal necrosis within a severe alveolar 
pulmonary oedema, the focal necrosis is characterised by its amorphousness and a severe eosinophilia; 
lung, E 322/09, H&E (GMA). B: At the high magnification, an indistinct layering of the caseation is 
visible, which possibly develops through deposition of fibrin; the number of inflammatory cells is still 
few in this early stage; lung, E 322 /09, H&E (GMA). C: The destruction of the lung parenchyma is 
obvious in the Silver staining; lung, E 322/09, Silver staining (GMA). D: Degeneration of oedematous 
alveolar septa develops at the borders of the focal necrosis; lung, E 322/09, Silver staining (GMA); 
bars in A = 200 µm, B and D = 50 µm, C = 100 µm. 
 
In addition to the caseation, calcification (Fig. 17) is also a characteristic process in bovine 
tuberculosis. Calcification was and is an important diagnostic indication of the presence of 
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tuberculosis in cattle and man. Foci of calcification occurred within the caseation of tubercles 
(Fig. 17 A) and in the caseation of the epithelioid cell granulomatous inflammation (Fig. 17 
B). The calcifications were often found nearby the tubercle centre. In the epithelioid cell 
granulomatous inflammation, the calcification developed in the caseation as well (Fig. 17 C), 
but occasionally the epithelioid cells showed direct calcification (Fig. 17 D) without previous 
caseation. 
 
 
Figure 17. Caseation and calcification in bovine tuberculosis: 
A: Several typical tubercles in a lymph node with extensive caseation; the calcificated foci are 
irregularly formed and are found in the centre of the caseation; mesenterial lymph node, E 113/09, 
H&E (Paraffin). B: Foci of epithelioid cell granulomatous inflammation with central foci of 
calcification; the plastic embedded tissue is not decalcified, therefore calcification frequently breaks 
out during cutting; mesenterial lymph node, S 413/14, H&E (GMA). C: Focal epithelioid cell 
granulomatous inflammation with caseation and central calcification; mesenterial lymph node,            
S 602/14, H&E (GMA). D: Focus of epithelioid cell granulomatous inflammation with a direct central 
calcification of degenerated cells without visible caseation; mesenterial lymph node, S 413/14, H&E 
(GMA); bars in A = 2 mm, B = 200 µm, C = 100 µm, D = 50 µm. 
 
4.3.2.1.2. Inflammatory Cells 
 
4.3.2.1.2.1. Epithelioid Cells and Multinucleated Giant Cells 
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Epithelioid cells and multinucleated giant cells are components of the mononuclear phagocyte 
system (MPS). They are the crucial cells for the classification of an inflammation into the 
group of granulomatous inflammations. 
 
In tuberculous lesions in cattle, epithelioid cells appeared in two different arrangements. That 
could be as a component of a classic granulomatous inflammation, in a tubercle (Fig. 18 A 
and B) or as the predominant participant of the epithelioid cellular granulomatous 
inflammation (Fig. 18 C and D). Dendritic cells were another relevant cell type for the 
tuberculous inflammation, but they could not be identified through routine staining. 
 
 
Figure 18. Cytology of epithelioid and multinucleated giant cells in bovine tuberculosis: 
A: Epithelioid cells are located in the typical tubercle in a narrow, light zone (arrows) between the 
central caseation (1) and the zone with lymphocytes (2); mesenterial lymph node, S 598/14, H&E 
(GMA). B: Epithelioid cells form a narrow, eosinophilic band (arrow) between caseation (1) and the 
zone with lymphocytes (2); a vacuolisation of the cells is recognizable; adjacent is a fibrous capsule 
(3); mesenterial lymph node, S 598/14, H&E (GMA). C: Overview of a lymph node with numerous 
foci of epithelioid cell granulomatous inflammation; the foci are irregularly formed and have different 
sizes; mesenterial lymph node, S 594/14, H&E (Paraffin). D: Multiple foci with epithelioid cell 
granulomatous inflammation; the foci are almost homogenously organised, consist exclusively of 
cells, show no layering and have no central caseation; mesenterial lymph node, S 413/14, H&E 
(GMA); bars in A, C = 1 mm, B = 100 µm, D = 200 µm.  
 
Epithelioid cells were usually located in a small zone between the central caseous necrosis 
and the lymphocytic inflammatory zone in a tubercle (Fig. 18 A and B). At the lower 
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magnification in the H&E staining, this zone was mostly recognized as a light coloured 
margin around the caseous necrosis (Fig. 18 A). 
 
At the higher magnification, these cells appeared in a typical epithelioid cell morphology (see 
below) (Fig. 19 A and B) or they were vacuolated (Fig. 19 C and D), especially in close 
neighbourhood to the caseation. In semi-thin sections stained with Toluidine blue-safranin, 
the stored material within the vacuoles appeared as lipids (Fig. 19 E). 
 
 
Figure 19. Cytology of epithelioid and multinucleated giant cells in bovine tuberculosis: 
A: Zone with epithelioid cells (arrow) between caseation (1) and the zone with lymphocytes (2); 
retropharyngeal lymph node, S 409/14, H&E (GMA). B: The picture shows predominantly epithelioid 
cells with an extensive, eosinophilic cytoplasm; cell borders are not visible; the nucleus is lightly 
coloured, rich of euchromatin and has numerous small nucleoli; there are interspersed lymphocytes 
and single neutrophils; at the right border of the picture beginning caseation; retropharyngeal lymph 
node, S 409/14, H&E (GMA). C: Severe vacuolisation of epithelioid cells adjacent to the caseation; 
mesenterial lymph node, S 413/14, H&E (GMA). D: Vacuolisation of numerous epithelioid cells, in 
addition neutrophils and lymphocytes; retropharyngeal lymph node, S 409/14, H&E (GMA).             
E: Numerous intracytoplasmic blue coloured fat droplets are recognisable in the semi-thin section 
stained with Toluidine blue-safranin; mesenterial lymph node, E 325/09, TEM, (TEM No: 4938/3),                           
bars in A, C = 50 µm, B, D, E = 25 µm.  
 
The epithelioid cell granulomatous inflammation occurred in various extensions: from 
individual cells, which were clearly visible especially in lymph nodes, to extensive cell 
accumulations (Fig.18 D). The quantity of foci with epithelioid cells was also variable (Fig.18 
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C). The characteristic features of epithelioid cell granulomatous inflammation, in contrast to 
the tubercles, were the lack of layering of the cells, the irregular form of the foci, and the 
predominance of the epithelioid cells within the foci (Fig. 20 A and B). It has already been 
mentioned that the epithelioid cell granulomatous inflammation was frequently surrounded by 
lymphocytes easily recognizable in the lung (Fig. 20 B). The possibility of caseation within an 
epithelioid cell granulomatous inflammation is described in Chapter 4.3.2.1.1. 
 
 
Figure 20. Cytology of epithelioid and multinucleated giant cells in bovine tuberculosis: 
A: Overview of an epithelioid cell granulomatous inflammation, the roundish foci are homogenously 
organised and surrounded by a margin of lymphocytes; lung, E 322/09, H&E (GMA). B: Coalescent 
foci of epithelioid cell granulomatous inflammation, surrounded by lymphocytes; lung, E 322/09, 
H&E (GMA). C: Typical epithelioid cells with extensive eosinophilic cytoplasm, indistinct cell 
borders, elongated and partly indented, bright, vesicular nuclei with numerous small nucleoli; in the 
edge regions lymphocytes; lung, E 322/09, H&E (GMA). D: Specially the numerous small nucleoli 
within the vesicular nucleus are obvious in the Giemsa staining; lung, E 322/09, Giemsa (GMA); bars 
in A = 100 µm, B = 50 µm, C, D = 25 µm. 
The epithelioid cells were large cells with abundant, eosinophilic cytoplasm in H&E stainings 
(Fig. 20 C). The cell borders of the epithelioid cells were indistinct. The nucleus was large, 
had an elongated, often shoe soles like shape or was occasionally deeply indented; the nucleus 
was pale and vesicular (rich in euchromatin). The nucleoli were numerous (up to eight per 
nucleus), small and usually located near the nuclear wall which was clearly seen especially in 
the Giemsa stained slides (Fig. 20 D). Ultrastructural, mitochondria and a distinct rough 
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endoplasmic reticulum dominated (Fig. 21 A). Nucleus and nucleoli correlated to the light 
microscopical description. The surface of the epithelioid cells was irregularly formed. 
 
 
Figure 21. Cytology of epithelioid and multinucleated giant cells in bovine tuberculosis: 
A: Overview of the ultrastructure of epithelioid cells; they possess extensive cytoplasm, which 
contains numerous organelles, the surface of the cells is pleomorphic; there are mainly lymphocytes 
beside the epithelioid cells. B: A high magnification of A; the extensive cytoplasm contains numerous 
mitochondria and a well formed endoplasmic reticulum; the nucleus has scant heterochromatin, which 
is located predominantly at the nuclear wall; mesenterial lymph node, E 325/09, TEM.  
 
Multinucleated giant cells occurred, just as the epithelioid cells, in two localisations: in the 
epithelioid cell granulomatous inflammation (Fig. 22 A) or within the tubercle in the 
neighbourhood to central caseation (Fig. 22 B). Individual cells could be found among the 
autochthonous lymphocytes of the altered lymph nodes. In these two localisations, they were 
lacking (Fig. 20 B), occurred in small amounts (Fig. 22 C) or large amounts, so that they were 
the predominant cell type (Fig. 22 D).  
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Figure 22. Cytology of epithelioid and multinucleated giant cells in bovine tuberculosis: 
A: Foci with epithelioid cell granulomatous inflammation with a higher content of multinucleated 
giant cells in a lymph node; mesenterial lymph node, S 414/14, H&E (GMA). B: Tubercle with 
numerous multinucleated giant cells in the epithelioid cell zone adjacent to the central caseation; 
mesenterial lymph node, S 594/14, H&E (GMA). C: Epithelioid cell granulomatous inflammation 
with a single multinucleated giant cell; mesenterial lymph node, S 606/14, H&E (GMA). D: 
Epithelioid cell granulomatous inflammation consisting predominantly of multinucleated giant cells; 
mesenterial lymph node, S 612/14, H&E (GMA); bars in A = 200 µm, B =100 µm, C, D = 50 µm. 
 
Langhans-type giant cell was the typical multinucleated cell for the tuberculosis. The diameter 
of the roundish giant cell was up to 120 µm. Elongated cells could reach a length of 160 µm. 
The Langhans-type multinucleated giant cells had lower numbers of nuclei (up to 30 in a 
section) in comparison to foreign body-type multinucleated giant cells. The nuclei had a 
typical horse-shoe or circular arrangement at the periphery (Fig. 23 A to C). The nuclei had a 
very similar morphology among each other and had similarity with the nuclei of the 
epithelioid cells (abundant euchromatin, numerous small nucleoli). The cytoplasm was 
eosinophilic and mostly homogeneous. But there were also multinucleated giant cells with a 
mild to severe degree of vacuolisation at the periphery of the cell (Fig. 23 D and E), up to the 
presence of Touton-type giant cells (Fig. 23 F) with centrally located nuclei and a high degree 
of vacuolisation at the periphery of the cell. 
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A frequently observed phenomenon was emperipolesis, in which a viable cell penetrated into 
another living cell. These penetrating cells could be neutrophils or lymphocytes (Fig. 23 G to 
I). 
 
 
Figure 23. Cytology of epithelioid and multinucleated giant cells in bovine tuberculosis: 
A-C: Typical Langhans-type multinucleated giant cells with horse shoe-shaped (A, C) or annular (B) 
arranged nuclei; the cytoplasm is homogenous and eosinophilic; the nuclei are mainly monomorphic. 
D-F: Vacuolisation of the giant cell at the periphery of the cytoplasm, mild (D), moderate (E) and 
severe (F); the cell in F is a Touton-type giant cell with annular vacuolisation of the cytoplasm at the 
periphery and centrally arranged nuclei. G-I: Different grades of emperipolesis, mainly with 
lymphocytes, in C a single neutrophil; mesenterial lymph node, S 606/14, S 602/14, 598/14, H&E 
(GMA); bar for A-I = 10 µm. 
 
Lysozyme and the antibody against the myelomonocytic antigen calprotectin (MAC387) were 
suitable as immunohistochemical markers for cells of the mononuclear phagocyte system 
(MPS). It has been shown that lysozyme reacts only with cells of the MPS. The MAC387 
antibody detected mainly neutrophilic granulocytes, but the recognition of MPS-cells is 
difficult.  
 
Epithelioid cells in the epithelioid cell granulomatous inflammation and in tubercles showed a 
positive reaction with the antibody against lysozyme (Fig. 24). The positive reaction was 
present in the cytoplasm of the cells. The volume of the cells and the cell borders are 
distinctly visible due to the positive reaction. The nucleus was usually located eccentrical 
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(Fig. 24 A, B, D, and G); the positive reaction product was commonly not clearly related to 
the cell nucleus (Fig. 24 C). The intensity of the positive reaction in the cells was seen in 
varying degrees (Fig. 24 A versus F). The reaction product was partly homogenous and partly 
granular (Fig. 24 C and G).  
 
 
Figure 24. Cytology of epithelioid and multinucleated giant cells in bovine tuberculosis: 
A-I: Immunohistochemical detection of lysozyme in epithelioid cells. The cytoplasms of the cells react 
strongly positive; the circumference of the cells and the cell borders are clearly visible. The nucleus is 
most commonly eccentrical (A, B, D). The strength of the reaction occurs in different intensities (A to 
H); the reaction product can be homogenous (D, F, I) or granular (A, C, G). The antibody reacts 
positive only with a part of the epithelioid cells; lung S 1256/12, mesenterial lymph node, S 1257/12, 
retropharyngeal lymph node S 1259/12, mesenterial lymph node, S 1260/12; bar for A-I = 10 µm. 
 
The reaction of the multinucleated giant cells with the antibody against lysozyme (Fig. 25) 
was weaker than the reaction of epithelioid cells. The reaction product was found in the 
voluminous cytoplasm within the cell centre. The positive reaction was found either in the 
whole cytoplasm (Fig. 25 A and G) or annular within the cytoplasm (Fig. 25 B and H). The 
reaction product was partly homogenous (Fig. 25 E) and partly granular (Fig. 25 B) as seen in 
the epithelioid cells. Completely negative giant cells occurred occasionally (Fig. 25 I). 
 
RESULTS 81 
 
Figure 25. Cytology of epithelioid and multinucleated giant cells in bovine tuberculosis: 
A: Immunohistochemical detection of lysozyme in Langhans-type giant cells; the cytoplasm in the 
centre of the cells reacts in varying degrees positively; the reaction product is partly fine granular (B, 
C); in addition to a homogenous reaction, there is also an annular positivity (B, H); completely 
negative single giant cells (I); mesenterial lymph node, S 1258/12, retropharyngeal lymph node,           
S 1259/12, mesenterial lymph node, S 1260/12; bar for A-I = 10 µm. 
 
The immnohistochemical detection of the myelomonocytic antigen calprotectin (MAC387) 
(Fig. 26) revealed only a weak reaction in epithelioid and in giant cells. In contrast, 
neutrophils showed a strong positive reaction (Fig. 26 C) so that it was often difficult to 
discern the multilobulated nuclei. 
 
 
Figure 26. Cytology of epithelioid and multinucleated giant cells in bovine tuberculosis: 
A-C: Immunohistochemical detection of calprotectin (MAC387). The reaction is weak in epithelioid 
cells (A) and in multinucleated giant cells (B). Contrary to that, neutrophils react strong. The 
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recognition of the lobulated nucleus is difficult; mesenterial lymph node, S 1258/12; bar for              
A-C = 10 µm. 
 
For the relations between epithelioid and multinucleated giant cells and the other 
inflammatory cells in the tuberculous inflammation see in Chapter 4.3.2.1.. 
 
4.3.2.1.2.2. Polymorphonuclear Leukocytes 
 
Polymorphonuclear leukocytes were observed in varying amounts within all different forms 
of the tuberculous inflammation. The cells either appeared morphologically intact or they 
were in different stages of disintegration. The intact neutrophils were recognized by their 
multilobulated nuclei and a homogenous and eosinophilic cytoplasm in H&E staining (Fig. 27 
A). However, they were easier recognizable in Giemsa staining by their purple granules, a 
pale pink cytoplasm, and deep blue-violet nucleus. The disintegrated neutrophils consisted of 
the accumulations of nuclear debris (leukocytoclasia) (Fig. 27 C); the recognition of these 
remnants as neutrophils was possible only by an infiltration of intact neutrophils in the 
neighborhood (Fig. 28 A) or by a typical spatial arrangement within the inflammation (Fig. 29 
A). 
 
By immunohistochemistry neutrophils were significantly positive for the myelomonocytic 
antigen MAC387 (calprotectin). The differentiation between neutrophils and epithelioid cells 
might often be difficult (Fig. 27 B).  
 
 
Figure 27. Cytology of neutrophils in bovine tuberculosis: 
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A: Cluster of intact neutrophils in a granuloma with the typical nuclear morphology and cytoplasmic 
staining; mesenterial lymph node, S 612/14, H&E (GMA). B: Immunohistochemical demonstration of 
MAC387 (calprotectin), strong positivity in neutrophils (arrows); retropharyngeal lymph node,              
S 1259/12, IHC (Paraffin). C: Accumulation of necrotic neutrophils in a caseous necrosis 
(leukocytoclasia); retropharyngeal lymph node, S 409/14, H&E (GMA); bar for A-C = 10 µm. 
 
Neutrophils occurred in small numbers and scattered in many locations of the tuberculous 
inflammation. Localizations, where they were found in larger amounts, are: a) in the inner 
inflammatory zone around larger caseous necrosis (focal or band-like arranged) (Fig. 28 A), 
b) in the satellite granulomas within the inflammatory zone of larger caseating necrosis (Fig. 
28 B), c) within epithelioid cell granulomatous inflammation in varying amounts (Fig. 28 C 
and D), d) within large foci of caseous necrosis (Fig. 29 A), e) in the acute tuberculous 
inflammation of the lung (Fig. 29 B), f) in the area of intrusions of tuberculous inflammation 
into bronchi/bronchioli (Fig. 29 C), g) in the inner zone of tuberculous cavitating lesions (Fig. 
29 D). Here only the typical localizations of neutrophils are listed, the relations to the other 
cells of the tuberculous granulomatous inflammation are given in Chapter 4.3.2.1.. 
 
 
Figure 28. Distribution of neutrophils in bovine tuberculosis: 
A: Inner zone of a large caseous necrosis (Macro-pattern I), the neutrophils at the periphery are still 
intact (1), the degree of disintegration increases with the transition into the caseating necrosis (2); 
retropharyngeal lymph node, S 409/14, H&E (GMA). B: Infiltration of neutrophils in satellite 
granulomas within the inflammatory/fibrous zone of a large granuloma (Macro-pattern I), the left 
focus shows intact neutrophils (1) and the right one already disintegrated cells (2); liver, E 110/09, 
H&E (GMA). C: Epithelioid cell granulomatous inflammation with a low number of intact neutrophils 
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between epithelioid and multinucleated giant cells; mesenterial lymph node, S 602/14, H&E (GMA). 
D: Epithelioid cell granulomatous inflammation with numerous intact neutrophils in the center, where 
epithelioid cells are already destroyed; mesenterial lymph node, S 602/14, H&E (GMA); bars in         
A = 100 µm, in B = 200 µm, in C and D = 50 µm. 
 
 
Figure 29. Distribution of neutrophils in bovine tuberculosis: 
A: Centre of a large caseous necrosis (Macro-pattern I) with numerous disintegrated neutrophils; lung, 
E 322/09, H&E (GMA). B: Acute inflammation of lung, alveolar lung oedema with severe focal 
infiltration of neutrophils; lung, E 322/09, H&E (GMA). C: Lung with an intrusion of tuberculous 
inflammation into a bronchiole; lung, E 322/09, H&E (GMA). D: Bordering zone of a cavitating 
lesion of the lung; lung, S 770/13, H&E (GMA); bars in A, C and D = 100 µm, in B = 200 µm. 
 
4.3.2.1.2.3. Lymphocytes and Plasma Cells 
 
It was easily possible to determine the amount of lymphoid cells involved in the tuberculous 
inflammation in alterations of non-lymphoid organs, such as lung (Fig. 30 A) or liver (Fig. 30 
C). On the contrary, the presence of autochthonous lymphocytes and the impossibility to 
differentiate them from inflammatory lymphoid infiltrates made it nearly impossible to 
estimate the quantity of these cells within lymph nodes. 
 
Large infiltrates of lymphoid cells occurred in two forms in tuberculous inflammation: on the 
one hand as concentric accumulations around large caseous necrosis (Fig. 30 A and C) and 
epithelioid cell granulomatous inflammation (Fig. 30 B); on the other hand, as irregularly 
RESULTS 85 
formed, large aggregates of lymphocytes between epithelioid cell granulomatous 
inflammation (Fig. 30 B).  
 
The concentric arrangements were frequently supported by concentric layered collagen fibres 
(Fig. 30 D). 
 
 
Figure 30. Cytology of lymphocytes and plasma cells in bovine tuberculosis:  
A: Large tuberculous granuloma in the lung with a broad zone of lymphocytes around the central 
caseation with calcification; lung, S 1256/12, H&E (Paraffin). B: Multiple foci of epithelioid cell 
granulomatous inflammation in the lung; the lymphocytes are found concentrically around the foci or 
as irregularly formed foci; lung, E 322/09, Giemsa (GMA). C: Large tuberculous granuloma in the 
liver with a broad zone of lymphocytes around a central caseation with calcification; liver, H&E 
(GMA). D: Lymphocytes at the periphery of a caseation; lymphocytes are supported by concentrically 
arranged collagen fibres (pale eosinophilic); liver, E 110/09, Giemsa (GMA); bars in A and                
B = 200 µm, in C = 1 mm, in D = 100 µm. 
 
Cytologically, lymphocytic infiltrates consisted predominantly of small lymphocytes, most 
obvious in larger aggregates (Fig. 31 A). Lymphoblasts occurred uncommonly and 
immunoblastic cells rarely (Fig. 31 C). Multifocally there were scattered plasma cells (Fig. 31 
B). Lymphoblasts had more abundant cytoplasm and finer chromatin in the nucleus when 
compared to lymphocytes. Immunoblasts within the granuloma could be activated B or T 
cells. They were large, round lymphocytes with large, distinctive light-stained nucleus, a large 
nucleolus and an intensely basophilic cytoplasm. On the other hand, small lymphocytes had 
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small amount of weakly basophilic cytoplasm and a round, dark-stained nucleus. The plasma 
cells were distinguished from lymphocytes by their high amount of cytoplasm and their 
eccentric, compact dark nucleus. Between larger lymphocytic infiltrates there occurred 
regularly single cells with a large vesicular nucleus and a faintly coloured cytoplasm (Fig. 31 
D). 
 
Immunohistochemically, CD3 T-lymphocytes dominated (Fig. 31 E). B-lymphocytes (CD20) 
occurred as aggregates, which can be occasionally extensive (Fig. 31 F). T-lymphocytes 
usually approximated to the caseation zone, while infiltration with CD 20-positive B-
lymphocytes started in a greater distance to the caseation zone. Strong CD 79a- positive B-
lymphocytes (Fig. 31 G) occurred only sporadically, usually in form of blastic cells or with 
plasma cell morphology. 
 
The relationships between lymphocytes and other inflammatory cells are presented in Chapter 
4.3.2.1.. 
 
 
Figure 31. Cytology of lymphocytes and plasma cells in bovine tuberculosis: 
A: A focal extensive aggregate of predominantly small lymphocytes in the lung; lung, E 322/09, 
Giemsa (GMA). B: Typical plasma cells scattered between lymphocytes; E 322/09, Giemsa (GMA). 
C: Few immunoblastic/ lymphoblastic lymphocytes; lung, E 322/09, Giemsa (GMA). D: Commonly 
found single large cells with large vesicular nucleus and poorly stained cytoplasm; lung, E 322/09, 
Giemsa (GMA). E: CD3-positive T-lymphocytes at the periphery of a caseation zone; mesenterial 
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lymph node, S 1257/12, IHC CD3. F: Infiltration with CD20-positive B-lymphocytes at the periphery 
of a caseation zone; the cells approximate not to the caseation zone; mesenterial lymph node,              
S 1257/12, IHC CD20. G: Few CD79a-positive lymphocytes, interspersed between numerous small 
lymphocytes; mesenterial lymph node, S 1257/12, IHC CD79a; bars in E for A, B, E, F, G = 25 µm 
and bar in D for C and D = 10 µm. 
 
4.3.2.1.2.4. Mast Cells and Eosinophilic Granulocytes 
 
Mast cells and eosinophilic granulocytes could only be recognized in Giemsa stained sections. 
Mast cells occurred in low amounts in the fibrous capsule and in the lymphocytic zone of the 
tubercle (Fig. 32). On the contrary, they were rare both in the epithelioid cell zone and nearby 
the caseation (Fig. 32 A). The mast cells showed typical metachromatic granules, the form of 
these cells were spindle-shaped. Rare eosinophilic granulocytes also occurred in the same 
localisations as mast cells (Fig. 32 B). 
  
 
Figure 32. Cytology of mast cells and eosinophilic granulocytes in bovine tuberculosis: 
A: Mast cells play a minor role in the tuberculous inflammation. They occur in the fibrous capsule and 
in the lymphocytic zone of the tubercle. They are rarely found both in the epithelioid cell zone and 
nearby the caseation (the right side of the picture); portal lymph node, E 325/09, Giemsa (GMA). B: 
Eosinophilic granulocytes occur nearby the mast cells. Their nucleus is two-lobed; the granules are 
orange in colour after Giemsa staining; portal lymph node, E 325/09, Giemsa (GMA); bars in             
A = 50 µm, B = 25 µm. 
  
4.3.2.1.3. Fibrous Connective Tissue 
 
The fibrous connective tissue was recognized as bundles of spindle-shaped cells in H&E 
staining with their central, oval, and hyperchromatic nucleus (fibroblasts and fibrocytes). 
They were admixed with collagen fibres and could be detected in varying arrangements and 
amounts within the tuberculous inflammation. The histological evaluation of the fibrous 
connective tissue reaction in the tuberculous inflammation was more reliably by using Silver 
staining of the collagen fibres (Fig. 33 to 36). It was shown that the amount and the 
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arrangement of the fibrous connective tissue were influenced by numerous factors. Thus, 
there was an association between the macroscopic pattern, the histological type of the 
inflammation and the affected organ as well as with the chronicity of the inflammation.  
 
The dependency on the macroscopic pattern of the tuberculous inflammation was obvious. In 
pattern I and II (Fig. 33), completely developed typical tubercles, a distinct fibre-rich capsule 
developed (Fig. 33 A). 
 
 
 
Figure 33. Fibrous connective tissue in bovine tuberculosis: 
A: Demonstration of collagen fibres in the overview of a classic tubercle with a distinct connective 
tissue capsule (1), the lymphocytic zone (2) as well as epithelioid cells (3), the central caseation (4) 
and adjacent liver tissue (5); liver, E 110/09, Silver staining (GMA). B: Detail of Fig. A, the 
concentrically arranged collagen fibres in the capsule and in the lymphocytic zone are clearly visible 
as well as the different density and thickness of the fibres in both zones; remnant of fibres in the 
caseation are detectable; liver, E 110/09, Silver staining (GMA); bars in A = 200 µm, B = 100 µm. 
 
However, loosely arranged collagen fibres were also found in the lymphocytic zone (Fig. 33 
B). Similarly as in the capsule, the collagen fibres were arranged around the central caseation. 
The occurrence of the fibres within the caseation is described in Chapter 4.3.2.1.1.  
 
In the macroscopic pattern III, in which the different components of the inflammation were 
arranged completely irregular, there was a similar disarranged pattern of the collagen fibres 
(Fig. 34). Irregularly arranged foci of inflammation and caseation were interspersed with 
dense fibre bundles and the remnants of the local tissue (Fig. 34 A). At higher magnification, 
it was apparent that the inflammation and the caseation were adapted to the arrangement of 
the collagen fibres (Fig. 34 B), suggesting that the reactively formed collagen fibre-rich 
connective tissue could be subjected to an acute inflammation and caseation process again. 
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Figure 34. Fibrous connective tissue in bovine tuberculosis: 
A: Demonstration of the collagen fibres in lymph nodes with macroscopic pattern III (see 4.3.1.1.3.); 
there is a disarranged side by side of collagen fibres (1), local lymph node tissue (2) with foci of 
epithelioid cell granulomatous inflammation (3) and longitudinal foci of caseous necrosis (4); 
mediastinal lymph node, E 108/09, Silver staining (GMA). B: An analogue picture in the lymph node 
of another animal with a higher amount of collagen fibres; mediastinal lymph node, E 322/09, Silver 
staining (GMA). C: It is recognizable at the higher magnification, that the reactively formed collagen 
fibres are subjected to a caseation again and that the caseation aligns the orientation of the fibres; 
mediastinal lymph node, E 108/09, Silver staining (GMA). D: Another part of the same lymph node 
with a higher proportion of collagen fibres, which are also subjected to a beginning caseation; 
mediastinal lymph node, E 108/09, Silver staining (GMA); bars in A for A and B = 1 mm, in C for C 
and D = 200 µm. 
 
The side by side arrangement of chronic-reactive fibrosis and acute inflammation with 
caseation resulted in the completely disorganized picture of macroscopic pattern III, and it 
also explained the difference in the form of the foci, namely roundish in patterns I and II (see 
above). 
 
The two previously described patterns of fibrosis occurred in chronic inflammatory processes. 
Young tuberculous inflammations were either the epithelioid cell granulomatous 
inflammation or younger tubercles (Fig. 35). Only a few collagen fibres within the foci and at 
the periphery of the foci were detecable in the epithelioid cell granulomatous inflammation 
(Fig. 35 A and C), there was no distinctive arrangement of the fibres. 
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Figure 35. Fibrous connective tissue in bovine tuberculosis: 
A: Demonstration of collagen fibres in a young tuberculous inflammation, with foci of epithelioid cell 
granulomatous inflammation (1) and beginning tubercle formation with caseation (2); mesenterial 
lymph node, E 108/09, Silver staining (GMA). B: Another area of the same lymph node with 
numerous young tubercles; mesenterial lymph node, E 108/09, Silver staining (GMA). C: Epithelioid 
cell granulomatous inflammation with a low amount of collagen fibres at the periphery of the foci; 
mesenterial lymph node, E 108/09, Silver staining (GMA). D: Young tubercle, which develops in a 
focus with epithelioid cell granulomatous inflammation; there is also a low amount of collagen fibres, 
the formation of a capsule is only indistinctive; mesenterial lymph node, E 108/09, Silver staining 
(GMA); bars in A for A and B = 1 mm, in C for C and D = 200 µm. 
 
The amount of collagen fibers is low also in young tubercles with initiating caseation (Fig. 35 
B and D). There was no distinct capsule formation (Fig. 35 D).  
 
The tuberculosis of the lung differed from the tuberculosis of other organs by the occurrence 
of an acute inflammation with extensive oedema (Fig. 36). The earliest alteration was a 
roundish destruction of the lung parenchyma with severe neutrophilic infiltration (Fig. 36 A). 
A mild collagen fibre proliferation occurred at the periphery of these foci (Fig. 36 B). Another 
early encountered alteration was the epithelioid cell granulomatous inflammation (Fig. 36 C), 
where a mild formation of collagen fibres exists (Fig. 36 D). Young tubercles with beginning 
caseation were also accompanied by a mild to moderate deposition of collagen fibres (Fig. 36 
E and F), like young tubercles in the other organs. 
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Figure 36. Fibrous connective tissue in bovine tuberculosis: 
Demonstration of collagen fibres in different stages of the acute tuberculous inflammation in the lung: 
A and B: A focus of acute degeneration of severely oedematous lung parenchyma and aggregates of 
neutrophils in the centre of the focus; a beginning of deposition of collagen fibres at the periphery of 
the foci is visible in (B). C and D: Focus with epithelioid cell granulomatous inflammation; a mild 
deposition of collagen fibres is also detectable. E and F: Beginning tubercle formation in a focus with 
epithelioid cell granlomatous inflammation; the accumulation of collagen fibres is more obvious (F), 
but overall mild; a capsule formation is not visible; lung, E 322/09, Silver staining (GMA); bars in E 
for A, C, and E = 200 µm, in F for B, D, and F = 50 µm. 
 
4.3.2.2. The Types of Histological Alterations 
 
Histologically, tuberculous inflammation in cattle could be divided into four types. Besides 
the obligatory existence of epithelioid cells and a different amount of multinucleated giant 
cells, the major determinants were the amount of necrosis (caseation) and fibrosis, as well as 
the arrangement of these components. 
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Besides that, the lung lesions showed additional features, which were characteristic for 
pulmonary tuberculosis. These distinct features of the lung were evaluated separately in the 
organ description part (see 4.3.3.1.). 
 
4.3.2.2.1. Histo-type 1 
 
The type 1 was predominantly characterised by the presence of epithelioid cells. It could be 
divided into two subtypes. 
 
4.3.2.2.1.1. Subtype 1a 
 
This subtype (Fig. 37) predominantly consisted of epithelioid cells. The epithelioid cell 
aggregates varied in their size from areas consisting of a few cells (Fig. 37 A) to extensive 
infiltrations (Fig. 37 B). The foci occurred solitary (Fig. 37 A) or in form of numerous foci in 
different sizes side by side (Fig. 37 C and D). In addition to the epithelioid cells, 
multinucleated giant cells appeared in variable amounts. This subtype could reveal small foci 
of caseation (Fig. 37 D) up to necrosis occupying almost the entire focus. Neutrophils 
appeared in variable amounts, too. A thin layer of fibrous encapsulation might occur. 
 
 
Figure 37. Histo-types in bovine tuberculosis: 
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A: Histo-type 1, subtype 1a is characterised by focal aggregates of epithelioid cells, which can be 
located solitary as small foci in the tissue; lung, E 322/09 H&E, (GMA). B: Large aggregate of 
epithelioid cells surrounded by original lymph node tissue; mesenterial lymph node, S 602/14, H&E 
(GMA). C: Several foci of epithelioid cells of variable size in the lung, surrounded by numerous 
lymphocytes; lung, E 322/09, H&E (GMA). D: Large foci of epithelioid cells and few multinucleated 
giant cells, caseation (arrow) begins in some foci; mesenterial lymph node, S 413/14, H&E (GMA); 
bars in A and B = 100 µm, C and D = 200 µm. 
 
4.3.2.2.1.2. Subtype 1b 
 
This subtype predominantly consisted of epithelioid cells, too (Fig. 38). The foci were usually 
located solitary in the inflammatory reaction zone of larger tubercles (satellite foci) (Fig. 38 
B). The foci of variable size could be found in the lymphocytic zone (Fig. 38 B) or in the 
fibrosis (Fig. 38 C). These foci could increase in size, succumb to central caseation and they 
might finally coalesce with the central caseation of the tubercle thereby contributing its 
growth. 
 
 
Figure 38. Histo-types in bovine tuberculosis: 
A: Histo-type 1, subtype 1b is similar organised as the subtype 1a; essential difference is its location 
within the reaction zone of a larger tubercle (arrow); liver, E 110/09, H&E (GMA). B: Single 
epithelioid and giant cells in the lymphocytic zone (arrow), the central caseation of the tubercle at the 
right side of the picture; liver, E 110/09, H&E (GMA). C: Focus of epithelioid and giant cells near the 
fibrous capsule (arrow), the central caseation at the right side of the picture; liver, E 110/09, H&E 
(GMA). D: Large focus of epithelioid cells, which is in connection with the central caseation at one 
side; furthermore, the focus is surrounded by lymphocytes and the fibrous capsule of the tubercle; 
liver, E 110/09, H&E (GMA); bars in    A = 1 mm, B = 100 µm, C and D = 200 µm. 
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4.3.2.2.2. Histo-type 2 
 
Type 2 was the classical tubercle (Fig. 39) with its onionskin-like layering. The caseous 
necrosis was found in the centre with or without a variable number of calcified foci (Fig. 39 
A). The necrosis was followed by a reaction zone with several layers. The innermost layer 
adjacent to the caseation consisted of epithelioid cells and multinucleated giant cells, which 
became fatty degenerated first, then became necrotic and finally became part of the caseation. 
The subsequent zone consisted of lymphocytes and is variably thick. The outer layer was built 
by a fibrous capsule. Satellite foci with epithelioid cells occurred in lymphocytic zone and in 
the fibrosis (Histo-subtype 1b). They could caseate and coalesce with the central caseation 
(Fig. 39 A). According to the macro-patterns I and II, the tubercles occurred solitary (Fig. 39 
A) or smaller foci were found side by side (Fig. 39 B). 
 
 
Figure 39. Histo-types in bovine tuberculosis: 
A: Histo-type 2 is the classical tubercle with its onionskin-like layering, the central caseation (1) with 
calcification (2), the different layers of the reaction zone with the inner zone of epithelioid cells (3) 
and the lymphocytic zone (4) as well as the outer fibrous capsule (5). This solitary tubercle 
corresponds to the macro-pattern I; liver, E 110/09, H&E (GMA). B: Also numerous small tubercles 
with the same structure as the solitary tubercle can be found side by side corresponding to the macro-
pattern II; portal lymph node, E 110/09, H&E (GMA); bars in A = 1 mm, B = 2 mm. 
 
4.3.2.2.3. Histo-type 3 
 
Histo-types 3 and 4 were characterised by a completely disordered structure, which was 
clearly visible even at the macro-pattern (Pattern III and IV). 
 
The irregular structure of this type could best be seen at the lower magnification (Fig. 40 A 
and B). Details were visible only at the higher magnification. The typical component of histo-
type 3 was the fibre-rich fibrous connective tissue, which crossed the inflammation in 
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irregular streams (Fig. 40 C). The arrangement of the fibrous connective tissue suggested 
reparative processes in terms of scarring. There were focal aggregates of epithelioid cells, 
which again could undergo caseation (Fig. 40 D). Lymphocytes and neutrophils also occurred. 
Calcification was rare in comparison with histo-type 4.  
 
 
 
Figure 40. Histo-types in bovine tuberculosis: 
A: Histo-type 3 presents a completely disordered composition in the overview. This histological 
picture corresponds to the macro-pattern III; mediastinal lymph node, E322/09, H&E (GMA). B: The 
individual components also are not visible at the lower magnification; mesenterial lymph node;           
E 108/09, H&E (GMA). C: At the higher magnification, the large portion of fibrous connective tissue 
is visible, which is arranged in thick bundles; the fibrous tissue is intermingled with foci of epithelioid 
cells and caseation; mesenterial lymph node; E 108/09, H&E (GMA). D: Cell- and fibre-rich fibrous 
connective tissue with small foci of epithelioid cell, surrounded by foci of caseation; mesenterial 
lymph node; E 108/09, H&E (GMA); bars in A = 2 mm, B = 1 mm, C = 200 µm, D = 100 µm. 
 
4.3.2.2.4. Histo-type 4 
 
Type 4 was also irregularly arranged like histo-type 3 (Fig. 41 A). Its crucial component was 
the extensive, irregularly formed areas of caseation (Fig. 41 B), which underwent extensive, 
also irregularly formed calcification. The arrangement of the epithelioid cells was apparently 
looser than in histo-type 2 (Fig. 41 C). Remnants of the original tissue were often found in the 
extensive caseation (Fig. 41 D). Paler areas in the caseation could be an indication of oedema 
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(Fig. 41 D). Extension and arrangement of the caseation might point to an acute progressive 
destruction of the tissue (acute exudative phase).  
 
 
 
Figure 41. Histo-types in bovine tuberculosis: 
A: Histo-type 4 is also completely disordered; calcification is striking, which is also extremely 
variable in shape. This histological picture presents the macro-pattern IV; mesenterial lymph node,     
S 785/13, H&E (GMA). B: Extensive, irregularly formed calcification is visible at the higher 
magnification; mesenterial lymph node, S 785/13, H&E (GMA). C: The caseation is not surrounded 
by a distinct reaction zone, epithelioid cells and lymphocytes are loosely arranged; mesenterial lymph 
node, S 785/13, H&E (GMA). D: Remnants of the original tissue are found in the very large foci with 
caseation, the pale areas display areas with oedema; mesenterial lymph node, S 612/14, H&E (GMA); 
bars in A = 1 mm, B and D = 200 µm, C = 100 µm. 
 
4.3.2.3. Quantification of Histology Types 
 
A total of 238 paraffin tissue sections from affected organs were examined for the histological 
diagnosis of bovine tuberculosis and also regarding the histological typing of the tuberculous 
inflammation. 
 
The different histological types were present occasionally as individual types but often in a 
combination within an affected tissue. The occurrence of satellite epithelioid cell 
granulomatous inflammation (Histo-subtype 1b) together with type 2 was the most common 
combination type. As seen in Table 7, the most common types were subtype 1a and histo-type 
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2 (143/238 tissue sections). On the contrary, histo-type 4 was seen less common (41/238 
tissue sections). Histological types 3 and type 4 were common especially within the 
mesenterial lymph nodes. On the other hand, these two types were not present in liver and 
intestine; in addition, histo-type 4 was also not present in the retropharyngeal lymph node. 
Furthermore, subtype 1a was not observed in the liver and the intestine. 
 
Table 7. Quantification of the four histo-types of the tuberculous inflammation in individual organs. 
 
Organ Subtype 1a 
Subtype 
1b Type 2 Type 3 Type 4 
Lung 11 9 21 3 2 
Mediastinal lymph node 19 11 29 15 1 
Small intestine - 1 1 - - 
Mesenterial lymph node 100 33 61 40 36 
Liver - 5 7 - 1 
Portal lymph node 8 6 11 5 1 
Retropharyngeal lymph node 5 3 13 6 - 
 
4.3.2.4. Development of the Granulomatous Inflammation in Tuberculosis 
 
The findings of the histological examinations reveal different possible developmental stages 
of the granulomatous inflammation. Depending on the organs involved, two major initial 
alterations exist.  
 
The basic phenomenon of the granulomatous inflammation in bovine tuberculosis is the 
accumulation of epithelioid cells and/or multinucleated giant cells. As a second step 
commonly a central area of caseating necrosis develops often associated with neutrophils. 
Neutrophils might be a component in the development of caseous necrosis, but caseation 
without neutrophils also occurs. The caseation often underlies calcification. Thereafter, 
lymphocytes accumulate and formation of fibrous tissue takes place at the periphery of the 
tuberculous inflammation, thus forming a classical tubercle (Fig. 42 and 43). 
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Figure 42. Representative scheme for the initial stages of tubercle in bovine tuberculosis:  
First step is an epithelioid cell granulomatous inflammation, followed by the development of a central 
caseating necrosis often with neutrophil infiltration. Accumalation of lymphocytes and encapsulation 
by fibrous connective tissue is the last stage. 
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Figure 43. Initial stages in bovine tuberculosis: 
Representative tissue sections to demonstrate the development of a tubercle. A: Infiltration of 
epithelioid cells and MNGCs. B: The beginning of caseous necrosis with neutrophil infiltration. C: 
The lymphocyte infiltration, beginning of fibrous encapsulation and calcification within the caseation; 
mesenterial lymph node, S 413/14, H&E (GMA); bar in A for A - C = 200 µm. 
 
In the lung tuberculosis can start with a second, totally diffent initial lesion, the primary 
exudative-inflammatory reaction (according to PALLASKE, 1961), possibly due to the loose 
organization of lung tissue (Fig. 44). This picture is compatible with the macro-pattern VI. 
 
The exudative-inflammatory reaction is characterised by an extensive alveolar oedema, local 
deposition of fibrin going along with necrosis of alveolar tissue leading to caseation, too. This 
is followed by the accumulations of the inflammatory cells, first epithelioid cells later 
lymphocytes and connective tissue (see also Fig. 44).  
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Figure 44. Development of the exudative tuberculous inflammation of the lung in bovine tuberculosis. 
 
Accumulations of epithelioid cells and/or giant cells can develop in different localisations. A. 
The foci of macro-pattern I and II as classical tubercles, which correspond to histo-type 2, 
described above arise in the non-altered tissue. B. At the periphery of the larger tubercle as 
so-called satellite epithelioid cell granulomatous inflammation (see below), which 
corresponds to the histo-type 1b. C. Within the reparatively built fibre-rich connective tissue, 
this then leads to macro-pattern III and histo-type 3 as well.  
  
According to macro-patterns I and presumably II the growth of tubercles can occur 
appositionally by means of satellite granulomas (histo-type 1b) (see below). 
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Accumulations of epithelioid cells and multinuclear giant cells within larger masses of 
reparatively built fibre-rich connective tissue may indicate a protracted-recurrent growth, 
according to macro-pattern III and histo-type 3 (see Figs. 8, 9 and 40).  
 
Besides that, there are also extensive, rapidly growing foci of caseation with indistinct cellular 
demarcation, a rapidly progressive growth according to macro-pattern IV and histo-type 4 
(see Figs. 10 and 41). 
 
As described above, the growth in larger tubercles can take place appositionally. The 
appositional growth is characterised by an accumulation of the epithelioid cells and/or 
MNGCs, satellite epithelioid cell granulomatous inflammation (Histo-subtype 1b), within the 
inflammatory zone or fibrous capsule of the tubercle. Subsequently caseous necrosis occurs in 
the centre of this satellite epithelioid cell granulomatous inflammation, often accompanied by 
infiltration with neutrophils. This caseous necrosis extends and becomes integrated into the 
caseous necrosis of the large tubercle (Figs. 45 and 46). 
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Figure 45. Scheme of the appositional growth of the tuberculous inflammation in larger tubercles: 
Top: Occurrence of epithelioid cell granulomatous inflammation within the inflammatory zone of the 
large tubercle; middle: Beginning of the caseous necrosis following neutrophil accumulation; bottom: 
Integration into the caseation of the large tubercle.  
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Figure 46. Appositional growth of the tuberculous inflammation in larger tubercles: 
A: Accumulation of epithelioid cells and multinucleated giant cells in the inflammatory zone 
consisting mainly of lymphocytes (satellite focus). B: Beginning infiltration of a satellite focus by 
neutrophils. C: Massive infiltration by neutrophils with destruction of epithelioid cells and giant cells. 
D: Caseation of the focus, epithelioid cells are not longer detectable, neutrophils only as clastic cell 
remnants, the caseation has become contact with the central caseation in the large tubercle on the right 
side; liver, E 110/09, H&E (GMA), bar in C for A-D = 50µm. 
 
In addition to the local growth of the tuberculous foci (see above), a dissemination of the 
tuberculosis can also occur in the body. This dissemination can occur through lympho-
haematogenous way according to the macro-pattern II, for example in the regional lymph 
node, or in the lung following intrusion in the bronchioles also through canalicular way (see 
Fig. 47 und 52). 
 
4.3.3. Tuberculous Alterations of Individual Organs  
 
4.3.3.1. Lung 
 
Lung samples from 11 cattle showed tuberculous alterations. All macro-patterns described in 
Chapter 4.3.1.1 were found (Fig. 47 und 48). In addition, there was an acute inflammatory 
type of tuberculosis in the lung, the so-called exudative reaction type, which was 
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macroscopically characterised by a brownish colour, by a high water content and by pale foci 
of caseation (Fig. 47 A, see also Fig. 12 A).  
 
 
Figure 47. Macroscopic lung alterations in bovine tuberculosis: 
A: Focal acute exudative reaction with oedema and irregularly shaped foci of caseating necrosis; lung, 
S 1256/12. B: Solitary tubercle, view on the lung surface, the diameter of the focus is approximately   
4 mm; lung. C: Cut surface of the same focus as in B, an indistinctive layering is visible (Macro-
pattern I); lung. D: Multiple tubercles with a small diameter, the layering can be seen partly (Macro-
pattern II), an intrusion of the tuberculous inflammation in the small bronchus can be seen; lung,         
S 605/13. E: Large focus of a disarranged tuberculous inflamed tissue, compatible with macro-pattern 
III; lung, E 322/09; bars in A-E = 1 cm (specimens fixed in Klotz´s solution). 
 
On the cut surface, occasional intrusions of the tuberculous inflammation into the conducting 
airways could be found (Fig. 47 D). Another typical finding for the lung was the occurrence 
of melting cavities, the so-called cavitating tuberculosis (Fig. 48). Cavities were found either 
in the centre of tubercles (Fig. 48 A) or they incorporated areas with a size of a whole lung 
lobule (Fig. 48 B). 
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Figure 48. Macroscopic lung alterations in bovine tuberculosis: 
A: Multiple tubercles with distinctive layering comprising the entire cut surface of the lung lobe 
(Macro-pattern I), cavities are visible in several tubercles; lung, S 422/14. B: Large focus with a 
cavitating tuberculosis; lung, S 600/14; bars in A and B = 1 cm. (specimens fixed in formalin).  
 
Histologically, all four in Chapter 4.3.2.2. described histo-types could be found in the lung 
(Figs. 49 to 51). The most encountered histological granulomatous inflammation type was 
histo-type 2 (see Table 7 and Fig. 49). 
 
 
Figure 49. Lung alterations in bovine tuberculosis: 
A: Single lung lobule with multiple small tubercles, accordant with macro-pattern II, lung, S 770/13. 
B: The same lung lobule as in A, numerous layered tubercles are visible (histo-type 2); lung, S 770/13, 
H&E (GMA); bars in A = 1 cm, B = 2 mm. 
 
Histo-type 2 resulted from solitary or satellite foci of epithelioid cell granulomatous 
inflammation (Histo-subtypes 1a and 1b) (Fig. 50). The epithelioid cell granulomatous 
inflammation underwent caseation in variable extent (Fig. 50 C and D). Furthermore, 
alterations of histo-types 1 and 2 occurred side by side. 
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Figure 50. Lung alterations in bovine tuberculosis: 
A: Large focus with epithelioid cell granulomatous inflammation (Histo-subtype 1a); lung, E 322/09, 
H&E (GMA). B: Solitary focus of an epithelioid cell granulomatous inflammation, surrounded by 
lymphocytes, a caseation is not visible; pulmonary alveolar oedema at the top of the picture; lung,      
E 322/09, H&E (GMA). C: Focal epithelioid cell granulomatous inflammation with central caseating 
necrosis; lung, E 322/09, H&E (GMA). D: Focal epithelioid cell granulomatous inflammation with 
extensive caseation, a few epithelioid cells (arrow) in the periphery; lung, E 322/09, H&E (GMA); 
bars in A = 1 mm, in B for B, C and D = 100 µm.   
 
Besides the reaction types described above, an additional type was observed in the lung - the 
exudative reaction type (Fig. 51). The characteristic findings were an extensive amorphous, 
lightly eosinophilic alveolar oedema with occasionally foamy alveolar macrophages and 
hyperaemic alveolar capillaries. Therein lay small highly eosinophilic foci with necrosis of 
the alveolar septa and deposition of small irregular fibrils (fibrin) (Fig. 51 B). Other foci 
contained a high number of neutrophils (Fig. 51 C) or epithelioid cells surrounded by 
lymphocytes (Fig. 51 D).  
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Figure 51. Lung alterations in bovine tuberculosis: 
A: Acute exudative reaction of the lung, an overview with an extensive pulmonary alveolar oedema 
and numerous fresh foci with a beginning caseation; lung, E 322/09, H&E (GMA). B: Fresh focus 
with fibrin deposition within the oedema fluid and necrosis of alveolar septae; inflammatory cells are 
sparsely detectable; lung, E 322/09, H&E (GMA). C: Fresh focus with necrosis of alveolar septae and 
extensive aggregates of neutrophils; lung, E 322/09, H&E (GMA). D: Focus, which predominantly 
consists of epithelioid cell and is surrounded by lymphocytes, in the immediate vicinity of fresh 
caseous foci; lung, E 322/09, H&E (GMA); bars in A = 1 mm, in B for B, C and D = 100 µm.   
 
Another typical form of the tuberculous inflammation of the lung was the inflammatory 
intrusion into the airways (Fig. 52). The destructed bronchi and bronchioles were 
characterised by the absence of smooth muscle, cartilage (in bronchus) and the loss of the 
lining columnar epithelium. These structures were replaced by an amorphous, eosinophilic 
material consisting of destroyed cells, oedema, fibrin and intact as well as disintegrated 
neutrophils (Fig. 52 B and C). In some cases, the inflammation was of the acute type (Fig. 52 
B) in others of an older one (Fig. 52 C). Sometimes small accumulations of epithelioid cells 
within alveolar lumina occurred (Fig. 52 D). 
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Figure 52. Lung alterations in bovine tuberculosis: 
A: Intrusion of the tuberculous inflammation into the airways, small bronchus, extensive caseous 
necrosis of the bronchus wall, there are only remnants of the original epithelium left (arrow); lung,     
E 322/09, H&E (GMA). B: Intrusion of an acute exudative inflammation in a bronchiole with 
destruction of its wall; lung, E 322/09, H&E (GMA). C: Chronic tuberculous inflammation, which 
invades a bronchiole; lung, E 322/09, H&E (GMA). D: Aggregates of epithelioid cells in the lumen of 
an alveole adjacent to a tuberculous inflammation (right side of the picture); lung, E 322/09, H&E 
(GMA); bars in A = 1 mm, B and C = 100 µm, D = 50 µm. 
 
An additional typical tuberculous lesion of the lung was the liquefaction of tissue that 
underwent caseous necrosis leading to a cavitating tuberculosis (Fig. 53). Macroscopically, 
the roundish cavities were found in the centre of larger tubercles (Fig. 53 A). Histologically 
the cavities were lined by intact and disintegrated neutrophils intermingled with fibrin, 
followed by epithelioid cells and occasionally multinucleated giant cells, lymphocytes and 
plasma cells, the outer layer was the fibrous capsule (Fig. 53 B to D). 
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Figure 53. Lung alterations in bovine tuberculosis: 
A: Liquefaction of the caseous necrosis of tubercles as a first step in the formation of a cavitating 
tuberculous pneumonia, macroscopic picture with multiple cavities (arrow); lung, S 770/13. B: 
Overview of the border of a liquefied focus of caseous necrosis; lung, S 770/13, H&E (GMA). C: The 
demarcation of the cavity consists of neutrophils, fibrin and necrotic cells, followed by lymphocytes 
and fibroblasts with few collagen fibres as well as an outer fibrous capsule (left side of the picture); 
lung, S 770/13, H&E (GMA). D: At high magnification, the inner side of the border with neutrophils 
and fibrin, followed by lymphocytes and fibroblasts (left side of the picture); lung, S 770/13, H&E 
(GMA); bars in A = 1 cm, B = 1 mm, C = 200 µm, D = 50 µm. 
 
4.3.3.2. Serosa  
 
The classical tuberculous alteration of serous membranes is the pearl disease. It could be seen 
in the thoracic cavity of one cow (Fig. 54). Nodular alterations from 5 mm to maximal 20 mm 
in a diameter occurred focally on the pulmonary pleura (Fig. 54 A) and on the parietal pleura 
of the diaphragm. Their cut surface corresponded predominantly to the nodules of macro-
pattern I and occasionally also the foci of the macro-pattern III (Fig. 54 B and C). At the lung, 
the nodules were not only directly on the pleura (Fig. 53 A), but also formed lobulated 
annexes (Fig. 54 B). Their histology corresponded to the macroscopical picture, the classic 
tubercle predominated (Histo-subtype 1a) (Fig. 54 D), foci with a disordered structure of the 
tuberculous tissue could also occasionally be found (Macro pattern III). 
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Figure 54. The classic picture of pearl disease, only found in one animal: 
A: Numerous spherical structures on the pulmonary pleura; lung, S 770/13. B: The cut surface of the 
foci showed a distinct caseation; lung, S 770/13. C: Cut surface at higher magnification, besides the 
roundish foci with layering structure (tubercle, left side of the picture), there were also alterations of 
macro-pattern III with a disordered structure of the tuberculous tissues (middle of the picture); lung,   
S 770/13. D: The individual foci of the pearl disease showed predominantly layering structure of the 
classical tubercle (Histo-subtype 1a); pleura, S 770/13, H&E (Paraffin); bars in A, B and C = 1 cm,     
D = 1 mm. 
 
4.3.3.3. Small Intestine  
 
Only one tuberculous lesion in one animal could be found in the small intestine (Fig. 55). It 
was a small, roundish focus with a diameter of approximately 4 mm (Fig. 55 A). On the cut 
surface (Fig. 55 B), caseation and calcification were visible in the centre of the focus, 
compatible with the macro-pattern I. Histologically, there was a focal, roundish lesion within 
the mucosa and the sub-mucosa at the edge of a Peyer´s patch (Fig. 55 C). The tuberculous 
granuloma was compatible with the criteria described as histo-type 2 and subtype 1b. No 
severe destruction of villus epithelium and moderate numbers of macrophages, lymphocytes 
in the lamina propria were observed. The number of acid-fast bacteria that could be 
demonstrated within the lesion was very low, only single bacteria within an epithelioid cell 
(Fig. 55 D).  
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Figure 55. Small intestine alterations in bovine tuberculosis: 
A: A single tuberculous focus in small intestine, its diameter is approximately 4 mm. The spherical 
covering mucous membrane is intact; small intestine, E 102/09. B: Cut surface of the same focus as in 
A, caseation and calcification can be seen in its centre; small intestine, E 102/09. C: The histological 
overview shows a typical tubercle with central caseation and calcification, a clear capsule is not 
visible; the mucous membrane is intact; the focus is found at the edge of a Peyer’s patch (bottom 
right); small intestine, E 102/09, H&E (Paraffin). D: The numbers of acid-fast bacilli, which are found 
in this focus, are extremely low. In the picture, an acid-fast bacillus in the cytoplasm of an epithelioid 
cell; small intestine, E 102/09, FF staining (Paraffin); bars in A, B = 1 cm, C = 1 mm, D = 10 µm. 
 
4.3.3.4. Liver 
 
Tuberculous alterations in the liver could be found in a total of 5 animals (Fig. 56). All of 
them consisted of typical tubercles, which were associated with macro-pattern I. The foci 
were well visible layered (Fig. 56 A), with caseation and calcification in the centre, the pale 
brown reaction-zone with inflammatory cells and a well visible fibrous capsule. The foci were 
in variable in their size (Fig. 56 B), up to 2 foci per liver could be found.  
 
Histologically, the foci showed also a distinctive concentrically layered structure, they were 
compatible with histo-type 2 and subtype 1b.  
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Figure 56. Liver alterations in bovine tuberculosis: 
A: Tuberculous foci in the liver were only compatible with macro-pattern I, large foci with an 
onionskin-like structure. There is yellowish, dry caseation with whitish foci of calcification in the 
centre, which is surrounded by the reaction zone, predominantly consisting of epithelioid cells, 
lymphocytes and the fibrous capsule at the outer as well; liver, E 110/09 (the organ was fixed in 
Klotz´s solution). B: The foci in the liver are in different sizes, a small focus is found in the liver of 
this animal; liver, E 322/09 (the organ was fixed in Klotz´s solution). C: Histological overview of a 
typical tuberculous focus (tubercle) in the liver, with its layering structure; liver, E 110/09, H&E 
(GMA). D: Higher magnification of the focus with central caseation and calcification, the light zone of 
epithelioid cells, the lymphocytic zone and at the outer fibrous capsule, the typical structure of a 
tubercle; liver, E 110/09, H&E (Paraffin); bars in A and B = 1 cm, C = 2 mm, D = 1 mm. 
 
4.3.3.5. Lymph Nodes 
 
Paraffin and GMA tissue sections from mesenterial (132), mediastinal (40), portal (14) and 
retropharyngeal (14) lymph nodes were examined from 81 cattle. All five macro-patterns (see 
4.3.1.1.) occurred in the lymph nodes (Fig. 57). Also all four different histo-types of the 
granulomatous inflammation occurred in the lymph nodes (except histo-type 4 in the 
retropharyngeal lymph nodes). 
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Figure 57: Lymph node alterations in bovine tuberculosis. All five macro-patterns occurred in lymph 
nodes: 
A: Macro-pattern I with large roundish foci with a distinct cup shaped structure; mesenterial lymph 
node, E 113/09. B and C: Macro-pattern II with only a few or numerous small roundish foci, the 
layering structure can macroscopically not easily be recognized; mediastinal lymph node, S 1256/12. 
D: Macro-pattern III with an irregular and not circular arranged tuberculous tissue; mesenterial lymph 
node, E 97/09. E: Macro-pattern IV shows caseation in the larger part of the tissue section; mesenterial 
lymph node, E 110/09. F: Macro-pattern V with cavity formation (arrow); mesenterial lymph node,    
S 412/14; bar for A - F = 1 cm.  
 
4.3.4. Detection of Mycobacteria and Mycobacterial Antigens 
 
4.3.4.1. Acid-fast Staining Modified According to Fite-Faraco (FF Staining) 
 
Acid-fast bacilli were detected in at least one organ of 70 out of the 84 cattle with tuberculous 
lesions comprising 163 out of the 238 investigated tissue sections (see also RIESEBERG, 
2016). They appeared as lightly curved or rod-shaped. Except for a few cases, only sparse 
acid-fast bacilli were found in the granulomatous lesions, as described in detail in the study of 
RIESEBERG (2016).  
 
Bacteria were most frequently found in the caseation (Fig. 58 A to C), including the 
calcification (Fig. 58 D). Often several bacteria in the positive cases could easily be found in 
both localisations, wherein the bacteria were then often agglomerated in foci.   
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Figure 58. Demonstration of acid-fast bacteria in bovine tuberculosis: 
A: Bacteria within the caseous necrosis, a single bacterium (arrow); mesenterial lymph node, S 
128/13, FF (Paraffin). B: Medium amount of bacteria; mesenterial lymph node, S 179/13 FF 
(Paraffin). C: The single tissue with a high bacterial load; mesenterial lymph node, E 102/09, FF 
(Paraffin). D: Bacteria within the calcified area of a caseous necrosis; mesenterial lymph node             
S 179/13, FF (Paraffin), acid-fast staining; bar in C for A-D = 10 µm. 
 
Predominantly single or rarely more bacteria could be observed in the cytoplasma of 
epithelioid cells (Fig. 59 A), on the other hand much more single bacteria in the cytoplasm of 
multinucleated giant cells (Fig. 59 B). Infrequently, remnants of bacteria appeared in the 
cytoplasm of degenerated neutrophils (Fig. 59 C). Bacteria were found at the border of viable 
epithelioid cells and the central caseation (Fig. 59 D). Low numbers of acid-fast bacilli were 
also detected in the high-grade alveolar oedema of the lung. Bacteria could never be found in 
the zone with lymphocytes or the fibrous capsule. 
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Figure 59. Demonstration of acid-fast bacteria in bovine tuberculosis: 
A: Single bacterium in the cytoplasm of an epithelioid cell; liver, E 324/09, FF (Paraffin). B: Single 
bacterium in the cytoplasm of a multinucleated giant cell; mesenterial lymph node, S 415/14, FF 
(Paraffin). C: Remnants of bacteria in the cytoplasm of degenerating neutrophils; lung, E 323/09, FF 
(Paraffin). D: Bacteria at the border between viable epitheliod cell (1) and the area with caseating 
necrosis (2); mesenterial lymph node, S 179/13, FF, acid-fast staining; bar in C for A-D = 10 µm. 
 
4.3.4.2. Immunohistochemical (IHC) Demonstration of Mycobacterial Antigens 
 
The immunohistochemical investigations were performed on tissue sections from 232 paraffin 
blocks using a polyclonal rabbit anti-M. tuberculosis complex (Rb x Tbc) antibody and a 
polyclonal rabbit anti-M. bovis antibody on some selected sections. The positive reaction 
occurred as amorphous or fine granular light to dark brown colour. Samples were evaluated 
according to the localisation and the strength of positive reaction. Embedded cultured bacteria 
served as a positive control (see 4.2.).  
 
4.3.4.2.1. Comparison of Anti Mycobacterial Antibodies 
 
During the IHC investigations with polyclonal rabbit anti-M. tuberculosis complex antibody 
(Rb x Tbc) positive reaction was controlled using the positive control sections in each run 
Sensitivity and specificity of the polyclonal rabbit anti-M. tuberculosis complex (Rb x Tbc) 
antibody were compared with the polyclonal rabbit anti-M. bovis (Rb x M. bovis) antibody on 
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selected tissue sections. The positive reaction within the necrotic zone was similar for both 
antibodies, but the strength of the positive reaction obtained by the antibody against M. 
tuberculosis complex was stronger than of the antibody against M. bovis. Furthermore, the M. 
tuberculosis complex antibody showed a positive reaction intracellular in the cytoplasm of 
epithelioid cells and part of the multinucleated giant cells, while the M. bovis antibody gave 
only a weak positive reaction in these cells. On the basis of these results, M. tuberculosis 
complex antibody was more sensitive as compared with the M. bovis antibody.   
 
4.3.4.2.2. Distribution of the Mycobacterial Antigen  
 
An amorphous or fine granular brown positive reaction product could be observed in different 
areas of the tuberculous lesions (Figs. 60 and 61), thus areas of the granulomatous 
inflammation were divided into three groups for the evaluation of a positive reaction (Fig. 
62). Zone 1 was the necrotic centre of the granulomatous inflammation. Positive reaction 
occurred in 149 out of the 232 tissue sections in this zone. The strength of the positive 
reaction was in 31/149 strong (+++), in 30/149 tissue samples moderate (++), and in 89/149 
tissue samples weak (+). The inflammatory zone adjacent to the caseaous necrosis was termed 
as zone 2, which showed the positive reaction intracellular in the cytoplasm of the epithelioid 
cells (Fig. 60 B and D) and MNGCs (Fig. 60 A) in 142 out of the 232 tissue sections. The 
strength of the positive reaction was strong in 21/142, moderate in 46/142 and weak in 
75/142. Zone 3 presented the outer zone of the granulomatous inflammation, mainly the area 
with lymphocytes, and the positive signal was detected intracellular in single large cells with a 
large pale nucleus (Fig. 61 C and D) in 154 out of the 232 tissue sections. The strength of the 
positive reaction was in 21/154 (strong), in 44/154 moderate and in 91/154 weak positive 
reaction. Bacterial antigen could also be demonstrated in cells of the epithelioid cell 
granulomatous inflammation, this means in epitheliod cells (Fig. 61 A) and in MNGCs (Fig. 
61 B). In some cases, cells carrying bacterial antigen occurred in sinus of lymph nodes with a 
tuberculous inflammation (Fig. 61 E). 
 
The distribution of the mycobacterial antigens within the tissue sections and the strength of 
the reaction are depicted in the Fig. 62 and Table 8.  
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Figure 60. Immunohistochemical demonstration of mycobacterial antigen: 
A: Overview over a tubercle, antigen is visible in the caseous necrosis (1) and in the zone of 
inflammatory cells, escpecially within multinucleated giant cells (2); mesenterial lymph node,              
S 415/14, IPO. B: Overview over a tubercle, antigen can be demonstrated mainly in epithelioid cells in 
the inner zone of inflammatory cells; mediastinal lymph node, E 321/09, IPO. C: Large amount of 
bacterial antigen in the caseous necrosis (strong reaction); mesenterial lymph node, E 102/09, IPO.   
D: Mycobacterial antigen in epithelioid cells in the immediate vicinity to the caseous necrosis; 
mesenterial lymph node, E 97/09, IPO; bars in A for A and B = 100 µm, in C for C and D = 50 µm. 
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Figure 61. Immunohistochemical demonstration of mycobacterial antigen: 
A: Epithelioid cell granulomatous inflammation with bacterial antigen in several epithelioid cells; 
mesenterial lymph node, E 320/09, IPO. B: Epithelioid cell granulomatous inflammation with a weak 
positive reaction in multinucleated giant cells and a strong reaction in epithelioid cells; mesenterial 
lymph node, E 320/09, IPO. C: Strongly granular positive cells scattered between lymphocytes in the 
outer inflammatory zone; mesenterial lymph node, S 1258/12, IPO. D: Higher magnification of a 
corresponding location as in (C) with single cells showing a marked granular positive reaction in their 
cytoplasm; mesenterial lymph node, E 108/09, IPO. E: clearly positive cells in a sinus of a lymph node 
with tuberculous inflammation; mesenterial lymph node, S 1258/09; bars in C for A, B, C, E = 50 µm, 
D = 25 µm. 
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Figure 62. Immunohistochemistry (anti-M. tuberculosis complex antibody): 
0: not detectable (Zone 1) Mycobacterial antigen is detectable a) within the centre of caseous necrosis 
(Zone 1a); b) in the periphery of the necrosis (Zone 1b); c) intracellular in cells of the inflammatory 
mantle zone (Zone 2); d) in single cells of the outer zone (Zone 3). 
 
Table 8. The localisation of the mycobacterial antigens within the tissue and the strength of the 
positive reaction. 
 
The localisation 
of the bacilli 
Numbers of the 
tissue sections Strong reaction 
Moderate 
reaction Weak reaction 
First zone (1) 149 31 30 89 
Second zone (2) 142 21 46 75 
Third zone (3) 154 21 44 91 
Total number 232 73 120 255 
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4.3.4.2.3. Quantification of the Immunohistochemistry Results 
 
A total of 209 out of the 232 (90%) investigated tissue sections gave positive reaction with the 
polyclonal rabbit anti-M. tuberculosis complex (Rb xTbc) antibody. The number of the 
positive tissue sections of the different organs is given in Table 9.   
 
Table 9. Number of immunohistochemically positive tissue sections and organ distribution of 
mycobacterial antigens. 
 
Organ Number of investigated sections Number of positive sections 
Lung 28 22 
Mediastinal lymph node 37 32 
Small intestine 1 1 
Mesenterial lymph node 131 125 
Liver 8 5 
Portal lymph node 14 14 
Retropharyngeal lymph node 12 12 
 
4.3.4.3. Comparative Analyses of Fite-Faraco (FF) Staining and Immunohistochemistry (IHC) 
 
The detection of mycobacteria or bacterial antigen was performed in 232 out of the 238 
paraffin tissue sections for both FF staining and IHC. Out of the 232 paraffin tissue sections 
151 were positive in both methods and 11 were negative in both methods. Furthermore, 60 
tissue sections were detected positive in IHC, but were negative in FF staining. Eleven tissue 
sections were positive in FF staining, but there was no reaction in the IHC. The detailed list is 
given in Appendix 9.1.2. Tab. 11. 
 
4.3.4.4. In Situ Investigations (ISH) 
 
A light purple reaction was obtained in the positive control slides using a cocktail of the M. 
tuberculosis complex-oligonucleatid DNA probes (MTB187, MTB226, MTB770). The 
method was performed on several tissue sections (S 183/13, S 179/13, S 409/14, S 413/14, S 
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415/14), which had a lot of acid fast bacilli in the FF staining and had moderate to strong 
positive reaction (++/+++) with rabbit anti-M. tuberculosis complex antibody in 
immunohistochemstry. Different alternative ISH methods were tested to obtain a positive 
reaction in the tissue sections (listed in Materials and Methods 3.2.1.1.6.2.), but the positive 
reaction product was not as clear as in positive control slides. Similarly, the positive control 
slides gave a positive reaction with the EU bacteria-oligonucleatid DNA probes, but it failed 
in the investigated tuberculous tissue sections.  
 
4.3.4.5. Investigations by Transmission Electron Microscopy (TEM) 
 
4.3.4.5.1. Semi-thin Sections  
 
A total of 294 semi-thin tissue sections out of the 404 epoxy resin blocks were evaluated 
using toluidine blue-safranin staining. The histological findings of the tissue sections included 
only necrotic zone with or without calcification, necrotic and non-necrotic granulomatous 
inflammations and also non-altered tissue samples. The different granulomatous inflammation 
types in toluidine blue-safranin staining were similar as that in H&E staining.  
 
The screening of the semi-thin sections served also to select tissue blocks for the further 
immunohistological investigations. A total of 157 out of the 294 tissue sections were found 
appropriate for IHC investigations. They showed granulomatous inflammation with necrotic 
and non-necrotic zones, and included the different tissue components, such as fibrous tissue, 
capillaries or lymphatic vessels. 
 
Postembedding immunohistochemistry was performed on these 157 selected tissue sections 
using the primary Rb x Tbc antibody (Fig. 63). Embedded cultured bacteria served as positive 
control (see 4.2.). A dark to light brown positive reaction occurred in 50 out of the 157 semi-
thin sections (Fig. 63). The distribution of mycobacterial antigen was principally the same as 
in the paraffin sections. A positive reaction was observed in 24/50 tissue sections in the 
caseous necrosis zone and in 39/50 in the inflammatory zone as well as in the outer zone of 
the granulomatous inflammation. Appropriate tissue sections for the transmission electron 
microscopical investigations were 7 out of the 50 positive semi-thin sections.    
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Semi-thin sections showing a positive immunohistochemical reaction at definitive, easily 
retrievable tissue components were preferred for the TEM investigations (Fig. 63). These 
definitive components in the semi-thin sections guided to find the immunolabeled structures 
in the TEM. 
 
4.3.4.5.2. Ultra-thin Sections  
 
Seven ultra-thin sections were examined using TEM. The corresponding immunolabeled areas 
and cells were searched for the demonstration of mycobacteria in the TEM. The definitive 
tissue components guided to find the required areas and cells. Extracellular bacteria were 
determined in 2/7 mesenterial lymph node tissue samples (Fig. 63 C). Longitudinal and cross 
sections of mycobacteria were found at the same localisation of the positive reaction seen in 
the semi-thin slide with IHC. Morphologically, the bacterial cell wall appeared densely and 
the innerpart contained lipid vacuoles (Fig. 63 D). Only in one case, an intracellular bacillus 
was detected in the cytoplasm of a macrophage in the mesenterial lymph node. Bacterial 
antigen within the single cells in the outer inflammatory zone could not be detected in 
immunohistochemistry on semi-thin sections, so the nature of the positive reaction product in 
the immunohistochemistry on paraffin sections could not be elucidated. 
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Figure 63. Transmission electron microscopical investigations in bovine tuberculosis: 
A: Semi-thin section with disseminated spot-like dark-brown positive reaction products; mesenterial 
lymph node. B: High-power magnification of A (indicated by an arrow), single positive regions are 
marked (1 - 3), regions that were examinated ultrastructurally; mesenterial lymph node, E 325/09, 
postembedding immunohistochemistry on semi-thin sections with anti-Mycobacterium tuberculosis 
complex antibody. C: extracellularly laying bacteria; mesenterial lymph node, E 325/09, TEM. D: 
bacteria with the phenotype of mycobacteria at a higher magnification; mesenterial lymph node, E 
325/09, TEM; bars in A = 200 µm, B = 25 µm, C = 2 µm, D = 1 µm. 
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5. DISCUSSION  
 
Bovine tuberculosis is still an important disease for cattle in Germany although Germany is 
regarded as tuberculosis free. The number of outbreaks has increased in Allgäu, Bavaria since 
2008. The major relevant etiologic agent has been detected as M. caprae (LGL, 2014), which 
causes tuberculous inflammation. The diagnosis of tuberculous granulomatous inflammation 
and detection of acid-fast bacilli are possible using a light microscopy or an electron 
microscopy. However, special methods are required for the determination of mycobacteria, 
mycobacterial antigen or mycobacterial DNA.  
 
The present study was performed on 84 cattle with bovine tuberculosis derived from several 
herds in Bavaria. The aim of the study was to determine the possible routes of infection, to 
investigate the macroscopical and histological alterations and development of tuberculous 
inflammation, to demonstrate the morphology of the tuberculous inflammation and to 
demonstrate the localisation and distribution of the mycobacteria within the tuberculous 
inflammation. 
 
5.1. Interpretation of Possible Routes of Infection and Lesion Distribution 
 
Bavaria has recently been reported to have bovine tuberculosis prevalence rate of 0.91% in 
cattle and in red deer (GERSTMAIER, 2011). Subsequently, the prevalence of M. caprae has 
been investigated in Austria and Alpine countries, including Bavaria. The pastures of these 
regions, shared by the same cattle and deer populations, are estimated as a possible reason for 
the transmission of the tuberculous infection from the infected deer to cattle (SCHOEPF et al., 
2012). This assumption could also be associated with the samples in the present study by 
alimentary or aerogenous route of infection. The highest percentage (63%) of the lesions was 
detected in gastrointestinal tract, contrary to the previous studies (WHIPPLE et al., 1996; 
LIEBANA et al., 2008). Thus, the alimentary route was regarded as the first route of infection 
in the present study. But contrary to that, the aerogenous route has previously been considered 
to be the most important route of infection (PRITCHARD, 1988; NEILL et al., 2001). The 
second most common route of infection was the aerogenous route (19%) in the present study. 
Lesions were commonly found in the mediastinal lymph nodes, in the lung parenchyma and 
also on the pleura. There were also cases with concurrent alimentary and respiratory lesions 
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(13%). These lesions were found either in the respiratory and gastrointestinal tract side by 
side, or only in retropharyngeal lymph node. It has been described that retropharyngeal lymph 
nodes are more frequently associated with lung and mediastinal lymph node lesions than with 
mesenterial lymph node lesions (STAMP, 1944). However, retropharyngeal lymph node 
alterations could be related to both the alimentary and the aerogenous routes of infections in 
the present study. 
 
5.2. Interpretation of Macroscopic Findings  
 
Lung, mediastinal lymph node, liver, portal lymph node, small intestine, mesenterial lymph 
node and retropharyngeal lymph node from 84 cattle showed typical macroscopic findings of 
tuberculosis consisting of yellowish, caseified and mostly calcified nodules at the post-mortal 
examination. The lesions were compatible with primary tuberculous inflammation and 
comprised both as complete or in-complete primary complexes, as described by NIEBERLE 
(1938). The incomplete complexes were especially found in the mesenterial lymph nodes, 
followed by the mediastinal lymph nodes and portal lymph nodes. Chronic organ tuberculosis 
and post primary tuberculosis were not detected. 
 
Macroscopic lesions were found in five macro-patterns, as described by RIESEBERG (2016). 
In the present study, these five macro-patterns were re-evaluated and compared with their 
histological counterparts. The results of this comparative study were considered highly 
convincing, 80% concordance between macroscopic and histologic findings. The 
characteristics defined for macro-patterns I and II showed typical tuberculous inflammation 
with a regular layered structure, which is the distinctive feature for the differentiation from 
other patterns. The lesions in macro-pattern II had foci with smaller diameters, which were 
verified by measured analysis, and were present in a greater number than macro-pattern I. The 
occurrence of the tuberculous foci in different diameters has also been used by STAMP 
(1948) for the interpretation of pulmonary tuberculosis in cattle. However, the histological 
overviews of both macro-patterns I and II were identical, consisting of a regular layered 
structure of the tuberculous inflammation (Histo-type 2). On the contrary, macro-pattern III 
displayed extremely disarranged structure. All the cut surface of the affected organ was 
altered in this macro-pattern. The histological overview was also identical whereby showing 
irregular composition of inflammatory cells and fibrous tissue (Histo-type 3). Like macro-
pattern III, macro-pattern IV also showed extensive alterations in the affected organs in 
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comparison with macro-patterns I and II. Especially, large caseous necrosis and thin layer of 
fibrous tissue were distinctive on the cut surface of the affected organ. The histology showed 
a small zone of inflammatory cells and a thin layer of fibrous tissue around the caseous 
necrosis (Histo-type 4). The features and differences of the histological types of tuberculous 
inflammation are interpreted below (5.3.). Macro-pattern V presented cavitating tuberculosis 
in this study. This macro-pattern was most frequently accompanied by another macro-pattern 
and was found in the lung and lymph nodes. In addition to five macro-patterns, exudative 
pulmonary tuberculosis was also found in some lung samples, macro-pattern VI. But, 
pulmonary cavitating tuberculosis and macro-pattern VI are discussed below (see 5.4.)  
 
5.3. Interpretation of Histological Findings 
 
The results of the histological examination in the present study revealed that the main 
components of the tuberculous inflammation were caseous necrosis, neutrophils, epithelioid 
cells and Langhans-type giant cells, lymphocytes and fibrous connective tissue. However, 
mast cells and eosinophil granulocytes might also have a small role in tuberculous 
inflammation.  
 
It is supposed that the central caseous necrosis is a result of the delayed type hypersensitivity 
to limit the mycobacterial growth, because they cannot multiply in the necrosis 
(DANNENBERG, 1991). It has already been indicated that caseous necrosis can liquefy or 
calcify (JUBB & KENNEDY, 1963). In the present study, caseous necrosis was commonly 
accompanied by variable amounts of calcification foci. Both of the caseous necrosis and 
calcification have been seen as common features for the tuberculous inflammation 
(LIEBANA et al., 2008).  
 
Epithelioid cells and Langhans-type multinucleated giant cells, the cells of the mononuclear 
phagocyte system (MPS), played the principal role in the tuberculous inflammation. In the 
present study, they were arranged either in individual epithelioid cell granulomatous 
inflammation (Histo-type 1) or in the classical tubercles (Histo-type 2). Contrary to other 
studies (WANGOO et al., 2005; LIEBANA et al., 2008), epithelioid cell granulomatous 
inflammations also comprised caseous necrosis with or without calcification. It was assumed 
that fatty degenerated epithelioid cells underwent caseation. In addition, some epithelioid cell 
granulomatous inflammations demonstrated a focus of central calcification without any 
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indication of former caseation. In a tubercle (Histo-type 2), epithelioid and Langhans-type 
giant cells were found in the inner layer of the inflammatory zone, as described in other 
studies in men and cattle (ULRICHS et al., 2005; PALMER et al., 2007). 
Immunohistochemically, these cells could be determined by lysozyme and calprotectin 
(MAC387). The positive reaction obtained by lysozyme was more distinct than those by 
calprotectin (MAC387). 
 
Intact and disintegrated neutrophils were found scattered or in aggregates in different 
localisations. Most commonly, they were detected in the caseous necrosis or around the 
caseous necrosis in combination with epithelioid cells and giant cells. These findings were 
compatible with a previous experimental study with calves (CASSIDY et al., 1999). Indeed, 
the role of the neutrophils in the pathogenesis of the tuberculous granulomatous inflammation 
in the early stage of infection has already been shown in an experimental study (PEDROSA et 
al., 2000). The participation of the neutrophils in the epithelioid cell granulomatous 
inflammation might be a trigger mechanism for the beginning of the caseous necrosis 
(TURNER et al., 2003). They also have a striking role in the regulation of the young 
granuloma formations in the chronic phases of infection (SEILER et al., 2003). In the present 
study, neutrophils are also involved in the acute lung tuberculous inflammation, which is 
discussed below (see 5.4.)   
 
In addition to the neutrophils and macrophages (epithelioid cells), the cell mediated immune 
response is required to control and eliminate the mycobacteria, and it causes the development 
of the tuberculous inflammation (FLYNN & CHAN, 2001). In the present study, lymphocytes 
participated in the early and also later stages of the tuberculous inflammation. In agreement 
with a previous study (ULRICHS et al., 2005), the inflammatory zone was characterised by 
massive lymphocyte infiltration, which was rich in T and B lymphocytes. In accordance with 
the study of WANGOO and coworkers (2005), the majority of lymphocytes were CD3 T 
cells. They were seen throughout the inflammation. On the other hand, the aggregates of B 
lymphocytes were most prominent at the periphery of the inflammation.  
 
The most prominent role seen for the fibrous tissue is the encapsulation of the tuberculous 
inflammation and the restriction of the progression of the inflammation. In the present study, 
the fibrous tissue encapsulation was clearly seen as a grey band in macro-patterns I and II, and 
as a thin layer in macro-pattern IV. Histological demonstration was performed by Masson´s 
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trichrome and Silvering stainings. The different amounts of fibrous connective tissue 
displayed regular and irregular arrangements and that could be related to the chronicity of the 
tuberculous inflammation. New collagen-fibre has also been shown in different stages of the 
tuberculous inflammation. It has been concluded that the increased degree of new collagen 
formation indicates the advancement of the lesion development (WANGOO et al., 2005). 
 
Regardless of the composition of these components, tuberculous inflammation was evaluated 
on the basis of four different histo-types and also on an additional acute exudative type of 
pulmonary tuberculous inflammation. These four histo-types could be related to the sequential 
alterations in the development of tuberculous inflammation. 
 
Histo-type 1 showed epithelioid cell granulomatous inflammation and was divided into two 
subtypes depending on the localisations. Histo-subtype 1a presented solitary epithelioid cell 
granulomatous inflammation, while histo-subtype 1b occurred as satellite epithelioid cell 
granulomatous inflammation within the inflammatory or fibrous zone of the tuberculous 
inflammation. It was assumed that the development of a tuberculous inflammation could start 
with an accumulation of the MPS cells, from an individual cell to extensive cell 
accumulations. The development of such an epithelioid cell granulomatous inflammation has 
been demonstrated by the maturation of monocytes into macrophages and then into 
epithelioid cells (ADAM, 1974). Thus, histo-subtype 1a corresponded to the initial stage of 
tuberculous inflammation in the present study. It might progress to the histo-type 2 after the 
development of both caseating necrosis and fibrous tissue. Histo-type 2 was characterised by 
a central caseous necrosis, which was surrounded by concentric layers of inflammatory cells 
and fibrosis. All of these components showed distinctive layers, as onionskin-like structure. 
This histo-type represents the classical tuberculous granuloma (MARIANO, 1995). Histo-type 
3 could develop later than histo-types 1 and 2. This type showed especially proliferative and 
disordered fibrous tissue. Inflammatory cells also displayed disordered arrangement in 
combination with fibrous tissue. Although caseation and calcification were seen in this type, 
they were not as severe as seen in histo-type 4. Thus, histo-type 4 could be evaluated as the 
latest stage due to the thin layer of fibrous tissue encapsulation and large caseous necrosis and 
calcification as well. Caseation and calcification have also been demonstrated as the latest 
stages in an experimental study (WANGOO et al., 2005). 
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It was concluded that a tuberculous inflammation could progress appositionally either in an 
organ, or could disseminate by lympho-haematogenously to the other organs, or intra-
canaliculary in the air ways of the lung (see 5.4.). Appositional growth was characterised by 
an epithelioid cell granulomatous inflammation, which could arise as a satellite granuloma 
(Histo-subtype 1b) within the inflammatory zone of a large tubercle. Thereafter, central 
caseation necrosis could occur in histo-subtype 1b and it could integrate into the large caseous 
necrosis of the large tubercle (Histo-type 2).  
 
5.4. Pulmonary Tuberculosis 
 
In the present study, tuberculous lesions of the respiratory tract were commonly found both in 
lung and in the regional mediastinal lymph nodes, in form of complete or incomplete primary 
complexes, as described previously (NIEBERLE, 1938; STAMP, 1944). Primary lung foci 
were detected in different macro-patterns. Previously, the macroscopic alterations of 
pulmonary primary foci have also been classified by Stamp. In that study, most of the primary 
lesions were found encapsulated, large, caseous and calcified, in many cases reaching up to 5 
or 6 cm in diameter, mostly with cavity formations (STAMP, 1948). These characteristics 
showed similarity to the lung samples with macro-pattern I and II, and also those in a 
combination with pattern V. However, in the present study, the diameter in macro-pattern I 
reached a maximum of 2.4 cm. Furthermore, they comprised oedema with fibrin, 
disintegrated and intact neutrophils and also lymphocytes. They could be a sign for 
progressive pulmonary tuberculous inflammation. AUERBACH (1959) also describes that 
progressive primary complexes have the tendency to liquefaction and cavity formation. 
 
STAMP (1944) referred that pleural involvement of the tuberculous inflammation can occur 
after a primary lung infection by direct lymphatic drainage from the lesion to the pleura. 
Lymphogenous spread could also be the cause of the pleural lesions in case number S 770/13, 
because there were no other findings indicating a haematogenous spread in that case.  
 
Histological findings were compatible with their macro-patterns. Epithelioid cell 
granulomatous inflammations (Histo-subtypes 1a - 1b) and also classic tubercle granulomas 
(Histo-type 2) were the most common findings. They were also compatible with the 
productive type of tuberculous inflammation described by NIEBERLE (1938) and 
PALLASKE (1961). Furthermore, distinctive findings were bronchial wall necrosis and air-
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way intrusions. The extension of caseous necrosis could cause the necrosis of bronchial walls 
and the loss of lining columnar epithelium. Thereafter, oedema with fibrin, degenerated 
columnar epithelial cells and disintegrated and intact neutrophils could replace the destructed 
bronchial walls.  
 
Exudative alterations could also be detected in the lung in the present case. It was assumed 
that the development of these lesions could start at first with an acinar necrosis with an 
alveolar pulmonary oedema at the periphery of the necrosis, followed by the appearance of 
inflammatory cells, described by PALLASKE (1961). In addition, PALLASKE also 
mentioned that no bacilli are found in the alveolar pulmonary oedema. Contrary to that, a few 
numbers of acid-fast bacilli were found in the alveolar pulmonary oedema in the lung sections 
with FF staining. 
 
5.5. Detection Methods 
 
The detection of the mycobacteria was performed by different methods. While using FF 
staining and IHC bacteria and their antigenic fragments were detectable, ISH failed to give 
any positive reaction in the material from cattle. FF staining has already been considered as 
highly specific but less sensitive for the detection of acid-fast bacilli (WATRELOT-VIRIEUX 
et al., 2006). In the present study, a high percentage of the cases (83%) were detected FF 
positive, which could be interpreted as high specificity and sensitivity (RIESEBERG, 2016).  
 
The specificity of the immunohistochemistry against mycobacteria has already been 
controversially discussed (HUMPHREY & WEINER, 1987; CASSIDY et al., 1999; 
WATRELOT-VIRIEUX et al., 2006; PUROHIT et al., 2007). However, it has been indicated 
that the use of monoclonal antibodies might be more specific than the use of polyclonal 
antibodies (CORNER et al., 1988).  
 
The immunohistochemistry has been considered as a sensitive method for the determination 
of the mycobacterial antigens in the tuberculous inflammation (PUROHIT et al., 2007). In the 
present study, high percentage of the cases (90%) was obtained positive by polyclonal rabbit 
anti-M. tuberculosis complex primary antibody. Furthermore, the sensitivity was controlled 
by comparative study using polyclonal rabbit anti-M. bovis primary antibody and revealed 
that M. tuberculosis complex primary antibody works more sensitively than M. bovis primary 
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antibody. In addition, mycobacteria were also detected by TEM in the areas which were 
positive in IHC, but it still remained unclear due to the low number of cases. 
 
The mycobacterial antigen was detected throughout the inflammation and also in the non-
altered areas. Positive signals were detected most commonly in the caseation necrosis (Zone 
1). Large amounts of positive signal were found intracellular in the epithelioid and Langhans-
type giant cells in the inflammatory zone (Zone 2). That could be an indication for high 
phagocytic activity of these cells. On the other hand, the positive reaction was also detected 
intracellularly in large cells, which were outside the tuberculous inflammation (Zone 3). This 
situation has also been described previously in humans with pulmonary tuberculosis, and has 
been considered that mycobacteria could not only be found within the granulomatous 
inflammation, but also distant parts of the lung (ULRICHS et al., 2005).   
 
Although there was a positive correlation between FF staining and IHC results, more positive 
localisations (Zones 1, 2, 3) were obtained by IHC. Contrary to that, the correlation between 
IHC results and TEM investigations was not identical. Although there were numerous positive 
extracellular areas and positive epithelioid cells in the semi-thin sections, only few 
mycobacteria could be found in the TEM investigations. 
 
5.6. Conclusion 
 
In conclusion, this study showed possible routes of infection for bovine tuberculosis and also 
revealed different macro-patterns and histo-types of tuberculous inflammation in the affected 
cattle. This classification of the macroscopic and histological findings, the predicted 
development and growth of the tuberculous inflammation and the evaluation of the 
components involved in the tuberculous inflammation could serve to further studies for a 
better understanding of the pathogenesis of bovine tuberculosis.  
 
Furthermore, the detection of mycobacteria was performed using a light microscopy and 
TEM. Different detection methods were performed for this aim. It was assumed that only few 
numbers of mycobacteria could be found in the tuberculous inflammation, and FF staining 
could be the most sensitive method for the detection of mycobacteria. Due to the unclear 
sensitivity of IHC, this method could be an alternative method for FF staining.  
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6. SUMMARY 
 
Several outbreaks of bovine tuberculosis, caused by M. caprae, occurred in the years between 
2009 and 2014 in some cattle herds of Bavaria, Germany. The suspected cattle were 
investigated in context of the regulations of Germany. Following the culling, tissue samples 
including lung, liver, small intestine, their regional lymph nodes, and retropharyngeal lymph 
node were collected from 84 cattle for the further bacteriological and pathomorphological 
investigations. 
 
The organs were evaluated macroscopically and light-microscopically. Furthermore, 
mycobacteria and mycobacterial antigens were demonstrated using acid-fast staining and 
immunohistochemistry, respectively. The ultrastructural demonstration of bacteria was carried 
out using semi-thin sections, in which the mycobacterial antigens were demonstrated by 
postembedding-immunohistochemistry.    
 
Macroscopic alterations were associated with five patterns. Pattern I were typical layered 
tubercles with a larger diameter (up to 2.4 cm), they appeared single or in low numbers. 
Pattern II showed numerous small (up to 0.5 cm) layered tubercles. Pattern III had no clearly 
discernible structure and pattern IV consisted of extensive caseous necrosis. Pattern V were 
cavities emerging from liquefaction of caseous necrosis, especially in the lung; exclusively to 
the lung an additional acute exudative type of inflammation was observed.  
 
The histological alterations were divided into four types. Type 1 predominantly consisted of 
non-layered accumulations of epithelioid cells and multinucleated giant cells. The type 2 
corresponded to the classical layered tubercle and therefore paralleled the macroscopic 
patterns I and II. Type 3 showed disordered collections of fibre-rich fibrous tissue, foci with 
epithelioid cells, and with caseation necrosis, according to the pattern III. The type 4 had 
extensive, poorly restricted caseous foci analogous to pattern IV.  
 
The distribution of the tuberculous lesions in the different organs and lymph nodes revealed 
that the most important route of infection was the alimentary tract (68%), followed by the 
aerogenous infection (19%). A combination of both routes of infection was present in 13% of 
the cases.  
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The acid-fast staining revealed that the numbers of detectable bacteria in the most of the 
infectious foci was very low. Caseation and calcification showed the highest amounts; single 
acid-fast bacteria regularly occurred in the multinucleated giant cells, and only sporadically in 
epithelioid cells. No bacteria could be detected outside of the inner inflammatory zone of the 
tubercles. 
 
The immuohistochemical demonstration of mycobacterial antigens was positive in caseous 
foci, in epithelioid and multinucleated cells as well as in cells, which were found in the 
tubercles individually lying between the lymphocytes in the outside areas. 
 
Mycobacteria could be demonstrated by transmission electron microscopy. The reliable 
detection of mycobacterial DNA by in situ hybridization failed. 
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7. ZUSAMMENFASSUNG 
 
Mehrere Ausbrüche von Rindertuberkulose, verursacht durch M. caprae, traten in den Jahren 
2009 bis 2014 in bayerischen Rinderbeständen auf. Die verdächtigen Tiere fielen im Rahmen 
der Schlachtung auf. Bei der nachfolgenden Keulung wurden für die vorliegende Studie von 
84 Rindern Proben aus Lunge, Leber, Dünndarm und den regionären Lymphknoten sowie 
Retropharyngeallymphknoten für pathomorphologische und bakteriologische Untersuchungen 
gewonnen.  
 
Die Organe wurden makroskopisch und lichtmikroskopisch beurteilt. Ferner wurden 
Mykobakterien mittels säurefester Färbung und mykobakterielle Antigene 
immunhistochemisch nachgewiesen. Der ultrastrukturelle Nachweis von Bakterien erfolgt 
anhand von Semidünnschnitten, in denen zuvor bakterielles Antigen durch postembedding-
Immunhistochemie nachgewiesen worden war.  
 
Die makroskopischen Veränderungen konnten fünf Mustern zugeordnet werden. Muster I 
waren typische geschichtete Tuberkel mit einem größeren Durchmesser (bis 2,4 cm), die 
einzeln oder in geringer Anzahl vorlagen. Muster II zeigte zahlreiche kleinere (bis 0,5 cm) 
geschichtete Tuberkel. Muster III wies keine klar erkennbare Strukturierung auf und Muster 
IV bestand aus umfangreichen Verkäsungsherden. Muster V waren Einschmelzungskavernen, 
vor allem in der Lunge; ausschließlich an der Lunge konnte zusätzlich eine akut-exsudative 
Entzündung nachgewiesen werden.  
 
Die histologischen Veränderungen wurden in vier Typen eingeteilt. Typ 1 bestanden 
überwiegend aus ungeschichteten Ansammlungen von Epitheloidzellen und mehrkernigen 
Riesenzellen. Der Typ 2 entsprach dem klassischen geschichteten Tuberkel und somit den 
makroskopischen Mustern I und II. Typ 3 zeigte eine ungeordnete Ansammlung von 
faserreichem Bindegewebe, Herden mit Epitheloidzellen und Verkäsungsherden, 
entsprechend dem Muster III. Der Typ 4 wies umfangreiche, schlecht begrenzte 
Verkäsungsherde analog zum Muster IV auf, die histologisch schlecht begrenzt waren.  
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Die Verteilung der tuberkulösen Läsionen in den verschiedenen Organen und Lymphknoten 
ergab, dass der wichtigste Infektionsweg die älimentare Infektion (68%) war, gefolgt von der 
aerogenen (19%). In 13 % der Fälle lag eine Kombination beider Infektionswege vor.  
 
Die säurefeste Färbung zeigte insbesondere, dass die Anzahl nachweisbarer Bakterien in den 
meisten Entzündungsherden sehr gering war. Die höchsten Gehalte wiesen Verkäsung und 
Verkalkung auf; in den mehrkernigen Riesenzellen traten regelmäßig einzelne säurefeste 
Stäbchen auf, selten dagegen in Epitheloidzellen. Außerhalb der entzündlichen Innenzone 
konnten keine Bakterien in den Tuberkeln nachgewiesen werden. 
 
Der immunhistochemische Nachweis von mykobakteriellem Antigen war positiv in 
Verkäsungsherden, in Epitheloidzellen und mehrkernigen Riesenzellen sowie Zellen, die sich 
in Tuberkeln einzeln zwischen den im Außenbereich liegenden Lymphozyten fanden.  
 
Mykobakterien konnten transmissionselektronenmikroskopisch nachgewiesen werden. Es 
gelang hingegen nicht, mykobakterielle DNA verläßlich durch in Situ Hybridisierung zu 
detektieren. 
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9. APPENDIX 
 
9.1. Tables  
 
9.1.1. Table 10. Macro-pattern distribution of individual organs.  
Abbreviations: Animal No.: animal number LN: lymph node. 
 
Animal No. Organ Macro-pattern 
E 96/09 Mesenterial LN - 
E 97/09 Mesenterial LN III 
E 98/09 Mesenterial LN III 
E 100/09 Mediastinal LN - 
 Portal LN - 
E 102/09 Small intestine I 
 Mesenterial LN IV 
E 106/09 Mesenterial LN III – IV  
E 107/09 Mediastinal LN III 
E 108/09 Mediastinal LN III 
 Mesenterial LN III 
E 110/09 Liver I 
 Portal LN I – III  
 Mediastinal LN I 
 Lung - 
 Mesenterial LN IV 
E 112/09 Mesenterial LN I 
 Portal LN - 
E 113/09 Mesenterial LN I 
E 114/09 Mesenterial LN III 
E 312/09 Mesenterial LN - 
E 313/09 Portal LN - 
 Mesenterial LN - 
E 316/09 Mesenterial LN - 
E 317/09 Portal LN - 
 Lung I 
 Mediastinal LN II –III  
 Liver - 
 Mesenterial LN - 
E 320/09 Mesenterial LN - 
E 321/09 Mediastinal LN - 
E 322/09 Lung II 
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Animal No. Organ Macro-pattern 
 Mediastinal LN III 
 Mesenterial LN - 
 Portal LN - 
 Liver I 
E 323/09 Lung II 
 Mesenterial LN - 
E 324/09 Liver / Peritoneum - 
E 325/09 Portal LN - 
 Liver - 
E 325/09 Mesenterial LN - 
E 326/09 Mesenterial LN - 
S 1224/12 Lung - 
S 1256/12 Mediastinal LN II 
 Lung III 
S 1257/12 Mesenterial LN III 
S 1258/12 Mesenterial LN III 
S 1259/12 Retropharyngeal LN II 
S 1260/12 Mesenterial LN I 
S 126/13 Mediastinal LN III 
S 127/13 Mediastinal LN II 
S 128/13 Mesenterial LN III 
S 173/13 Mediastinal LN - 
S 175/13 Retropharyngeal LN I 
S 179/13 Mesenterial LN III 
S 183/13 Portal LN I 
 Mesenterial LN I – III  
S 292/13 Mesenterial LN I 
S 293/13 Portal LN I 
S 294/13 Portal LN III 
 Mesenterial LN II – III – IV  
S 295/13 Portal LN - 
 Mesenterial LN III 
S 298/13 Mesenterial LN II 
S 299/13 Retropharyngeal LN I – IV  
 Mesenterial LN III 
S 300/13 Mesenterial LN I – III  
S 605 /13 Mediastinal LN I – II  
 Lung II 
S 607/13 Lung - 
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Animal No. Organ Macro-pattern 
 Mediastinal LN III 
S 770/13 Mesenterial LN III 
 Lung I –V  
 Mediastinal LN - 
S 776/13 Mesenterial LN - 
 Retropharyngeal LN - 
S 778/13 Mesenterial LN - 
S 778/13 Retropharyngeal LN - 
S 779/13 Mediastinal LN - 
S 780/13 Mediastinal LN - 
S 782/13 Mediastinal LN - 
S 783/13 Mesenterial LN - 
S 785/13 Mesenterial LN - 
S 789/13 Mediastinal LN I – V  
S 1200/13 Mediastinal LN III 
S 1202/13 Mediastinal LN III 
S 1204/13 Mesenterial LN III 
S 1205/13 Mesenterial LN IV 
S 1207/13 Mesenterial LN II 
S 409/14 Retropharyngeal LN II 
S 410/14 Mesenterial LN - 
S 411/14 Mesenterial LN - 
S 412/14 Mesenterial LN I – III – V  
S 413/14 Mesenterial LN II – III 
S 414/14 Mesenterial LN III 
S 415/14 Mesenterial LN III 
S 416/14 Mesenterial LN III 
S 418/14 Mesenterial LN - 
S 419/14 Mesenterial LN I – III  
S 422/14 Lung I – V  
S 423/14 Mesenterial LN III 
S 425/14 Mesenterial LN III 
S 426/14 Mesenterial LN III 
S 594/14 Mesenterial LN III 
S 598/14 Mesenterial LN II 
S 599/14 Mesenterial LN III 
S 600/14 Mesenterial LN - 
 Lung I –V  
S 602/14 Mesenterial LN III 
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Animal No. Organ Macro-pattern 
S 606/14 Mesenterial LN III 
S 607/14 Mesenterial LN III 
S 611/14 Mesenterial LN III 
S 612/14 Mesenterial LN III 
S 1067/14 Mesenterial LN I 
S 1068/14 Mesenterial LN III 
 
9.1.2. Table 11. Histological examination of the tissue samples.  
Abbreviations: Animal No.: animal number; LN: lymph node; NI: not investigated; FF: Fite-Faraco 
staining; IHC: immunohistochemistry, 1: necrotic zone, 2: inflammatory zone, 3: outer zone; +++: 
strong positive immune reaction, ++: moderate positive immune reaction, +: weak positive immune 
reaction with the polyclonal rabbit anti-M. tuberculosis (Rb x Tbc). 
 
Animal No. Organ Histo-type FF IHC 
E 96/09 Mesenterial LN 1a – 2    + 2, 3 + 
E 97/09 Mesenterial LN 3 + 1, 2, 3 + 
E 98/09 Mesenterial LN 1a – 2 – 3  + 2 + 
E 100/09 Mediastinal LN 2 + 1, 2, 3 + 
 Portal LN 3 + 2, 3 + 
E 102/09 Small intestine 1b – 2      + 1 +++, 2 +, 3 ++ 
 Mesenterial LN 1 3 + 1, 2 + 
 Mesenterial LN 2 1a – 1b – 2  - 1 + 
E 106/09 Mesenterial LN 3 + 1, 2, 3 + 
E 107/09 Mediastinal LN 1a – 1b – 2 – 3  + 1, 2 + 
E 108/09 Mediastinal LN 1 1b – 4  + - 
 Mediastinal LN 2 1a – 3   + - 
 Mediastinal LN 3 3  + - 
 Mesenterial LN 1 1a – 1b – 2 – 4   + 1, 2 + 
 Mesenterial LN 2 1a – 1b – 4  - 1, 2, 3 + 
 Mesenterial LN 3 1a – 1b – 4 + - 
 Mesenterial LN 4 1a – 3  + 2, 3 + 
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Animal No. Organ Histo-type FF IHC 
 Mesenterial LN 5 1a – 2 – 4  - - 
E 110/09 Liver 1 1b – 2  - - 
 Liver 2 1b – 2 - 1 + 
 Liver 3 1b – 2 + 1 + 
 Liver 4 1b – 2 - 1 ++ 
 Portal LN 1 3 + 1, 2, 3 + 
 Portal LN 2 1b – 2 + 1, 2, 3 + 
 Portal LN 3 1b – 2 + 1, 2, 3 + 
E 110/09 Portal LN 4 1b – 2 - 1, 2, 3 + 
 Mediastinal LN 1 1b – 2 + 1 +, 2+ 
 Mediastinal LN 2 1b – 2 + 3 + 
 Lung 1b – 2 - 
1 +++, 2 ++, 3 
+ 
 Mesenterial LN 1 2 + 1 ++, 2, 3 +++ 
 Mesenterial LN 2 2 - 1 + 
E 112/09 Mesenterial LN 1 2 – 4  + 2 + 
 Mesenterial LN 2 1a – 1b – 2 – 4   + 2 + 
 Portal LN 1b – 2 + 1 + 
E 113/09 Mesenterial LN 2 + 1 + 
E 114/09 Mesenterial LN 1 1a – 3 - NI 
 Mesenterial LN 2 1a – 3 - 1 + 
 Mesenterial LN 3 1a – 3 - 1 ++ 
E 312/09 Mesenterial LN 3 + 1, 2, 3 + 
E 313/09 Portal LN 1b – 2 + 2, 3 + 
 Mesenterial LN 1b – 2 – 3  - 1, 2, 3 + 
E 316/09 Mesenterial LN 1b – 2 + 1, 2, 3 + 
E 317/09 Portal LN 1a – 1b – 2 + 1, 2, 3 + 
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Animal No. Organ Histo-type FF IHC 
 Lung 1a - 2 + 
 Mediastinal LN 1b – 2 + 1, 2, 3 + 
 Liver 2 - - 
 Mesenterial LN 1 1a – 1b – 2 + 1 + 
 Mesenterial LN 2 1a – 1b – 3 + 1 + 
E 320/09 Mesenterial LN 1 1a – 2    - 2, 3 + 
 Mesenterial LN 2 1a – 2 – 4     + 1, 2, 3 + 
E 321/09 Mediastinal LN 1b – 2 + 1, 2, 3 + 
E 322/09 Lung 1 2 - 1+ 
 Lung 2 2 + 1+ 
 Lung 3 4 + 1+ 
 Lung 4 4 - - 
 Mediastinal LN 3 + 1 + 
 Mesenterial LN 1 1a – 4  + 1 +++, 2, 3 ++ 
 Mesenterial LN 2 1a + 3 + 
 Mesenterial LN 3 1a – 4 + 1, 2, 3 + 
 Mesenterial LN 4 4 + 1, 2, 3 + 
 Mesenterial LN 5 4 - 3 + 
 Mesenterial LN 6 1a – 4 + 2 + 
 Mesenterial LN 7 1a – 4 + 2, 3 + 
 Portal LN 1a – 4 + 1 + 
 Liver 2 - - 
E 323/09 Lung 1a – 1b – 2 + NI 
 Mesenterial LN 3 + 
1 +++, 2 ++, 3 
+ 
E 324/09 Liver / Peritoneum 1a + 2, 3 + 
E 325/09 Portal LN 2 - 1 +++, 2, 3 ++ 
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Animal No. Organ Histo-type FF IHC 
 Liver 2 + 1 + 
 Mesenterial LN 1a – 1b – 2 - 4 + 1 ++, 2, 3 +++ 
E 326/09 Mesenterial LN 1a – 2 – 3 – 4  + 1, 2, 3 +++ 
S 1224/12 Lung 1a – 1b – 2 + - 
S 1256/12 Mediastinal LN 1 1a – 1b – 2 + 3 + 
 Mediastinal LN 2 1a – 1b – 2 + 3 + 
 Mediastinal LN 3 2 + 1 + 
S 1256/12 Lung 1 1a – 2  + 2 +  
 Lung 2 1a – 1b – 2 + 2 + 
S 1257/12 Mesenterial LN 1a – 2 – 4  + 1 ++, 2, 3 + 
S 1258/12 Mesenterial LN 1a – 3 + 1, 2, 3 +++ 
S 1259/12 Retropharyngeal LN 1a – 2  + 1, 3 + 
S 1260/12 Mesenterial LN 1a – 1b – 2  + 1, 2, 3 +++ 
S 126/13 Mediastinal LN 1 1a + 3 + 
 Mediastinal LN 2 1a + 3 + 
 Mediastinal LN 3 3 + NI 
S 127/13 Mediastinal LN 2 + 1, 2, 3 ++ 
S 128/13 Mesenterial LN 1a – 4 + 3 + 
S 173/13 Mediastinal LN 1a + 3 + 
S 175/13 Retropharyngeal LN 1 2 – 3  - 3 + 
 
Retropharyngeal LN 
2 2 – 3 + 1 +, 2, 3 ++ 
S 179/13 Mesenterial LN 1 1a – 4 + 1 ++, 3 + 
 Mesenterial LN 2 1a – 4 + 1, 3 + 
S 183/13 Portal LN 1a – 2 - 3 + 
 Mesenterial LN 1 1a – 1b – 2 + 3 + 
 Mesenterial LN 2 1a – 1b – 2 + 2 + 
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Animal No. Organ Histo-type FF IHC 
 Mesenterial LN 3 1a – 1b – 2 + 1, 3 +  
S 292/13 Mesenterial LN 1 2 + 1, 2, 3 ++ 
 Mesenterial LN 2 2 – 3 + 1 ++ 
S 293/13 Portal LN 2 – 3 + 1, 2, 3 ++ 
S 294/13 Portal LN 1a – 2 – 3  + 3 +  
 Mesenterial LN 1 1a – 3 + 1 +  
 Mesenterial LN 2 1a – 2 – 3 + 2 + 
S 294/13 Mesenterial LN 3 1a – 2 – 3 + 1, 2 +  
 Mesenterial LN 4 1a – 2 – 3 + 2 + 
 Mesenterial LN 5 1a – 2 – 3 + 1 +, 2 + 
S 295/13 Portal LN 1a – 2 – 3 - 3 + 
 Mesenterial LN 1 1a – 2 - 2, 3 + 
 Mesenterial LN 2 3 + 1, 2, 3 + 
 Mesenterial LN 3 1a – 3 + 1, 3 ++ 
 Mesenterial LN 4 1a – 3 + 1 ++ 
S 298/13 Mesenterial LN 1 1a – 2 - - 
 Mesenterial LN 2 1a – 2 - - 
S 299/13 Retropharyngeal LN 1 1a – 1b – 2 + 1, 2, 3 + 
 
Retropharyngeal LN 
2 1a – 2 – 3 + 1 ++, 2, 3 + 
 
Retropharyngeal LN 
3 1b – 2 – 3 + 1 + 
 Mesenterial LN 1 2 – 3 + 1 +, 2, 3 ++ 
 Mesenterial LN 2 1a – 2 – 3 + 2, 3 + 
S 300/13 Mesenterial LN 1 1a – 2 – 3 + 3 + 
 Mesenterial LN 2 1a – 3 + 1, 2 ++ 
 Mesenterial LN 3 3 + 1, 2 ++ 
 Mesenterial LN 4 1a – 2 – 3 + 1, 2 +++ 
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Animal No. Organ Histo-type FF IHC 
S 605 /13 Mediastinal LN 1 A: 1b - 2 / B: 2 A: + / B: + A:1 +++ /        B: 1, 2 ++ 
 Mediastinal LN 2 
A: 1a – 1b – 2  
/ B: 1a – 2  A: +/ B:+ 
A: 1 +++ /       
B: 1, 2, 3 +++ 
 Mediastinal LN 3 2 + 2, 3 + 
 Mediastinal LN 4 2 + 1 +++ 
 Lung 1 
A: 1a – 2 /      
B: 1a – 2   A: + / B: + A 2 + / B - 
 Lung 2 2 - - 
 Lung 3 A: 2 / B: 2 A:+ / B: + 
A:1 +++ /          
B: 1 ++, 2 + 
S 607/13 Lung 1a + 1 +++, 3 + 
 Mediastinal LN 1b – 2  + 1 + 
S 770/13 Mesenterial LN 1 A: 1a – 2 – 3 / B: 1b – 2 A:+ / B: + 
A: 1 +++ /       
B: 1, 2 +++ 
 Mesenterial LN 2 2 – 3  + 1, 2 +++ 
 Lung 1 3 + 1, 2 + 
 Lung-Pleura 2 2 + - 
 Lung-Pleura 3 3 + - 
 Mediastinal LN 1 2 + - 
 Mediastinal LN 2 2 – 3 + 3 + 
 Mediastinal LN 3 3 + 2, 3 + 
S 776/13 Mesenterial LN 2 - NI 
 
Retropharyngeal LN 
1 3 - NI 
 
Retropharyngeal LN 
2 1a – 2 – 3 - NI 
S 778/13 Mesenterial LN 1 1b – 2 + 2, 3 +++ 
 Mesenterial LN 2 1a – 1b – 2 - 1 +, 2, 3 +++ 
 Mesenterial LN 3 1a – 1b – 2 + - 
 
Retropharyngeal LN 
1 1a – 2 - 1 ++ 
 
Retropharyngeal LN 
2 1b – 2 + 3 + 
S 779/13 Mediastinal LN 1 1a – 2 – 3 - 1, 3 + 
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Animal No. Organ Histo-type FF IHC 
 Mediastinal LN 2 1a – 2 – 3 + 3 + 
S 780/13 Mediastinal LN 1 1a – 2 – 3 - - 
 Mediastinal LN 2 1a – 2 – 3 - 1 ++ 
S 782/13 Mediastinal LN 1a + 3 + 
S 783/13 Mesenterial LN 1a – 4  + 1 + 
S 785/13 Mesenterial LN 1 1a – 4 + 1 +++ 
 Mesenterial LN 2 1a – 4 + - 
S 789/13 Mediastinal LN 1 1b – 2 – 3 - - 
 Mediastinal LN 2 1a – 2  - - 
S 1200/13 Mediastinal LN 1 1a – 2 – 3 + 2, 3 ++ 
 Mediastinal LN 2 1a – 2 + 1 +, 2, 3 ++ 
 Mediastinal LN 3 1a – 2 + 1 +, 2, 3 ++ 
S 1202/13 Mediastinal LN 1 1a – 2 – 3 + 1 +, 2, 3 ++ 
 Mediastinal LN 2 3 + 1 +, 2, 3 ++ 
S 1204/13 Mesenterial LN 1 1a – 3 – 4  + 1 +, 2, 3 ++ 
 Mesenterial LN 2 1a – 4 + 1, 2, 3 + 
S 1205/13 Mesenterial LN 1 3 + 1 +, 2, 3 ++ 
 Mesenterial LN 2 1a – 3  + 1, 2, 3 + 
S 1207/13 Mesenterial LN 1a - 3 + 
S 409/14 Retropharyngeal LN 1 1a – 2 + 2, 3 +++ 
 
Retropharyngeal LN 
2 1a – 2 + 2, 3 ++ 
 
Retropharyngeal LN 
3 1a – 2 + 1 +, 2, 3 ++ 
 
Retropharyngeal LN 
4 1a – 2 + 1 +++, 3 +++ 
S 410/14 Mesenterial LN 1 1a – 2 - 1 +, 2, 3 + 
 Mesenterial LN 2 1a – 2 - 1, 2 +, 3 ++ 
S 411/14 Mesenterial LN 1a – 2 - 2 +, 3 ++ 
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Animal No. Organ Histo-type FF IHC 
S 412/14 Mesenterial LN 1 1a – 1b – 2 - 1 +, 2, 3 ++ 
 Mesenterial LN 2 1a – 1b – 3 + 1 +, 2, 3 ++ 
 Mesenterial LN 3 1a – 2 - 1 +, 2, 3 +++ 
 Mesenterial LN 4 1a – 1b – 2 – 3  + 1 +, 2, 3 ++ 
S 413/14 Mesenterial LN 1 1a – 2 + 1, 2, 3 + 
 Mesenterial LN 2 1a – 1b – 4  + 1, 2, 3 + 
 Mesenterial LN 3 1a – 1b – 3 + 1 +++, 2, 3 ++ 
S 413/14 Mesenterial LN 4 1a – 1b – 4 - 1 +, 2, 3 ++ 
S 414/14 Mesenterial LN 1 1a – 1b – 2 - 1, 2, 3 ++ 
 Mesenterial LN 2 1a – 1b – 2 - 1 ++, 2, 3 +++ 
S 415/14 Mesenterial LN 1 1a – 4 + 1, 2, 3 + 
 Mesenterial LN 2 1a – 2 – 4  + 1, 2, 3 +++ 
 Mesenterial LN 3 1a – 2 + 1, 2, 3 +++ 
S 416/14 Mesenterial LN 1 1a - 3 ++ 
 Mesenterial LN 2 1a – 2 – 4 - 1, 2, 3 +++ 
 Mesenterial LN 3 1a – 4 - 1, 2, 3 ++ 
S 418/14 Mesenterial LN 1 1a – 1b – 2 + 1 ++, 2, 3 + 
 Mesenterial LN 2 1a – 1b – 2 + 1, 2, 3 ++ 
S 419/14 Mesenterial LN 1 1a – 1b – 2 + 1, 2, 3 ++ 
 Mesenterial LN 2 1a – 1b – 4 + 1, 2, 3 + 
 Mesenterial LN 3 1a – 1b – 2 - 1, 2, 3 + 
S 422/14 Lung 1 2 - 1, 2, 3 +++ 
 Lung 2 1a – 1b – 2 - 2, 3 ++ 
 Lung 3 1b – 2 + 1, 2, 3 +++ 
 Lung 4 1b – 2 - 1, 2, 3 ++ 
 Lung 5 1a – 1b – 2 - 1, 2, 3 ++ 
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 Lung 6 1a – 1b – 2 - 2, 3 ++ 
S 423/14 Mesenterial LN 1 1a – 1b – 2 - 1, 2, 3 ++ 
 Mesenterial LN 2 1a – 1b – 2 - 1, 2, 3 ++ 
 Mesenterial LN 3 1b – 2 + 1 +, 2, 3 + 
S 425/14 Mesenterial LN 1 1a – 4 + 1 +, 2, 3 + 
 Mesenterial LN 2 1a - 1 +, 2, 3 + 
S 426/14 Mesenterial LN 1 1a – 2 + 1, 2, 3 ++ 
S 426/14 Mesenterial LN 2 1a – 2 + 1, 2, 3 + 
S 594/14 Mesenterial LN 1 1a - 3 + 
S 598/14 Mesenterial LN 1 1a – 1b – 2 - 1 +, 2 ++, 3 +++ 
 Mesenterial LN 2 1a – 1b – 2 - 1 +, 2, 3 ++ 
 Mesenterial LN 3 1b – 2 - 2 +, 3 ++ 
S 599/14 Mesenterial LN 1 1a + 1 +, 3 + 
 Mesenterial LN 2 1a – 4 + 1, 2 + 
S 600/14 Mesenterial LN 1a - 3 ++ 
 Lung 1 2 - 1, 3 +++, 2 ++ 
 Lung 2 2 + 2, 3 + 
 Lung 3 1a – 3  + 3 + 
 Lung 4 2 + 1 +, 2, 3 ++ 
S 602/14 Mesenterial LN 1 1a + 1 ++, 2, 3 +++ 
 Mesenterial LN 2 1a - 3 ++ 
S 606/14 Mesenterial LN 1 1a – 3 + 1, 2, 3 +++ 
 Mesenterial LN 2 3 + 1 +, 2 ++ 
S 607/14 Mesenterial LN 1 1a - 2, 3 ++ 
 Mesenterial LN 2 1a – 3 + 1 +++, 2, 3 ++ 
S 611/14 Mesenterial LN 3 + 1, 2, 3 + 
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Animal No. Organ Histo-type FF IHC 
S 612/14 Mesenterial LN 1 1a – 4 + 1 ++, 2, 3 + 
 Mesenterial LN 2 1a – 4 - 
1 +++, 2 ++, 3 
+ 
 Mesenterial LN 3 1a - 2, 3 + 
S 1067/14 Mesenterial LN 1 1a - 3 + 
 Mesenterial LN 2 1a - 3 + 
 Mesenterial LN 3 2 - 3 + 
S 1068/14 Mesenterial LN 1 1a – 4 - 1 +++, 3 + 
 Mesenterial LN 2 1a – 4 - 1 +++, 2, 3 + 
 
9.2. Fixation Solutions 
 
9.2.1. Formaldehyde Solution (4%) 
 
• 1 l 37-40% formaldehyde (SAV Liquid Production, Flintsbach, No. FO-1000-37-1) 
• 1 l phosphate buffer (Appendix 9.2.1.1.) 
• 8 l aqua dest. 
 
9.2.1.1. Phosphate Buffer  
 
• 40 g sodium-dihydrogen-phosphate-monohydrate (Applichem, Darmstadt, No. 
A1372.1000) 
• 65 g di-sodiumhydrogenphosphate (Applichem, Darmstadt, No. A1373.1000) 
• 10 l aqua dest.   
 
9.2.1.2. Klotz´s Solution 
 
• 500 g sodium-chloride 
• 1100 g sodium-sulphate 
• 900 g sodium-carbonate 
• 1000 g chloral-hydrate 
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• 1000 ml formaldehyde (40%) 
• 90 l aqua dest.  
 
9.3. Solution Solutions for the Staining of Paraffin Sections 
 
9.3.1. Haemalaun Eosin Staining 
 
9.3.1.1. Haemalaun Solution 
 
• Mayer`s haemalaun solution (VWR, International GmbH, Darmstadt, No. 
1.09249.2500) 
 
9.3.1.2. HCl-alcohol Stock Solution  
 
• 7000 ml 96% ethanol  
• 100 ml 25% hydrochloric-acid (Roth, Karlsruhe, No. X8971) 
• 2500 ml aqua dest. 
 
9.3.1.3. HCl-alcohol-Ready to Use-Solution (0.5%)  
  
• 100 ml HCl-alcohol stock solution (Appendix 9. 3.1.2.) 
• 100 ml 70% ethanol 
 
9.3.1.4. Eosin Solution (1%) 
 
• 10 g eosin (Merck, Darmstadt, No. 1.15935.0100) solve in warm aqua dest., then 
cooling down  
• 1.5 ml 96% acetic-acid  
• 1000 ml aqua dest.  
 
9.3.2. Giemsa Staining 
 
9.3.2.1. Phosphate Buffer (0.1 M) 
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9.3.2.1.1. Solution A  
 
• 13.61 g/l di-potassium-hydrogen-phosphate-anhydrous (Roth, Karlsruhe, Art.- No. 
P1949.1)  
• 1000 ml aqua dest.  
 
9.3.2.1.2. Solution B 
 
• 3.55 g/l disodium-hydrogen-orthophosphate (Spicker, Baierbrunn, No. A2530)  
• 250 ml aqua dest. 
 
The solutions must be kept in the fridge.  
  
9.3.2.2. Giemsa-Ready to Use-Solution 
  
• 97.5 ml solution A 
• 2.5 ml solution B 
 
Mix and heat up app. 70-80˚C. 
 
• 7 ml Giemsa stock solution (Merck, Darmstadt, No. 1.09204.1000) 
 
Adjust solution to pH 5.0 and filter. 
  
9.3.2.3. Acetic-acid (0.5%) 
  
• 5 ml acetic acid (Applichem, Darmstadt, No. A3701.2500PE) 
• 1000 ml aqua dest.  
 
9.3.3. Masson´s Trichrome Stain 
 
9.3.3.1. Weigert`s Iron Haematoxylin 
 
APPENDIX 178 
9.3.3.1.1. Solution A 
 
• 10 g haematoxylin crystallized (Merck, Darmstadt, No.1.04302.1000) 
• 1000 ml aqua dest. 
 
Leave the solution to cool down in a closed bottle. 
 
9.3.3.1.2. Solution B 
 
• 11.6 g iron(III)chloride (Merck, Darmstadt, No. 1.039430250) 
• 980 ml aqua dest.  
• 10 ml 25% hydrochloric-acid (Applichem, Darmstadt, No. A0658) 
 
Mix the solutions A and B in ratio 1:1 before use. 
 
9.3.3.2. Azophloxine Solution 
 
• 1.25 g azophloxine (Chroma Gesellschaft Schmid GmbH, Köngen, No. 18050) 
• 0.5 ml acetic-acid (Applichem, Darmstadt, No. A3701.2500PE) 
• 250 ml aqua dest. 
 
9.3.3.3. Red Color Stock Solution 
 
9.3.3.3.1. Solution A 
 
• 5 g acid fuchsine (Sigma, No. A2284) 
• 5 ml acetic-acid (Applichem, Darmstadt, No. A3701.2500PE) 
• 500 ml aqua dest. 
 
9.3.3.3.2. Solution B 
 
• 10 g xylidine-ponceau (RAL Diagnostic, Martillac, No. 223-178-3) 
• 10 ml acetic-acid (Applichem, Darmstadt, No. A3701.2500PE) 
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• 1000 ml aqua dest. 
 
9.3.3.4. Red Color-Ready to Use-Solution 
 
• 20 ml solution A (Appendix 9.3.3.3.1.) 
• 80 ml solution B (Appendix 9.3.3.3.2.) 
• 20 ml azophloxine (Appendix 9.3.3.2.) 
 
Filter them together.  
 
9.3.3.5. Phosphotungstic Acid-orange G 
 
• 15 g phosphotungstic-acid-hydrate (Merck, Darmstadt, No. 1.00583.0250) 
• 10 g orange G (Merck, Darmstadt, No. 1.15925.0025)  
• 500 ml aqua dest. 
 
9.3.3.6. Aniline Blue 
 
• 10 g aniline blue (Merck, Darmstadt, Art. - No.1279) 
• 10 ml acetic-acid (Applichem, Darmstadt, No. A3701.2500PE) 
• 1000 ml aqua dest 
 
9.3.3.7. Acetic-acid (5%) 
 
• 50 ml acetic-acid (Applichem, Darmstadt, No. A3701.2500PE) 
• 10 000 ml aqua dest.  
 
9.3.4. Acid-fast Staining according to Fite-Faraco 
 
9.3.4.1. Xylol Paraffin Oil 
 
• 300 ml paraffin oil (Roth, Karlsruhe, Art.- No. 9190.1) 
• 600 ml xylol (SAV Liquid Production, Flintsbach, No. X TR-5000-97-1) 
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9.3.4.2. HCL-alcohol (1%) Stock Solution  
  
• 7000 ml 96% ethanol (SAV Liquid Production, Flintsbach, No. ETO-30000-96-1) 
• 2500 ml aqua dest. 
• 100 ml 25% acetic-acid (Applichem, Darmstadt, No. A3701.2500PE) 
 
9.4. Solutions of the GMA Embedding Technique 
 
9.4.1. Rising Solution for GMA Embedding Machine 
 
 Preparation of Cacodylate Buffer (0.1 M) 
 
• 16.5 g dimethylarsinic-acid-sodium-salt-trihydrate (Applichem, No. A2140)  
• 6.23 ml 1 N hydrochloric-acid (Applichem, No. A1434) 
• 105 g sucrose (Merck, Darmstadt, No. 1.07687.5000) 
• 1.105 g potassium-chloride-dihydrate (Merck, Darmstadt, No. 2382) 
• 1500 ml aqua dest. 
 
Mix and adjust the pH value to 7.2. 
 
9.4.2. Solution A 
 
• 60 ml 2 hydroxethyl-methacrylate (Merck, Darmstadt, No. 800588) 
• 20 ml methyl-methacrylate (Merck, Darmstadt, No. 800590) 
• 16 ml ethylene-glycol-monobutyl-ether (Merck, Darmstadt, No. 801554) 
• 2 ml polyethylene-glycol (Merck, Darmstadt, No. 817003) 
• 388 mg benzoyl-peroxide (Merck, Darmstadt, No. 801641) 
 
9.4.3. Solution B  
 
• 50 ml solution A (Appendix 9.4.3.) 
• 100 µl N,N-dimethylaniline (Merck, Darmstadt, No. 803060) 
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9.5. Staining Solutions of GMA Sections 
 
9.5.1. Haematoxylin-Eosin-Phloxin Staining 
 
9.5.1.1. HCL-alcohol (1%) 
 
• 10 ml 25% hydrochloric-acid (Applichem, Darmstadt, No. A0658) 
• 700 ml 96% ethanol (SAV Liquid Production, Flintsbach, No. ETO-30000-96-1) 
• 250 ml aqua dest. 
 
9.5.1.2. Stock Solutions  
 
9.5.1.2.1. Eosin Stock Solution 
  
• 1.0 g eosin (Applichem, No. A0822) 
• 1000 ml aqua dest. 
  
9.5.1.2.2. Phloxine Stock Solution 
 
• 1.0 g phloxine B (Merck, Darmstadt, No. 15926) 
• 1000 ml aqua dest. 
 
9.5.1.3. Eosin-Phloxine-Ready to Use-Solution 
 
• 468 ml 96% ethanol (SAV Liquid Production, Flintsbach, No. ETO-30000-96-1) 
• 30 ml eosin stock solution (Appendix 9.5.1.2.1.) 
• 3 ml phloxine stock solution (Appendix 9.5.1.2.2.) 
• 2.4 ml 96% acetic-acid (Merck, Darmstadt, No. 1.00062.2500) 
 
9.5.2. Giemsa Staining 
 
9.5.2.1. Phosphate Buffer 
 
APPENDIX 182 
• 200 ml potassium-dihydrogen-phosphate (Merck, Darmstadt, No. 1.04873.1000) 9,12 
g/l 
• 160 ml disodium-hydrogen-phosphate-dihydrate (Merck, Darmstadt, No. 
1.06580.1000) 
 
Adjust the pH value to 6.7. 
 
9.5.2.2. Giemsa-Ready to Use-Solution 
 
• 200 ml phosphate buffer (Appendix 9.5.2.1.) 
• 14 ml Giemsa stock solution (Merck, Darmstadt, No. 9204) 
 
Adjust the pH value to 6.7. 
  
9.5.2.3. Acetic-acid (0.5%) 
 
• 5 ml acetic-acid (Applichem, Darmstadt, N. A3701,2500PE) 
• 1000 ml aqua dest. 
 
9.5.3. Silver Staining 
 
9.5.3.1. Methenamine Solution (3%) 
 
• 2.16 g methenamine (Merck, Darmstadt, No. 1,04343,0500) 
• 72 ml aqua dest. 
 
9.5.3.2. Borax Solution (2%) 
 
• 0.4 g disodium-tetraborate-decahydrate extra pure (EWG Merck, Darmstadt, No. 
1.06303.1000) 
• 20 ml aqua dest. 
 
9.5.3.3. Silver-nitrate Solution 
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• 5 g silver-nitrate (Merck, Darmstadt, No. 1.01512.0100) 
• 100 ml aqua dest. 
 
9.5.3.4. Gold-chloride Solution 
 
9.5.3.4.1. Gold-chloride Stock Solution 
 
• 1g 99.5% tetrachloroauric(III)acid trihydrate 
• 100ml aqua dest. 
 
9.5.3.4.2. Gold-chloride-Ready to Use-Solution (0.1%) 
 
• 10 ml gold-chloride stock solution (Appendix 9.5.3.4.1.) 
• 90 ml aqua dest. 
 
9.5.3.5. Periodic-acid Solution (0.1%) 
 
• 10 g periodic-acid (Roth, Karlsruhe, No. 32572) 
• 1000 ml aqua dest. 
 
9.5.3.6. Sodium-thiosulphate Solution (2%) 
 
• 20 g sodium-thiosulphate (Merck, Darmstadt, No. 6512.2500) 
• 1000 ml aqua dest. 
 
9.6. Solutions for Transmission Electron Microscopy 
 
9.6.1. Solutions for Resin Embedding  
 
9.6.1.1. Sørensen’s Phosphate Buffer  
 
9.6.1.1.1. Solution A 
 
• 2.269 g potassium-hydrogen-phosphate (KH2PO4) (NeoLab Art., No. 2830)  
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• 250 ml aqua dest. 
 
9.6.1.1.2. Solution B 
 
• 11.876 g sodium-hydrogen-phosphate-dihydrate (Na2HPO4.2H2O) (NeoLab, 
Heidelberg, Art., No. 4820) 
• 1000 ml aqua dest. 
 
Mix 80.8 ml solution B and 19.2 ml solution A and adjust the pH value to 7.4. 
 
9.6.1.2. Glutaraldehyde (6.25%) 
 
• 25 ml 25 % glutaraldehyde solution in water (Serva, Heidelberg, No. 23115) 
• 100 ml Sørensen’s phosphate buffer (Appendix 9.6.1.1.) 
 
9.6.1.3. Merthiolate Solution (1%) 
 
• 0.1 g ethylmercurithiosalicylic-acid-sodium salt (Serva, Heidelberg, No. 11375) 
• 10 ml aqua dest. 
 
9.6.1.4. Rinse Solution  
 
• 100 ml Sørensen’s phosphate buffer (Appendix 9.6.1.1.) 
• 6.84 g D(+)-sucrose (Roth, Kalsruhe, No. 4621.1) 
• 1 or 2 drops of 1% merthiolate solution (Appendix 9.6.1.3.) 
 
9.6.1.5. Osmium(VIII)oxide (OsO4) (1%) 
 
9.6.1.5.1. Osmium(VIII)oxide (2%) 
 
• 1 g ampule osmium(VIII)oxide 99.9% (Chempur, Karlsruhe, Art. - No. 006051) 
• 50 ml Aqua dest. 
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OsO4 for Fixation-Ready to Use-Solution (1%) 
 
• 0.45 g D(+)-sucrose (Roth, Kalsruhe, No. 4621.1) 
• 1 ml aqua dest. 
• 2 ml 0.1 N HCl (Roth, Kalsruhe, No. K0241.1) 
• 2 ml veronal buffer (Morphisto, Frankfurt, No. 12321) 
• 5 ml 2% osmium(VIII)oxide (Appendix 9.6.1.5.1.) 
 
9.6.1.6. Epon Glycidyl Ether Mix 
 
9.6.1.6.1. Solution A 
 
• 38.32 g glycidyl-ether 100 (Serva, Heidelberg, No. 2104502) 
• 45.30 g dodecenylsuccinic-acid-anhydride (DDSA) (Serva, Heidelberg, No.2075501) 
 
9.6.1.6.2. Solution B 
 
• 61.80 g glycidyl-ether 100 (Serva, Heidelberg, No. 2104502) 
• 56.34 g methylanic-anhydride (MNA) (Serva, Heidelberg, No. 2945201) 
 
Glycidyl Ether Mix-Ready to Use-Solution 
 
• 41.20 g solution A (Appendix 9.6.1.6.1.) 
• 75.00 g solution B (Appendix 9.6.1.6.2.) 
• 1.5 ml 2,4,6-tris(dimethylaminomethyl)phenol (DMP 30) (Serva, Heidelberg, 
 No. 3967501) 
 
9.6.2. Staining Solutions of Semi-thin Sections 
 
9.6.2.1. Toluidine Blue 
 
• 0.8 g toluidine blue O (Roth, Karlsruhe, No. 0300.2)  
• 1 g di sodium-tetraborate (Merck, Darmstadt, No. 6306) 
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• 100 ml aqua dest.  
 
9.6.2.2. Safranin 
• 1 g safranin O (Chroma-Waldeck GmbH, Münster, No. 1B463) 
• 1 g di-sodium-tetraborate (Merck, Darmstadt, No. 6306) 
• 40 g D(+)-sucrose (Neolab, Heidelberg, No. 5015) 
• 2-3 drops formalin 
• 100 ml aqua dest.   
 
9.6.3. Contrasting of the Ultra-thin Sections 
 
9.6.3.1. Uranyl-acetate (2%) 
 
• 1 g uranyl-acetate (Agar Scientific, Stansted, England, No. R1260A) 
• 50 ml aqua dest. 
 
9.6.3.2. Lead-citrate 
 
9.6.3.2.1. Solution A 
 
• 1.655 g lead-nitrate (Merck, Darmstadt, No. 7398) 
• 5 ml aqua dest. 
 
9.6.3.2.2. Solution B 
 
• 2.94 g sodium-citrate (Merck, Darmstadt, No. 6448) 
• 10 ml aqua dest. 
 
9.6.3.2.3. Solution C 
 
• 1 g NaOH-pellets (Neolab, Heidelberg, No. 1087) 
• 25 ml aqua dest. 
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Lead-citrate-Ready to Use-Solution 
 
• 6 ml solution B 
• 4 ml solution A (drop wise admitted) 
• 8 ml solution C  
 
Solve the mixed solution in 32 ml aqua dest. and then filtrate with a hard filter paper (Neolab, 
Heidelberg, No. H602) 
 
9.7. Solutions for Immunohistochemistry  
 
9.7.1. 0.5 M TBS (Tris Buffer Saline) pH 7.6 
 
• 60.5 g tris (Applichem, Darmstadt, No. A2264.1000) 
• 90 g NaCl (Applichem, Darmstadt, No. A1371.1000) 
• 2 N HCl (Roth, Karlsruhe, No. X897.2)  
• 700 ml aqua dest.  
 
Solve the tris-hydroxymethyl-aminomethane in aqua dest. and adjust the pH value to 7.6. Fill 
up with the aqua dest. to 1000 ml and control the pH-value again. For the use solution, dilute 
with aqua dest. to a concentration of 1:10. 
 
9.7.2. Tris/EDTA Buffer pH 9.0 for Microwave 
 
• 2 ml 0.5M EDTA (Applichem, Darmstadt, No. A5097) 
• 1.21 g tris (Applichem, Darmstadt, No. A2264.1000) 
 
Adjust pH value to 9.0. Solve 0.5 M EDTA solution in 1000 ml aqua dest. and add 1,21 g tris.  
 
9.7.3. Stock Solution A 
 
• 21.01 g citric-acid-monohydrate (Merck, Darmstadt, No. 1.00244.1000) 
• 1000 ml aqua dest. 
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9.7.4. Stock Solution B 
 
• 29.41 g sodium-citrate (Merck, Darmstadt, 6448.1000) 
• 1000 ml aqua dest. 
 
9.7.5. 10mM Citrate Buffer with Tween 20 
 
• 9 ml stock solution A (Appendix 9.7.3.) 
• 41 ml stock solution B (Appendix 9.7.4.) 
• 0.5 ml tween 20 
• 450 ml aqua dest. 
 
9.7.6. Hydrogen-peroxide (1%)  
 
• 6 ml 30 % hydrogen-peroxide solution (Applichem, Darmstadt, No. A1134.1000) 
• 174 ml aqua dest. 
 
9.7.7. DAB-Ready to Use-Solution 
 
• 10 mg 3,3'-diaminobenzidine-tetrahydrochloride-dihydrate (DAB) (tablets) (KEM-
EN-TEC Dig. Toostrup, No. 4170) 
• 10 ml aqua dest. (solve in dark place) 
 
Before use; add 1 µl 30% hydrogen-peroxide (Applichem, Darmstadt, No. A1134.1000) to 1 
ml DAB-solution.   
 
9.7.8. Avidin-biotin Complex (ABC)  
 
ABC (Vector Lab. Burlingame, PK 6100) 
 
• 5 µl reagent A 
• 5 µl reagent B 
• 500 µl TBS pH 7.6 (Appendix 9.7.1.) 
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Mix 30 min before use. 
 
9.7.9. Sodium-ethylate Solution  
 
• 2 g sodium-hydroxide pellets (Roth, Karlsruhe, No. 6771.1)  
• 100 ml 100 % ethanol (Roth, Karlsruhe, No. 9065.3) 
 
Solve the sodium-hydroxide pellets in the ethanol and incubate the solution for 3 days. The 
solution can be used after it turns brown.  
 
9.8. The Solutions for In Situ Hybridization 
 
9.8.1. Diethylpyrocarbonate (DEPC)-water 
 
• 9.1 ml DEPC (Applichem, Darmstadt, No. A0881) 
• 1000 ml aqua dest. (0.1% DEPC) 
 
Mix, let stand overnight, autoclave at 121˚C 
 
9.8.2. SSC (Saline Sodium Citrate) (20 x)  
 
• 175.30 g NaCl (3M) (Appendix 9.8.18.1.) 
• 88.20 g Na-citrate-dihydrate (0,3 M) (Applichem, Darmstadt, No. A3597) 
 
Solve in DEPC-water, adjust pH value to 7.0 (with 0.1 N HCl), add 1000 ml DEPC-water and 
autoclave. 
 
9.8.3. SSC (2x) 
 
• 100 ml SSC (20x) (Appendix 9.8.2.) 
• 900 ml aqua dest. 
 
Adjust pH value to 7 (with 0.1 N HCl), add 1000 ml DEPC-water and autoclave. 
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9.8.4. SSC (1x) 
 
• 50 ml SSC (20x) (Appendix 9.8.2.) 
• 950 ml aqua dest. 
 
Adjust pH value to 7.0 (with 0.1 N HCl), add 1000 ml DEPC-water and autoclave. 
 
9.8.5. SSC (0.1x) 
 
• 5 ml SSC (20x) (Appendix 9.8.2.) 
• 995 ml aqua dest. 
 
Adjust pH value to 7.0 (with 0.1 N HCl), add 1000 ml DEPC-water and autoclave. 
 
9.8.6. Herring sperm DNA 
 
9.8.6.1. Stock Solution  
 
• 250 mg herring sperm DNA (Invitrogen, Karlsruhe, No. 15634-017) 
• 12.5 ml TE-buffer (1x) (Appendix 9.8.17.) pH 8.0   
 
Heat to 50˚C, solve and freeze. 
 
9.8.6.2. Ready to Use-Solution (50 µg/ml) 
 
• 5 µl stock solution (Appendix 9.8.6.1.) 
• 995 µl TE-buffer (1x) (Appendix 9.8.17.) 
 
9.8.7. Deionized Formamide 
 
• 50 ml formamide (Applichem, Darmstadt, No. A3606) 
• 5 g mixed bed resin (BioRad, Munich, No. 1437424) 
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Mix for 30 min, filter 2 times and freeze at -20˚C. 
 
9.8.8. Dextran-sulphate 50% 
 
• 10 g dextran-sulphate (Applichem, Darmstadt, No. A4970) 
• 20 ml DEPC-water (Appendix 9.8.1.) 
 
Keep in the fridge. 
 
9.8.9. Proteinase K Buffer 
 
• 6 ml 0.5 M tris buffer pH 7.6 (Appendix 9.8.20.2.) 
• 10 µl proteinase K (Applichem, Darmstadt, No. A4392) 
• 54 ml aqua dest. 
 
9.8.10. Solution I 
 
For 1 ml: 
 
• 50 µl herring sperm-DNA-Ready to use-solution (Appendix 9.8.6.2.) 
• 70 µl formamid (Appendix 9.8.7.) 
• 20 µl MTB187 (Eurofins, No. 018117652) 
• 20 µl MTB770 (Eurofins, No. 018247388) 
• 20 µl MTB226 (Eurofins, No. 018247389) 
 
Mix solution and incubate at 95 ˚C in water bathtub, then on ice. 
 
9.8.11. Solution II 
 
• 430 µl formamide (Appendix 9.8.7.) 
• 200 µl SSC (20x) (Appendix 9.8.2.) 
• 20 µl Denhardt’s solution (Eppendorf, No. U103479K) 
• 100 µl dextran-sulphate (Appendix 9.8.8.) 
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• 110 µl aqua dest. 
 
Mix solutions and keep in ice. 
 
9.8.12. Buffer I 
 
9.8.12.1. Buffer I (2x) 
 
• 200 ml tris HCl (1 M), pH 7.5 (Appendix 9.8.20.1)  
• 60 ml NaCl (5 M) (Appendix 9.8.18.2.) 
 
Add 1000 ml DEPC-water (Appendix 9.8.1.) and autoclave. 
 
9.8.12.2. Buffer I (1x) 
 
• 100 ml buffer I (2x) (Appendix 9.8.12.1.) 
• 100 ml aqua dest. 
 
9.8.13. Buffer III pH 9.5 
 
• 15.8 g (100mM) tris-HCl (Applichem, Darmstadt, No. A2267) 
• 5.8 g (100mM) NaCl (Applichem, Darmstadt, No. A2942) 
• 700-800 ml DEPC-water (Appendix 9.8.1) and adjust the pH value to 9.5. 
• 4.75 g (50mM) MgCl2 (Merck, Darmstadt, No. 2382) 
• 1000 ml DEPC-water (Appendix 9.8.1)  
 
9.8.14. Equilibration Buffer 
 
For 1 ml: 
 
• 500 µl buffer I (2x) (Appendix 9.8.12.1.) 
• 50 µl normal goat serum (MP Biomedicals, Eschwege, No. 092939149) 
• 30 µl triton-X 10% (Applichem, Darmstadt, No. A4975) 
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• 500 µl aqua dest. 
 
9.8.15. Anti-digoxigenin Solution  
 
• 1:100 equilibration buffer 60 min 
• 1000 µl equilibration puffer (Appendix 9.8.14.) 
• 10 µl anti-digoxigenin-AP-fab-fragment (Roche, Mannheim, No. 1093274) 
 
9.8.16. NBT-BCIP Solution 
 
• 1000 µl buffer III 
• 4.5 µl nitro-blue-tetrazolium-chloride (NBT) (Roche, Mannheim No.14799527)  
• 3.5 µl 5-bromo-4-chloro-3-indolyl-phosphate, toluidine salt (BCIP) (Roche, 
Mannheim No. 13513022) 
• 2.5 µl levamisole (Appendix 9.8.19.) 
• 9.8.17. TE Buffer pH 8.0 
 
9.8.17.1. TE Buffer (1x) pH 8.0 
 
• 1.58 g (10 mM) tris (Applichem, Darmstadt, No. A2267) 
• 0.372 g (1 mM) EDTA (Applichem, Darmstadt, No. A5097) 
• 1000 ml DEPC-water (Appendix 9.8.1.)  
 
Adjust pH value to 8.0. 
 
9.8.17.2. TE Buffer (10x) pH 8.0 
 
• 15.76 g (100 mM) tris (Applichem, Darmstadt, No. A2267) 
• 3.72 g (10 mM) EDTA (Applichem, Darmstadt, No. A5097) 
• 1000 ml DEPC (Appendix 9.8.1.)  
 
Adjust pH value to 8.0.  
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9.8.18. NaCl Solution 
 
9.8.18.1. 3 M NaCl 
 
• 17.53 g NaCl (Applichem, Darmstadt, No. A2942) 
• 100 ml DEPC-water (Appendix 9.8.1.) 
 
9.8.18.2. 5 M NaCl  
 
• 146.1 g NaCl (Applichem, Darmstadt, No. A2942) 
• 500 ml DEPC-water (Appendix 9.8.1.) 
 
9.8.19. Levamisole 
 
• 96 mg levamisole (Applichem, Darmstadt, No. 4341) 
• 1 ml aqua dest  
 
9.8.20. Tris-HCl Buffer  
 
9.8.20.1. Tris-HCl Buffer (1 M) 
 
• 121.0 g tris (Applichem, Darmstadt, No. A2264) 
• 800 ml DEPC-water (Appendix 9.8.1.) 
 
Adjust pH value to 7.6 using HCl and autoclave. 
 
9.8.20.2. Tris-HCl Buffer (0.5 M) 
 
• 60.5 g tris (Applichem, Darmstadt, No. A2264) 
• 800 ml DEPC-water (Appendix 9.8.1.) 
 
Adjust pH value to 7.6 using HCl and autoclave. 
 
9.8.20.3. Tris-HCl Buffer (10 mM) 
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For 60 ml solution: 
 
• 0.6 ml tris-HCl Buffer (1 M) 
• 59.4 ml DEPC-water (Appendix 9.8.1.) 
 
9.8.21. Citrate Buffer (1 mM) 
 
• 0.1052 g citric-acid-monohydrate (Merck, Darmstadt, No. 100244.1000) 
• 500 ml aqua dest. 
 
9.8.22. Achromopeptidase Solving Solution 
 
• 350 µl achromopeptidase (Sigma, Taufkirchen, No. A3547-100KU) (60 U/ml in the 
end solution) 
 
Solve in 60 ml NaCl-tris HCl Buffer (0.01 M) (Appendix 9.8.22.1.) 
 
9.8.22.1. NaCl-tris HCl Buffer (0.1 M) 
 
• 1 ml NaCl (5 M) (Appendix 9.8.18.2.) 
• 10 ml 0.5 M tris (Appendix 9.8.20.2.)  
Add 489 ml DEPC-water (Appendix 9.1.) and adjust pH value to 8.0. 
 
9.8.23. Lysozyme (10 mg/ml) Solving Solution 
 
For 1 ml: 
 
• 100 µl tris-EDTA buffer (10x) (Appendix 9.8.17.2) 
• 100 µl lysozyme (Sigma, Taufkirchen, No. L1667-1G) (10 mg/ml in the end solution) 
• 800 µl DEPC-water (Appendix 9.8.1.) 
 
9.8.24. Achromopeptidase + Lysozyme Solving Solution 
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• 1.2 ml 0.5 M tris buffer (Appendix 9.8.20.2.) 
• 58.8 ml DEPC (Appendix 9.8.1.) 
• 175 µl achromopeptidase (30 U/ml in the end solution) 
• 600 µl lysozyme (1 mg/ml in the end solution) 
 
9.8.25. HCl Solution (0.01 M) 
 
For 60 ml: 
 
• 0.6 ml HCl  
• 59.4 ml DEPC-water (Appendix 9.8.1.) 
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